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Abstract 
Methanogenic archaea are strictly anaerobic organisms responsible for the 
production of all biologically produced methane making them key players of the 
global carbon cycle. These unusual organisms derive their energy from the 
reduction of one-carbon (C-1) compounds to methane. Among methanogenic 
archaea, Methanosarcina are the most metabolically diverse being able to use 
H2/CO2, acetate, methanol, methylamines and methyl sulfides as substrates for 
methanogenesis. This dissertation presents biochemical and genetic studies on 
pyruvate utilization in Methanosarcina as a substrate for methanogenesis and the 
regulation of methylotrophic methanogenesis in M. acetivorans in an effort to 
further delineate the intrinsic metabolic diversity found in Methanosarcina 
species.   
 
Organic compounds such as fatty acids and sugars are rarely substrates for 
methanogenesis unless they are co-metabolized by syntrophic associations. 
Previously, an M. barkeri mutant that had the capacity to use pyruvate as 
substrate was isolated. Chapter 2 of this dissertation is focused towards 
understanding the molecular basis of pyruvate utilization in these cells. Genetic 
and transcriptomic studies on two cell lines of the mutant strain revealed the 
presence of two mutations in both strains. These changes in genome sequence 
resulted in cells that over-expressed pyruvate ferredoxin oxidoreductase (Por) an 
enzyme responsible for the conversion of pyruvate to acetyl-CoA and lacked 
pyruvate carboxylase activity, the enzyme responsible for synthesis of 
oxaloacetate in the cells. Biochemical and transcriptomic experiments revealed 
that in order to make the central metabolite oxaloacetate this mutant was using 
an alternative reaction catalyzed by phosphoenolpyruvate carboxylase. 
Suprisingly, our results revealed that Por is essential in M. bakeri suggesting this 
enzyme to have an alternative function to pyruvate synthesis in the cells.  
 
Chapter three entails the characterization of the regulatory network that controls 
methylotrophic methanogenesis, the pathway used for growth on methylated 
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compounds like methanol, methylamines and methyl sulfides. Methylated 
compounds enter the methanogenesis pathway at the level of methyl-coenzyme 
M, the synthesis of which is mediated by the substrate specific methyltransferase 
complex MT1 and MT2. Growth on methanol requires the MT1 complex encoded 
by the mtaCB1 operon. Previous work showed that this MT1 complex is among 
the highest differentially regulated genes in Archaea and that its transcription is 
regulated by the methanol specific regulators msrA and msrB. Biochemical and 
transcriptomic data presented in this dissertation revealed that MsrA and MsrB 
are DNA binding proteins that activate the transcription of mtaCB1 by binding to 
its promoter as heterodimers. Transcriptomic data also revealed that MsrB could 
act as both repressor and activator of transcription, since its deletion caused an 
increase in expression of methylamine methyltransferase genes. 
Complementation of msrB deletion strains resulted in restoration of regulation, 
thus confirming the role of msrB in repression of methylamine methyltransferase 
genes. Finally, Chapter 4 of this dissertation is focused towards understating how 
Methanosarcina cells are able to sense and respond to environmental signals in 
order to activate the substrate specific methyltransferase genes. Bioinformatic 
analysis revealed the presence of three putative histidine kinases (MA0863, 
MA4377, MA4377), a response regulator (MA4376) and an msr-like protein 
(MA4375) that due to their genomic localization could be involved in the 
regulation of methyl sulfide methyltransferase (mts) genes. Deletion and 
transcriptomic studies revealed that the three-histidine kinases may be involved 
in the regulation of three methyl sulfide methyltransferases and that the single 
response regulator MA4376 may to be interacting with more than one of these 
histidine kinases in order to regulate mts genes. 
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Chapter 1: Introduction 
1.1 Methane in the Environment  
Methane (CH4) is the second most abundant greenhouse gas emitted in the 
United States (EPA, 2010). This greenhouse gas can be formed by abiotic 
reactions, as in gas flux from the Earth’s crust, or as a result of microbial activity 
(Kietavainen and Purkamo, 2015). Other sources of methane include methane 
hydrates and sedimentary formations (Kietavainen and Purkamo, 2015).  Two 
main types of geological methane have been described. Thermogenic methane, 
which is formed by the decomposition of organic matter at high temperatures and 
pressure and abiotic formation of methane, which is the formation of methane 
from inorganic compounds without the involvement of living organisms 
(Kietavainen and Purkamo, 2015). Among these sources, the most common is 
the digestion of organic matter mediated by anaerobic archaea, which accounted 
for the formation of 164 MMT CO2 eq (million metric tons of CO2 equivalents) in 
2013 (EPA, 2010).  
 
Methane concentration has been increasing at an average rate of 0.5-1% per 
year (EPA, 2010) and atmospheric concentration has increased from 715 (pre-
industrial era) to 1774 ppb (Khosa et al, 2011). Globally, over 60% of methane 
emissions come from anthropogenic sources including agriculture, industry and 
waste management facilities (Allen, 2016). CH4 is also emitted by a number of 
natural sources including wetlands, termites, sediments and volcanoes. Methane 
is one of the main contributors to the global greenhouse effect and although 
methane concentration and lifetime in the atmosphere is lower than that of 
carbon dioxide (CO2), methane is more efficient at trapping radiation. For this 
reason it is believed that the impact of CH4 with regard to climate change is 25 
times greater than CO2 when normalized over a 100-year period (EPA, 2010). 
Thus, numerous efforts have been implemented to reduce CH4 emissions, 
including repurposing CH4 as a renewable energy source. For instance, methane 
represents a renewable energy source given that it can replace fossil fuels in 
heat and power generation. Methane is more efficient and less carbon intensive 
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than other fossil fuels; its energy content is three times greater than that of 
hydrogen. As an example, methane rich biogas (biomethane) produced from 
waste treatment is currently employed to power generators that serve industrial 
facilities contributing to their power grid (Kumar, 2011). In addition, in some rural 
areas biomethanation is used for the disposal of domestic waste; biogas 
generated from this process is utilized in the homes’ heating and cooking 
systems (Kumar, 2011).  
 
Globally, agricultural practices are the number one anthropogenic source of CH4; 
in part because ruminant livestock produce a large amount of methane as part of 
their normal digestive process. In addition, anaerobic decomposition of livestock 
manure produces significant amounts of methane. To reduce CH4 emissions 
from this industry, efforts have been implemented to change the animal’s diet as 
a way to alter the microbial population in the rumen increasing animal 
performance with concomitant reduction of methane emissions. Current efforts 
are also focused in the development of a vaccine against methanogenic archaea 
in the rumen (Martinez-Fernandez et al., 2016, Odongo et al., 2007). 
 
1.2 Phylogeny and Ecology of Methanogenic Archaea 
Essentially all biologically produced CH4 is derived from methanogenic archaea. 
These strictly anaerobic microorganisms produce methane as the main by-
product of their metabolism. Methanogenic archaea are abundant in habitats 
where electron acceptors such as NO3-, SO4- and Fe3+ are limited, including 
gastrointestinal tracks of animals, freshwater sediments and hydrothermal vents 
(Offre et al., 2013). Microbial methanogenesis plays a central role in the global 
carbon cycle, as it is the terminal step in biomass degradation in many anaerobic 
environments. Anaerobic biomass degradation is a process that includes the 
decomposition of complex organic compounds into small organic compounds, as 
well as acetogenesis and methanogenesis (Fig 1.1). Methanogens obtain all of 
their energy from methanogenesis and grow using a limited number of substrates 
including methanol, H2 / CO2, methyl-amines, methyl-sulfides and acetate. Most 
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organic compounds such as sugars and long chain fatty acids are not substrates 
for methanogenic archaea, yet are known to support methanogenesis via 
communities of syntrophic organisms. Although not all methanogens are capable 
of utilizing acetate as a substrate, it is estimated that two-thirds of the total 
methane produced by these organisms is derived from this compound (Ferry, 
2015). 
 
Methanogens are abundant in anoxic habitats; however members of 
Methanocella and Methanosarcina have been found in aerated soils and it has 
been hypothesized that methanogens are universal inhabitants of upland soils 
(Aschenbach et al., 2013). Methanogenic archaea can be found in a wide range 
of salinity, from freshwater to hypersaline; in harsh environments including high-
altitude cold deserts and in an array of temperatures that can vary between 
marine sediments at 2°C to hydrothermal vents at 110°C. An adaptations to this 
wide set of environments is the presence of a thick methanocondroitin layer on 
freshwater members of the genus Methanosarcina that acts as a shield to protect 
the cells from turgor pressure. Methanogens are often outcompeted by sulfate 
reducers; iron reducers and denitrifying bacteria in habitats were electron 
acceptors other than CO2 are present. However, in the environment 
methanogens are responsible for keeping H2 partial pressure low, allowing the 
conversion of volatile fatty acids and alcohol to acetate, CO2 and H2 to be 
thermodynamically favorable (Fig 1.1). Since CO2 is a product of the 
fermentation it is seldom limiting in anaerobic environments, allowing 
methanogens to thrive in these ecosystems.  
 
Phylogenetic placement of methanogens in the archaeal tree and analysis of 
their core enzymes suggests that methanogenesis has an early origin within the 
Euryachaeota and that methanogenesis related genes were lost in the non-
methanogenic euryarchaeal lineages (Borrel et al., 2013). In fact, the first five 
steps of methanogenesis are conserved in some members of the 
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Figure 1.1 Anaerobic food chain for the decomposition of organic matter. 
 
Archaeoglobales, where they are known to be involved in the oxidation of lactate 
to CO2. Currently methanogens are classified in seven orders: 
Methanobacteriales, Methanococcales, Methanopyrales, Methanomicrobiales, 
Methanocellales, Methanomassiliiococcales and Methanosarcinales.  These 
orders differ in their lipid composition, cell envelope structure and motility. 
Methanogens are also classified by the substrate they use for methane 
production: H2/CO2 (hydrogenotrophs), acetate (acetotrophs) and methylated 
compounds (methylotrophs).  
 
Members of Methanopyrales, Methanococcales and Methanobacteriales are 
capable of producing methane from CO2 using H2 or formate (Methanococcales 
and Methanobacteriales) as electron donors. Cell wall of Methanobacteriales’ 
and Methanopyrales’ contain pseudomurein whereas those of the 
Methanococcales’ cell wall is composed of S-layer proteins.  Lipids in these three 
groups include archaeol, caldarchaeol and hydroxyarcaheol. Members of 
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Methanococcales and Methanopyrales are motile by means of flagella, have 
been isolated from marine habitats and have members that are thermophiles or 
hyperthermophiles respectively. Most species of Methanobacteriales are non-
motile with the exception of members of Methanothermus that are motile via 
peritricous flagella. Methanobacteriales are distributed in different habitats 
including freshwater sediments, soil, anaerobic digestors and animal 
gastrointestinal tracts. Some species within the Methanobacteriales have the 
ability to use methanol via H2-dependent methylotrophic methanogenesis. 
Among them is Methanosphaera stadtmanae, an organism that has lost the 
ability to reduce CO2 to methane or oxidize methanol to CO2 although it has kept 
most of the corresponding enzymes involved in both pathways (Borrel et al., 
2013). This observation has led to the hypothesis that specialization for H2-
dependent methylotrophic methanogenesis is an adaptation of the organism to 
the gut environment (Borrel et al., 2013). 
 
Growth by CO2 reduction is also found in Methanomicrobiales and 
Methanocellales, both capable of using H2, formate or alcohol as electron 
donors. Members of the Methanomicrobiales have a diverse morphology that 
includes rods and cocci, have protein or glycoprotein cell walls and cellular lipids 
that include the diether lipid archaeol and the tetraether lipid caldarchaeol. They 
are distributed in numerous anaerobic habitats including marine and freshwater 
sediments, anaerobic digestors, and gastrointestinal tracts. Methanocellales are 
abundant in upland soils including rice paddy fields, from which the first cultivable 
member of this order was isolated (Sakai et al., 2011). They are mesophilic, rod 
shaped and non-motile.  Similar to the Methanocellales, Methanomassiliicoccales 
were first discovered by sequencing of the 16S rRNA and mcrA gene from a 
variety of environmental samples. Members of the order were isolated from 
intestinal tracts of humans, termites and from anaerobic digesters (Lang et al., 
2015). Three Methanomassiliicoccales genomes had been sequenced as of 
2015, and each lacked the genes encoding the C1 pathway for reduction of CO2 
to methyl-CoM, but all have the genes needed for the utilization of other 
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substrates like methanol and methylamines, suggesting a novel strategy for 
energy conservation in this order (Lang et al., 2015).  In addition, culture 
independent techniques have recently allowed the identification of two new 
orders Candidatus Verstraetearchaeota and Candidatus Methanofastidiosales 
(Vanwonterghem et al., 2016, Nobu et al., 2016). Genome sequencing revealed 
these organisms might grow using methylated compounds or acetate, malonate 
or propionate respectively.  
 
Members of the order Methanosarcinales are the most metabolically versatile 
species, able to use methylated compounds, acetate and H2/CO2 as substrates 
for methanogenesis. Contrasting with other hydrogenotrophic methanogens, 
members of Methanosarcinales apparently cannot use formate as an electron 
donor. With the exception of Methanosarcina baltica most members of the 
Methanosarcinales are non-motile cocci, pseudosarcinae or rods (von Klein et 
al., 2002). Most cells have a cell wall made of protein and often a 
heteropolysaccharide external wall composed of a sulfated polymer known as 
methanochondroitin due to its similarty to chondroitin sulfate. Membrane lipids 
contain archaeol, hydroxyarchaeol, and caldarchaeol. Members of this order are 
mesophiles or moderate thermophiles that are present in freshwater and marine 
water sediments, gastrointestinal tracts, and anaerobic digestors. The order is 
divided into two families, Methanosarcinaceae and Methanosaetaceae. Members 
of the latter are represented by only one genus, Methanosaeta that is comprised 
of strains that are specialized acetate utilizers. The strains that are the focus of 
this study, Methanosarcina barkeri Fusaro and Methanosarcina acetivoras C2A, 
are members of the Methanosarcinaceae family. Methanosarcina barkeri, a 
nonhalophilic, mesophilic species, was isolated from a freshwater sample from 
Lago del Fusaro, Italy (Maeder et al., 2006). Among Methanosarcina, M. barkeri 
is the most metabolically diverse being able to use methylated compounds, 
acetate and H2/CO2 as methanogenesis substrates. M. acetivorans C2A, a 
marine isolate, is capable of using all substrates with the exception of H2/CO2.  
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1.3 Methanogenesis Substrates and Pathways 
While methanogens are phylogenetically diverse, they can only use a limited 
number of substrates for methanogenesis. Substrates for methane production 
include H2/CO2, acetate and methylated compounds, including the recent 
discovery of growth on methoxylated aromatic compounds (Mayumi et al., 2016). 
Two-thirds of the biologically generated methane results from acetoclastic 
methanogenesis, even though acetate utilization is limited to members of 
Methanosarcina and Methanosaeta genus. The other fraction is mainly derived 
from H2/CO2 and formate. Other substrates that have been reported to support 
growth of methanogens include pyruvate (Bock et al., 1994) and carbon 
monoxide. Methanogenesis from acetate, CO2 and methylated compounds 
proceeds via the following pathways: the CO2 reduction pathway, in which CO2 is 
reduced using H2 or an alternative compound as an electron donor; the 
methylotrophic pathway, which involves the disproportionation of methylated 
compounds into CO2 and CH4, the methyl respiration pathway in which the 
methyl group of methylated compounds is reduced to CH4 and the aceticlastic 
pathway, wherein the methyl group of acetate is reduced to methane using 
electrons derived from oxidation of its carbonyl group.  
 
1.3.1 The CO2 reduction pathway   
In hydrogenotrophic methanogenesis, CO2 is first reduced to a formyl group that 
is covalently attached to methanofuran (MF), in a reaction catalyzed by formyl-
MF dehydrogenase (Fmd) (Fig 1.2). The formyl group is then transferred to the 
carrier tetrahydromethanopterin (H4MPT) and is dehydrated to the methenyl form 
by methenyl-H4MPT cyclohydrolase (Mch). The methenyl group undergoes a 
series of reductions first to form a methylene group (methylene-H4MPT 
dehydrogenase, Mtd) and finally a methyl group (methylene-H4MPT reductase, 
Mer). The methyl group is then transferred to a third carrier, the sulfhydryl 
containing coenzyme M, by methyl-H4MPT methyltransferase (Mtr). This is an 
exergonic reaction that allows the export of Na+ across the membrane, resulting 
in the creation of an electrochemical gradient. The methyl group is finally reduced 
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to CH4 by methyl-S-CoM reductase (Mcr) using coenzyme B and generating the 
heterodisulfide CoM-S-S-CoB. This heterodisulfide is reduced to regenerate free 
thiols by the complex heterodisulfide reductase (Hdr). To perform this reaction 
the cells employ an electron bifurcation system, in which two pair of electrons 
enter the methanogenic pathway in a complex formed by Hdr and Fmd. Hdr uses 
one pair of electrons in the exergonic reduction of CoM-S-S-CoB to regenerate 
CoM-SH and SH-CoB (Costa and Leigh, 2014). The second pair of electrons is 
used in the endergonic reaction catalyzed by Fmd, in the reduction of CO2 to 
formyl-MF. By coupling the last and first steps of methanogenesis the electron 
bifurcating system creates a cyclic pathway called the Wolfe cycle (Thauer, 
2012).  
 
The cyclic nature of the hydrogenotrophic pathway may explain the limited 
amount of carbon substrates that hydrogenotrophic methanogens can use. 
However, several studies have shown that hydrogenotrophic methanogens 
expand their metabolic diversity by the broad utilization of electron donors other 
than H2. The use of formate and secondary alcohols as electron donors has been 
documented for members of the Methanobacteriales and Methanococcales. The 
use of formate requires the oxidation of formate to CO2 using an Hdr associated 
F420 formate dehydrogenase (Costa and Leigh, 2014). An anaplerotic input of 
electrons is required in the CO2 reduction step of the pathway. These electrons 
are provided by a membrane bound hydrogenase that uses H2 to reduce 
ferredoxin (Costa and Leigh, 2014). Recently it was shown that CO serves as an 
electron donor by means of acetyl-CoA synthase/carbon monoxide 
dehydrogenase system (Costa and Leigh, 2014). Finally, in the same study it 
was shown that in Methanococcus maripaludis overexpression of 
glyceraldehyde-3-phosphate: ferredoxin oxidoreductase acts as an alternate way 
of providing the anaplerotic electrons required for hydrogenotrophic growth.   
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1.3.2 Methylotrophic methanogenesis 
During methylotrophic methanogenesis, the methyl group of the C1 compound is 
transferred to a substrate-specific methyltransferase that subsequently transfers 
the methyl group to a cognate corrinoid protein. These two proteins together 
constitute the methyltransferase system 1 (MT1). The methyl group is then 
transfered to CoM by the methyltransferase system 2 (MT2)  (Fig 1.2). As in 
hydrogenotrophic methanogenesis, methyl-CoM is reduced to CH4, generating 
the CoM-S-S-CoB heterodisulfide. The electrons needed for regeneration of the 
thiol groups are derived by the oxidation of the methyl group to CO2, running the 
hydrogenotrophic pathway in reverse. The activation and transfer of each 
methylated compound requires a unique and substrate-specific set of 
methyltransferases.  
 
In contrast to hydrogenotrophic methanogens, methylotrophic methanogens do 
not rely in electron bifurcation. Heterodisulfide reduction in these organisms 
occurs by a membrane bound complex that allows the formation of an 
electrochemical gradient. Within methylotrophic methanogens members of the 
Methanomassiliicoccales represent a unique example, because even though 
they possess all the methanol-methyltranfersase genes, they lack all the genes 
required for the reduction of CO2 to the methyl level.  Instead, members of this 
genus like Candidatus Methanoplasma termitum have been shown to perform H2 
dependent reduction of methanol or methylamines (Lang et al., 2015). In 
addition, it has been hypothesized that Candidatus Methanoplasma termitum has 
a Hdr protein that has a dual function, working in electron bifurcation and as a 
terminal acceptor in redox processes in the cell.  
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Figure 1.2 Pathways for hydrogenotrophic (blue lines) and methylotrophic methanogenesis 
(orange lines).  Pathways share the reduction of methyl-SCoM and CoB-S-S-CoM. Abbreviations: 
Fmd, formyl-methanofuran dehydrogenase; FMR, methanofuran; H4MPT, 
tetrahydromethanopterin; Ftr, formyl-H4MPT formyltransferase; Mch, methenyl-H4MPT 
cyclohydrolase; Mtd, methylene-H4MPT dehydrogenase; Mer, methylene-H4MPT reductase; Mtr, 
methyl- H4MPT: CoM methyltransferase; CoB-S-S-CoM, coenzyme M-coenzyme B 
heterodisulfide; Mcr, methyl-S-CoM reductase; Hdr, heterodisulfide reductase; MP, 
methanophenezine; Fd, ferredoxin; F420, factor F420; Ech, energy conserving hydrogenase; Vht, 
methanophenezine dependent hydrogenase; Frh, F420 dependent hydrogenase. 
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1.3.3 The methyl respiration pathway 
As in methylotrophic methanogenesis, the methyl group of methylated 
compounds enters the methanogenesis pathway through methyl-CoM (Fig 1.3). 
However, in this pathway methylated compounds are not disproportionated to 
methane and CO2, but are converted directly into CH4 using electrons from H2. 
This pathway is found in M. barkeri.  
 
                
Figure 1.3 Methyl respiration pathway Abbreviations: CoM methyltransferase; CoB-S-S-CoM, 
coenzyme M-coenzyme B heterodisulfide; Mcr, methyl-S-CoM reductase; Hdr, heterodisulfide 
reductase; MP, methanophenezine; Vht, methanophenezine dependent hydrogenase. 
 
 
1.3.4 Acetoclastic methanogenesis 
Growth on acetate as a methanogenesis substrate is limited to members of the 
Methanosarcina or Methanosaeta genus. The first step of the pathway is the 
activation of acetate to acetyl-CoA. In Methanosarcina this step is done by the 
acetate kinase and phosphotransacetylase (Ack/Pta) system, using 1 ATP in the 
process (Fig 1.4). Methanosaeta uses the high affinity adenosine 
monophosphate (AMP) forming acetyl-CoA synthase. Once activated the acetyl 
group of acetyl-CoA is subsequently cleaved by the carbon monoxide 
dehydrogenase/acetyl-CoA synthase complex (CODH/ACS) into carbon 
monoxide and methyl-H4MPT. Carbon monoxide is oxidized to CO2 by CODH, 
providing the electrons needed for reduction of the methyl group to CH4. 
Electrons required for the regeneration of the coenzymes are derived in M. 
barkeri Fusaro from the reduced ferredoxin generated by the energy conserving 
CH3 SCoM
CH4
CoB-SHMP
MPH2
Hdr
CoB-S-S-CoM
H2
McrVht
CH3OH
CoM-SH
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hydrogenase (Ech) (Fig 1.4).  Methanosarcina acetivorans lacks hydrogenase 
genes; in this organism the electrons are derived from Rnf complex.  
 
1.3.5 Non-traditional substrates 
Carbon monoxide is not a common substrate for methanogenesis. However, it 
has been shown that M. barkeri and Methanothermobacter thermautotrophicus 
can use CO for growth (Daniels L, 1977). These strains are able to grow by 
disproportionation of 4 mol CO into 3 mol CO2 and 1 mol CH4 (Equation 1.1); 
producing large amounts of H2 in the process. The CODH complex catalyzes 
conversion of CO to CO2. H2 is formed by a hydrognease that oxidizes the 
reduced ferredoxin produced by CODH. H2 is then used to reduce CO2 to CH4. 
Use of CO by M. acetivorans proceeds by a different route that results in the 
formation of CH4, formate and acetate (Rother and Metcalf, 2004). This pathway 
requires the Ack/Pta system for the formation of acetate and generation of ATP 
via substrate level phosphorylation. Thus, M. acetivorans is an organism that is 
able to use the Ack/Pta pathway to growth either acetogenically or 
acetotrophically. 
 
Recently, the methoxydotrophic mode of methanogenesis was proposed 
(Mayumi et al., 2016). This pathway is proposed to couple o-demethylation, CO2 
reduction and acetyl-CoA metabolism to produce methane from methoxylated 
aromatic compounds (Mayumi et al., 2016). Pyruvate has also been shown to 
support methanogenic growth in M. barkeri Fusaro (Bock et al., 1994). Growth on 
pyruvate first requires the conversion of pyruvate into acetyl-CoA catalyzed by 
the anabolic enzyme pyruvate ferredoxin oxidoreductase (Por), generating CO2 in 
the process (Fig 1.4). Acetyl-CoA enters the acetoclastic methanogenesis 
pathway where the acetyl group is  subsequently reduced to CH4, generating 
1.25 mol CH4 and 1.75 mol CO2 for every mol of pyruvate. A portion of this thesis 
is focused on further characterizing pyruvate growth in this strain with the 
ultimate goal to understand pyruvate metabolism in the cells.  
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Figure 1.4 Pathways for acetoclastic methanogenesis (red) and pyruvate-derived 
methanogenesis (purple) in M. barkeri Fusaro. Acetate is split into a methyl group and an enzyme 
bound carbonyl group that is oxidized into CO2 by Codh/Acs, carbon monoxide dehydrogenase / 
acetyl-CoA synthase. Pyruvate is decarboxylated by Por, pyruvate ferredoxin oxidoreductase, 
into acetyl-CoA. Pathways share the enzymes from the oxidation of CO and reduction of CH3-
H4MPT to CH4. Abbreviations: Ack, acetate kinase; Pta, phosphotransacetylase.  
 
 
 
1.4 Anabolic Metabolism in Methanogens 
The majority of methanogens are autotrophs. Therefore methanogens need to 
use central metabolic pathways and anaplerotic reactions for the synthesis of 
precursors for macromolecular biosynthesis.  In this section I will discuss the 
synthesis of two central precursors for biosynthesis; acetyl-CoA and pyruvate, 
and the link between anabolic and catabolic reactions in methanogenic archaea.  
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1.4.1 Autotrophic acetyl-CoA biosynthesis 
Acetate is a key intermediate in the metabolism of methanogens, contributing 
60% of the cell carbon formed during heterotrophic growth of M. barkeri on 
methanol, acetate or H2/CO2 (Weimer and Zeikus, 1979).  Acetate serves as 
precursor for the synthesis of pyruvate and amino acids including alanine, 
aspartate and glutamate and it is the major product of autotrophic CO2 fixation 
(Weimer and Zeikus, 1979). Several pathways for CO2 fixation have been 
described in Archaea, all of which have in common the synthesis of acetyl-CoA 
from CO2 (Reviewed in (Berg et al., 2010)).  
 
Autotrophic methanogens assimilate CO2 using the reductive acetyl-CoA (Wood-
Ljungdahl) pathway. This is a non-cyclic pathway that results in the fixation of two 
molecules of CO2 into acetyl-CoA (Fig 1.5). One molecule of CO2 is reduced to 
the formyl level and bound to the carrier formyl-methanofuran; this group is 
subsequently reduced to a methyl group bound to H4MPT using the enzymes of 
the CO2 reduction pathway. The second CO2 molecule is reduced to CO and 
remains bound to the CODH/ACS complex. CODH/ACS accepts the methyl 
group bound to the H4MPT carrier and combines it with CO to ultimately form and 
release acetyl-CoA.  
 
1.4.2 Pyruvate metabolism in Methanosarcina spp. 
Pyruvate plays a central role in biosynthetic and catabolic reactions of all three 
domains of life. In Methanosarcina spp. it is a precursor for the synthesis of 
alanine and tricarboxylic acid cycle (TCA) intermediates including oxaloacetate 
and α-ketoglutarate. The TCA cycle provides intermediates for the synthesis of 
amino acids and tetrapyrroles. In most organisms pyruvate is derived from 
glycolysis via pyruvate kinase. Methanogens do not have the ability to grow on 
complex compounds, therefore they are required to synthesize pyruvate from 
acetyl-CoA using the enzyme pyruvate ferredoxin oxidoreductase (Por). 
Pyruvate dehydrogenase and pyruvate formate lyase are absent in methanogens 
suggesting that Por provides the only mechanism for pyruvate/acetyl-CoA 
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conversion in this group of organisms. However, in most anaerobic 
microorganisms Por catalyzes the oxidative decarboxylation of pyruvate into 
acetyl-CoA and CO2. In anaerobic acetogenic bacteria it acts as a link between 
glycolysis and the Wood-Ljungdahl pathway. But in Methanosarcina Por 
catalyzes the reverse reaction in order to replenish pyruvate in the cells and 
serve as a link between reactions from the Wood-Ljungdahl pathway and the 
incomplete oxidative branch of the TCA cycle (Fig 1.5). Por from M. barkeri is a 
heterotetramer, oxygen sensitive and is able to catalyze the oxidation of α-
ketobutyrate (Bock et al., 1997).  As will be shown in Chapter 2 of this thesis, Por 
is essential for the growth of M. barkeri Fusaro since, rescue with pyruvate could 
not be achieved. This result suggests an additional function of Por in the cells 
other than replenishing pyruvate/acetyl-CoA.  
 
In addition to pyruvate, oxaloacetate is an essential physiological component of 
methanogens (Mukhopadhyay et al., 2001). Methanogenic archaea have two 
enzymes capable of catalyzing the synthesis of oxaloacetate; pyruvate 
carboxylase (Pyc) and phosphoenolpyruvate carboxylase (Ppc).  Pyc is 
ubiquitous in all methanogens however, members from the Methanosarcinales 
and Methanothermobacter thermautotrophicus also posses phosphoenolpyruvate 
carboxylase  (Fig 1.5). The pyruvate carboxylase operon from M. barkeri Fusaro 
has a unique arrangement that encodes the two subunits of the biotin-dependent 
enzyme and its putative biotinylating enzyme (Bpl). This biotinylating enzyme 
gene is homologous to the bpl gene present in E. coli, which encodes a 
bifunctional protein that also acts as a repressor of the biotin operon (BirA) and 
Bpl subunit genes. This gene is homologous to the bpl gene present in E. coli, 
which is bifunctional with a repressor of the biotin operon (BirA) and Bpl subunits. 
Ppc activity is absent in M. barkeri extracts (Weimer and Zeikus, 1979). 
However, in Chapter 2 we show that Pyc mutants are viable without 
supplementation of oxaloacetate. This finding suggests that Ppc is expressed 
and is able to replenish oxaloacetate in the cells. Finally, M. barkeri also encodes 
an operon for pyruvate phosphate dikinase, an ATP-dependent enzyme 
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responsible for converting pyruvate into phosphoenolpyurvate (PEP), thus 
providing the PEP necessary for the Ppc activity.  
 
1.4.3 Other biosynthetic reactions  
Amino acid biosynthesis in methanogens resembles the pathways found in 
Bacteria and Eukarya. C13 labeling studies in M. barkeri using labeled acetate 
demonstrated that alanine, aspartate and glutamate are derived from pyruvate 
and oxaloacetate. Synthesis of TCA intermediates from OAA provides the 
precursors for more complex amino acids like lysine. Pyruvate acts as a 
precursor for the synthesis of α-ketobutyrate and hence isoleucine. Synthesis of 
pyrolysine, the 22nd genetically encoded amino acid, proceeds from two 
molecules of lysine (Gaston et al., 2011). In methanogens and other organisms 
growing on carbon sources different from hexoses, gluconeogenesis is an 
essential pathway for the synthesis of biosynthetic intermediates and 
polysaccharides. A recent study in M. acetivorans C2A showed that cells 
expressed all the enzymes required for gluconeogenesis and glycogen synthesis 
in a growth phase-dependent manner (Santiago-Martinez et al., 2016). M. 
acetivorans is able to synthesize glycogen in conditions where methanol was the 
carbon source. When the carbon source is depleted, cells are able to run the 
pathway in reverse (glycolytic direction) to synthesize acetyl-CoA via Por 
(Santiago-Martinez et al., 2016). Acetyl-CoA is then converted to CH4 providing 
an ATP supply to the cells.  
 
1.5 Transcription in Archaea 
Chapters 3 and 4 of this thesis focus on the transcriptional regulation of 
methylotrophic methanogenesis thus; in the next sections I will introduce the 
topic of transcription in Archaea. Archaeal gene expression processes have 
features corresponding to bacteria and eukaryotes. For example, archaea have 
basal transcription machinery that resembles that present in eukaryotes and  
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Figure 1.5 Anabolic reactions in Methanosarcina spp. In the reductive acetyl-CoA pathway 
(green) two molecules of CO2 are used to synthesize acetyl-CoA (abbreviations found on Figure 
1.2 legend). Reactions linked to pyruvate metabolism (pink arrows) provide the precursors for the 
synthesis of tricarboxilic acid cycle intermediates. Abbreviations: Cdh/Acs, carbon monoxide 
dehydrogenase / acetyl-CoA synthase; Por, pyruvate ferredoxin oxidoreductase; Pyc, pyruvate 
carboxylase; Ack/Pta, acetate kinase /phosphotransacetylase; Pps, phosphoenolpyruvate 
synthase; Ppc, phosphoenolpyruvate carboxylase. 
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some of their members have genomes that are organized by eukaryotic-like 
histones. However, archaeal gene organization and gene-specific transcription 
regulation are similar to those present in bacteria.  
 
1.5.1 Transcription basal machinery  
The archaeal transcription machinery shares a remarkable similarity to that of 
eukaryotes. The archaeal RNA polymerase is a 12-subunit polymerase that 
shares similar composition, structure and mechanism to the eukaryal RNA 
polymerase II (Ao et al., 2013). The canonical promoter of members of the 
Archaea consists of two well-conserved elements: the TATA box (A-T rich region 
25-27bp upstream of the transcription start site) and the B recognition-element 
(purine rich region) (BRE) (Fig 1.6). Two main transcription factors have been 
described for transcription initiation in Archaea: the TATA box binding protein 
(TBP) and the transcription factor B (TFB) (Isom et al., 2013). Binding of TBP to 
the promoter results in a recruitment cascade that triggers the binding of the TFB 
protein to BRE. The DNA-TBP-TFB complex recruits the transcription factor E 
(TFE) and the RNA polymerase to initiate transcription. TFE interacts with the 
nontemplate strand and aids in stabilizing open complex formation (Ao et al., 
2013). Transcription factor B on the other hand, facilitates the loading of the DNA 
into the RNA polymerase catalytic site (Lassak et al., 2013). A third promoter 
element has been described in Sulfolobus solfataricus, known as the initiator 
element (Inr) (Ao et al., 2013). Inr consensus sequence includes the transcription 
start site and was shown to enhance promoter strength.  
 
1.5.2 Transcription regulation in methanogens  
Two forms of transcription regulation have been described in archaea: one 
mediated by histone-like proteins and chromatin organization, and a second one 
mediated by small bacterial-like transcription factors.  
 
DNA condensation and organization is essential in all three domains of life to 
facilitate processes like transcription, replication and DNA repair. In bacteria, 
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Figure 1.6 Transcription basal machinery and promoter architecture in Archaea (modified from 
Karr, 2014). Abbreviations: RNAP, RNA polymerase; TFB, transcription factor B; BRE, B 
recognition element; TBP, TATA box binding protein; TATA, TATA box; Inr, initiator element; +1, 
transcription start site.  
 
chromosomes are organized into supercoiled domains using nucleoid-associated 
proteins (Peeters et al., 2015). Members of the Archaea, including methanogenic 
archaea, organize their genomes using histone-like proteins similar to the ones 
present in eukaryotes. Histone octamers wrap DNA around them forming 
structures known as nucleosomes. In eukaryotic models it has been shown that 
the position of the nucleosomes in the genome plays an important role in gene 
regulation. Moreover, histone modifications are an important mechanism to 
regulate gene accessibility [Reviewed in (Peeters et al., 2015)]. Several studies 
have shown a link between chromatin organization and transcription regulation in 
archaea. Archaeal histones do not have the sites for posttranslational 
modifications that allow eukaryal histones to have regulatory functions. 
Therefore, it seems unlikely that these proteins regulate transcription initiation in 
Archaea (Pereira et al., 1997). Nevertheless histone binding is decreased in 
regions that are highly transcribed like the mcr gene in Methanothermobacter 
thermautotrophicus, suggesting a relationship between position of nucleosomes 
and levels of gene expression (Pereira et al., 1997). Methanococcus voltae 
represents another example of gene regulation mediated by histone-like proteins. 
Deletion of chromatin gene htsA in this strain resulted in the overexpression of 
genes related to autotrophic reactions in M. voltae, suggesting once more a 
relationship between chromatin organization and gene regulation in Archaea.  
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Figure 1.7 A. Transcription factor acting as an activator. Binding of transcription factors aids in 
the recruitment of TFB and TBP into promoter region, helping in the recruitment of the RNA 
polymerase and to initiate transcription. B. Transcription factor acting as a repressor of 
transcription. Binding of transcription factor to promoter region inhibits binding of TFB and TBP 
preventing recruitment of RNA polymerase and transcription initiation.  
 
In archaea, gene regulation as a physiological response is mediated by small 
bacterial-like transcription factors (TF). Transcription factors are defined by their 
ability to bind a specific DNA sequence and modulate gene expression. They can 
act as repressors binding to a promoter and preventing recruitment of the RNA 
polymerase (Fig 1.7) or as activators aiding in the recruitment and stabilization of 
the polymerase and other transcription factors. Most of archaeal transcription 
regulators are similar to the ones present in bacteria having a helix-turn-helix 
motif, but they differ from bacterial regulators in their sensory domains. Several 
families of regulators have been described for the archaea, three of which have 
been characterized in methanogens.  
 
The transcription regulator MsvR (methanogen specific V4R domain-containing 
regulator) was first characterized in M. thermautotrophicus (Karr, 2010). The N 
terminus domain contains a helix-turn-helix DNA binding domain and the C 
terminus has five-cysteine containing domain VR4 (Fig 1.8). MsvR is a redox 
sensing transcriptional regulator that binds to its own promoter and the promoter 
of the fpaA-rlp-rub operon (involved in oxidative stress response) in this strain. 
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Similar to M. thermautotrophicus MsvR, M. acetivorans MsvR (MaMsvR) binds to 
its own promoter in a redox dependent manner. However, it does not seem to be 
involved in regulation of oxidative stress response genes (Isom et al., 2013). Gel 
filtration experiments revealed that MaMsvR acts as a dimer and mutational 
analysis showed that the five-cysteine residues are important for redox sensing 
and gene regulation. The second regulator described in methanogenic archaea 
 
 
 
Figure 1.8 Protein domains of the three transcriptional regulators described in Methanosarcina. 
Abbreviations: TrmB, sugar metabolism regulator; HTH, helix-turn-helix domain; V4R, predicted 
small molecular binding domain; DUF1724, domain of unknown function present only in archaea.  
 
is Mre, a regulator of Methanosarcina energy-converting metabolism (Reichlen et 
al., 2012). Mre has an amino-terminal DNA binding domain and lacks the 
sensory domain typically found in bacterial transcription factors (Fig 1.8). It was 
shown that mre is highly expressed during growth on acetate and that its gene 
product is able to bind the promoters and activate the transcription of genes 
related to acetate metabolism. In addition, it was shown that Mre could also act 
as a repressor of methylotrophic methanogenesis genes. This dual function of 
archaeal transcription factors as both activators and repressor has been reported 
in other archaeal regulators including methanol specific regulators (Msr) present 
in M. acetivorans and which are further studied in this thesis. 
The methyltransferase genes (refer to Fig 1.2) of Methanosarcina are among the 
most highly regulated genes in all Archaea (Bose and Metcalf, 2008). Studies on 
the factors that allow this stringent regulation led to the identification of the third 
kind of transcription factors in Methanosarcina, the Msr proteins. Six Msr 
regulators have been described by the Metcalf lab (Bose and Metcalf, 2008) all of 
which have a N-terminal helix-turn-helix domain and a domain of unidentified 
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function (DUF1724) found only in Archaea (Fig 1.8). Mrs proteins form a 
heterodimer that binds to the promoter of the methyltransferase gene to either 
repress or activate its transcription (unpublished data). Part of the work in this 
thesis focuses on elucidating the sensory mechanisms that trigger Msr mediated 
regulation.  
 
1.5.3 Two-component systems in methanogenic archaea 
Even though multiple transcription factors have been described in Archaea, the 
mechanisms that trigger the regulatory responses remain understudied. Two 
component (TCS) systems are one way by which microorganisms sense and 
respond to their environments. TCS are typically composed of a sensory histidine 
kinase (HK) and its cognate response regulator (RR) (Fig 1.9). HK proteins are 
phosphorylated at a conserved histidine residue as a result of an environmental 
signal. The phosphoryl group is then transferred to a conserved aspartate 
residue in the cognate response regulator, which in turn regulates gene 
expression in the cell (Najnin et al., 2016).  Multiple sensory domains have been 
identified in HKs including CHASE, PAS and HAMP, enabling HKs to sense and 
respond to a wide variety of stimuli. Characteristic RRs have a receiver domain 
(REC), which is linked to an effector domain that mediates DNA or ligand binding 
(Li et al., 2014).  However, this effector domain is rarely present in RRs 
annotated in Archaea suggesting that archaeal response regulators act in a 
different way than those of bacteria, possibly by modulating the activity of other 
transcriptional regulators (Wuichet et al., 2010).  
 
Only two TCS have been biochemically characterized in Archaea both in 
members of the methanogens. The first TCS characterized is present in 
Methanosaeta hurundinacea, where phosphorylation assays showed that the HK 
Fill was able to autophosphorylate, followed by transfer of the phosphoryl moiety 
to two independent response regulators FilR1 and FilR2 (Li et al., 2014). In 
addition, it was shown that the phosphorylation state of the RRs affected the 
expression of genes related to acetoclastic methanogenesis in M. hurundinacea. 
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Recently a temperature sensitive TCS was characterized in the psychrophilic 
archaeon Methanococcoides burtonii (Najnin et al., 2016). Methanococcoides 
burtonii histidine kinase LtrK has a HisKA, HATPase and the sensory domain  
 
 
 
 
Figure 1.9 Schematic of a two-component system (adapted from Laub, 2007). The extracellular 
domain senses a stimuli that triggers a conformational change in the cytoplasmic region if the HK. 
HK autophosphorylates and transfers the phosphoryl group to the receiver domain of the 
response regulator. The response regulator undergoes a conformational change that allows it to 
do gene regulation.  
 
CHASE, while the response regulator LtrR has both a receiver and an effector 
domain. Kinase and phosphatase activities on wild-type and mutant proteins 
showed the ability of LtrK to autophosphorylate and transfer the phosphoryl 
group to LtrR in a temperature-dependent manner. Two component systems 
remain vastly understudied in the Archaea. Chapter 4 of this thesis focuses on 
the study of three histidine kinases systems and their effect in the control of 
genes related to methylotrophic methanogenesis in M. acetivorans C2A, 
expanding our knowledge of gene regulation in Archaea.  
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Chapter 2: Genetic, Genomic and Transcriptomic Studies of Pyruvate 
Metabolism in Methanosarcina barkeri Fusaro* 
2.1 Abstract  
Pyruvate, a central intermediate in the carbon fixation pathway of methanogenic 
archaea, is rarely used as an energy source by these organisms. The sole 
exception to this rule is a genetically-uncharacterized Methanosarcina barkeri 
mutant capable of using pyruvate as a sole energy and carbon source (Pyr+ 
phenotype). Here, we show that the Pyr+ mutant is able to metabolize pyruvate 
by overexpressing pyruvate ferredoxin oxidoreductase (por) and mutating genes 
involved in central carbon metabolism. Genomic analysis showed that the Pyr+ 
strain has two mutations localized to Mbar_A1588, the biotin protein ligase 
subunit of the pyruvate carboxylase (pyc) operon, and Mbar_A2165, a putative 
transcriptional regulator. Mutants expressing the Mbar_A1588 mutation showed 
no growth defect when compared to WT, yet the strains lacked pyc activity. Re-
creation of the Mbar_A2165 mutation resulted in a two-fold increase of Por 
activity and gene expression, thereby suggesting a role in por transcriptional 
regulation. Further transcriptomic analysis revealed that Pyr+ strains also 
overexpress the gene encoding phosphoenolpyruvate carboxylase, indicating the 
presence of a previously uncharacterized route for synthesizing oxaloacetate in 
M. barkeri an explaining the unimpaired growth in the absence of Pyc. 
Surprisingly, stringent repression of the por operon was lethal, even when the 
media were supplemented with pyruvate and/or casamino acids, suggesting that 
por plays an unidentified essential function in M barkeri.   
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barkeri Fusaro. J. Bacteriol. 197, 3592–3600. Copyright (2015) American Society for Microbiology.	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2.2 Introduction 
A diverse group of strictly anaerobic archaea are responsible for virtually all 
biologically produced methane, making them key players in the global carbon 
cycle (Thauer et al., 2008). These unusual microorganisms grow using a very 
limited number of substrates, obtaining all of their energy from the methanogenic 
process. While most methanogens use only H2/CO2 or formate as growth 
substrates, members of the Methanosarcinales show some metabolic diversity, 
with many species using H2/CO2, various one-carbon (C-1) compounds (e.g. 
methanol, methylamines, and methyl-sulfides) and acetate as growth substrates. 
A few methanogenic species can use longer chain alcohols as energy sources, 
but these molecules are not assimilated. Instead they are oxidized to provide the 
reducing equivalents needed for reduction of CO2 to methane, then excreted 
(Widdel, 1986). Larger organic compounds, such as sugars and fatty acids, are 
almost never substrates for methanogenic archaea, although they are co-
metabolized via syntrophic microbial communities (McInerney et al., 2009). The 
sole exception to this rule is Methanosarcina barkeri, which has been reported to 
grow on pyruvic acid. 
 
Two reports of methanogenic growth on pyruvate appeared in the early 1990s. In 
the first, a pyruvate-utilizing (Pyr+) mutant of M. barkeri Fusaro, was obtained 
after prolonged incubation (8-12 weeks) of methanol-grown cells inoculated into 
a medium containing pyruvate as the sole substrate (Bock et al., 1994). Although 
initial growth was rather slow, repeated passages in pyruvate medium gave rise 
to a strain with a doubling time of ca. 24 hrs. The conclusion that growth on 
pyruvate was enabled by mutation, rather than by adaptation, was based on the 
observation that the long lag needed for switching from methanol to pyruvate was 
lost in this strain. Characterization of the mutant suggested that growth involved 
a pathway in which pyruvate was oxidized to acetyl-CoA and CO2 using the 
enzyme pyruvate:ferredoxin oxidoreductase (Por), with subsequent conversion of 
acetyl-CoA to CO2 and CH4 by the standard aceticlastic pathway for 
methanogenesis (Bock et al., 1994, Bock and Schonheit, 1995). The reducing 
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equivalents produced by pyruvate oxidation were also used to reduce CO2 to 
CH4, probably using H2 as an intermediate. Interestingly, the mutant displayed 
limited non-methanogenic growth when methanogenesis was inhibited by 
addition of bromoethanesulfionic acid (BES); however, growth ceased after ca. 
eight generations (Bock and Schonheit, 1995). Thus, the notion that all 
methanogens are obligate methanogens remains intact. Rajagopal and LeGall 
also reported growth of M. barkeri on pyruvate (Rajagopal and Legall, 1994), but 
using different strains (227, MS and UBS). The phenotype of these strains when 
grown on pyruvate was substantially different than the one observed in the Pyr+ 
mutant of M. barkeri Fusaro. M. barkeri 227, MS and UBS grew substantially 
slower (doubling time ~150 hr vs 25 hr), with lower levels of methane production 
(~0.7 mol CH4/mol pyruvate vs ~1.25 mol CH4/mol pyruvate) and significantly 
lower growth yields (~1.7 g/mol CH4 vs ~14 g/mol CH4), relative to the M. barkeri 
Fusaro mutant. Whether growth of these strains on pyruvate required mutation or 
adaptation was not addressed. 
In addition to serving as an energy source, pyruvate plays a critical role as a 
biosynthetic intermediate for numerous anabolic pathways in methanogens 
(reviewed in (Simpson and Whitman, 1993)). Based on biochemical data, M. 
barkeri synthesizes pyruvate by reductive carboxylation of Ac-CoA mediated by 
Por, which is a freely reversible enzyme (Furdui and Ragsdale, 2000). Pyruvate 
then enters the gluconeogenic pathway via phosphoenolpyruvate (PEP) and the 
branched tricarboxylic cycle via oxaloacetate (OAA). The former is produced via 
the enzyme PEP synthase (Weimer and Zeikus, 1979), whereas the latter is 
produced via the biotin-dependent enzyme pyruvate carboxylase (Pyc, 
(Mukhopadhyay et al., 2001)).  
The genetic basis for the Pyr+ phenotype of the M. barkeri Fusaro mutant has yet 
to be established. In this chapter, I explored the molecular, genetic and 
biochemical bases for growth of the M. barkeri Fusaro Pyr+ mutant on pyruvate. 
The Pyr+ mutant is able to metabolize pyruvate by overexpressing pyruvate 
ferredoxin oxidoreductase (por) and mutating genes involved in central carbon 
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metabolism. Genomic analysis showed that the Pyr+ strain has two mutations 
localized to Mbar_A1588, the biotin protein ligase subunit of the pyruvate 
carboxylase (pyc) operon, and Mbar_A2165, a putative transcriptional regulator. 
Mutants expressing the Mbar_A1588 mutation showed no growth defect when 
compared to WT, yet the strains lacked pyc activity. Re-creation of the 
Mbar_A2165 mutation resulted in a two-fold increase of Por activity and gene 
expression, thereby suggesting a role in por transcriptional regulation. Further 
transcriptomic analysis revealed that Pyr+ strains also overexpress the gene 
encoding phosphoenolpyruvate carboxylase, indicating the presence of a 
previously uncharacterized route for synthesizing oxaloacetate in M. barkeri an 
explaining the unimpaired growth in the absence of Pyc. Surprisingly, stringent 
repression of the por operon was lethal, even when the media were 
supplemented with pyruvate and/or casamino acids, suggesting that por plays an 
unidentified essential function in M barkeri. Collectively, the work presented here 
reveals a complex interaction between anabolic and catabolic pathways involving 
pyruvate metabolism in Methanosarcina barkeri Fusaro.  
2.3 Materials and Methods 
2.3.1 Strains, media and growth conditions 
Methanosarcina strains used in the study are shown in Table 2.1. All 
Methanosarcina strains were grown under strictly anaerobic conditions. 
Derivatives of M. barkeri WWM85 (Guss et al., 2008) were grown in single cell 
morphology at 37°C in high-salt (HS) medium (Metcalf et al., 1997). M. barkeri 
DSM804, Pyr-1 and Pyr-2 were grown in aggregated cell morphology at 37°C in 
imidazole medium as previously described (4). Growth substrates provided were 
125 mM methanol, 120 mM acetate, 100 mM sodium pyruvate, or a mixture of 
methanol (125 mM) and acetate (120 mM); methanol (125 mM) and pyruvate 
(100 mM); methanol (125 mM), acetate (120 mM) plus pyruvate (100 mM); or 
methanol (125 mM) with H2/CO2 (80:20) at 200 kPa over ambient pressure. 
Substrates were sterilized by filtration using a 0.2 µm filter. M. barkeri Pyr-1 was 
independently maintained after transfer to the Metcalf lab in January, 2004, M. 
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barkeri Pyr-2 has been maintained in the Schönheit laboratory since its isolation 
(Bock et al., 1994). M. barkeri DSM804 was received from DSMZ in May 2011. 
Growth on media solidified with 1.5% agar was as described previously (William 
Metcalf, 1996). All plating manipulations were carried out under strictly anaerobic 
conditions in an anaerobic incubator as described (William Metcalf, 1998). 
Puromycin (CalBiochem, San Diego, CA) was added from sterile, anaerobic 
stocks at a final concentration of 2 µg/ml for selection of Methanosarcina strains 
carrying puromycin transacetylase gene (pac). The purine analog 8-aza-2,6-
diaminopurine (Sigma, St. Louis, MO) was added from sterile, anaerobic stocks 
at a final concentration of 20 µg/ml for selection against the hpt gene. 
Tetracycline was added to a final concentration of 100 µg/mL to induce 
expression of genes driven by the pMcrB(tetO1) promoter. Unless otherwise 
stated 10% inoculum was used as a starting culture for pyruvate-utilizing strains 
Table 2.1 Methanosarcina strains used in this study. 
Strain Genotype Source 
Methanosarcina barkeri DSM804 wild type DSMZa 
Methanosarcina barkeri Pyr-1 Pyr+, see Table 2 lab stock 
Methanosarcina barkeri Pyr-2 Pyr+, see Table 2 (Bock et al., 1994) 
Methanosarcina barkeri WWM85 Dhpt::ϕC31int-attP (Guss et al., 2008) 
Methanosarcina barkeri WWM818 Dhpt:: ϕC31int-attP, pycC1 this study 
Methanosarcina barkeri WWM940 Dhpt:: ϕC31int-attP, pycC1, 
Mbar_A2165(G59R) 
this study 
Methanosarcina barkeri WWM941 Dhpt:: ϕC31int-attP, 
pMcrB(tetO1)::porCDAB 
this study 
Methanosarcina barkeri WWM945 Dhpt:: ϕC31int-attP, 
pMcrB(tetO1)::porCDAB,pycC1 
this study 
aLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures.  
2.3.2 Construction and verification of mutant strains 
M. barkeri strains WWM818 and WWM940 were constructed by markerless 
genetic exchange via liposome-mediated transformation (Metcalf et al., 1997, 
Pritchett et al., 2004b). WWM818 was made from WWM85 using pML09. 
WWM940 was made from WWM818 using pML34. WWM941 was made by gene 
replacement (Zhang et al., 2002) after transformation of WWM85 to puromycin 
resistance with pML44. All plasmids were confirmed by DNA sequencing at the 
W. M. Keck Center for Comparative and Functional Genomics, University of 
Illinois. All mutations were verified by PCR and DNA hybridization experiments 
	   33	  
(data not shown). DNA hybridizations were performed using the DIG System 
(Roche, Mannheim, Germany) as recommended using MagnaGraph Nylon 
transfer membranes (Micron Separations Inc, Westborough, MA). Standard 
methods were used to isolate and manipulate plasmid DNA from E. coli strains 
(Ausubel, 1992). For plasmid descriptions and strain genotypes refer to Table 2.2 
and Table 2.1 respectively. 
 
2.3.3 Genome sequencing and mapping analysis 
Genomic DNA from M. barkeri was isolated as described in (Paolo Boccazzi, 
2000) and sequenced on the Illumina HiSeq2000 platform at the W. M. Keck 
Center for Comparative and Functional Genomics, University of Illinois. DNA 
libraries were prepared with Illumina TruSeq DNAseq Sample Prep kit (Illumina, 
San Diego, CA); quantified by qPCR and sequenced for 100 cycles using a 
TruSeq SBS sequencing kit 
 
Table 2.2 Plasmids used in this study. 
Plasmids Description Reference 
pMP44 Ampicillin resistant vector used to mutate cells using the markerless exchange method in Methanosarcina barkeri 
(Pritchett et 
al., 2004a) 
   
pML09 
NotI/SpeI digested 2kb PCR product surrounding the mutation on 
Mbar_A1588 (using primers Mbar_A1588F and Mbar_A1599R) 
cloned into NotI/SpeI digested pMP44 
This study 
   
pML34 
NotI/SpeI digested 2kb PCR product surrounding the mutation on 
Mbar_A2165 (using primers Mbar_A2165F and mbar_A2165 R) 
cloned into pMP44 NotI/SpeI digested pMP44 
This study 
   
pGK050 Kanamycin resistant vector used for testing gene essentiality using PmcrB (tetO1) 
(adam m 
guss, 2008) 
   
pML42 ApaI/NcoI digested 1.5kb por upstream PCR product (using primers por_up_F and por_up_R) cloned into ApaI/NcoI digested pGK50 
 
This study 
 
   
pML44 
NdeI/SpeI digested 1.5kb por downstream PCR product (using 
primers por_gene_F and por_gene_R) cloned into NdeI/SpeI 
digested pML42 
This study 
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(Illumina, San Diego, CA). Reads were trimmed (quality: 0.001, maximum: 100, 
minimum: 99) and mapped to the M. barkeri reference genome of (NC_007333, 
NC_007349) using CLC genomics workbench (CLC Genomics Workbench 7.0.3; 
CLCbio, Aarhus, Denmark). Parameters for mapping were mismatch: 2, 
insertion: 3, deletion: 3, length: 0.8, similarity: 0.95, mapped randomly. The same 
program was used to identify point mutations, insertions, and deletions 
(parameters for single nucleotide polymorphism detection max coverage: 10, 
variant count: 2, variant probability: 90, parameters for insertions-deletions p-
value: 0.0001, mismatch: 3, minimum number of reads: 2). A variant ratio of 0.9-1 
and a frequency of 90-100% were used as selection criteria for the mutations. All 
mutations identified by this method were confirmed by Sanger sequencing of 
PCR products amplified from the appropriate strains. Genome sequencing data 
are deposited in GenBank SRP059541.  
2.3.4 Transcriptomic analyses (RNA-seq) 
Strains were adapted to specific growth substrates for at least 30 generations 
prior to RNA isolation. RNA was extracted from triplicate cultures grown to mid 
exponential phase using a modification of the ZR Fungal/Bacterial RNA MiniPrep 
kit (Zymo Research Irvine, CA). Briefly, 10 mL cultures were quickly chilled in a 
dry ice/ethanol bath to stop RNA synthesis. Cultures were pelleted by 
centrifugation for 10 min at 4 °C, then resuspended in 800 µL TRIzol Reagent 
(ThermoFisher, Grand Island, NY).  Total RNA was extracted following 
manufacturer’s instructions. Ribosomal RNA was depleted using subtractive 
hybridization employing biotinylated rRNA probes as previously described (Fu 
and Metcalf, 2015), except that probes were generated using M. barkeri rDNA 
templates.  
RNA sequencing was performed at the W. M. Keck Center for Comparative and 
Functional Genomics, University of Illinois using strand specific libraries prepared 
with the Illumina ScriptSeq version 2 (Epicentre Biotechnologies, Madison, WI). 
Bar-coded libraries were pooled and sequenced for 101 cycles on a HiSeq2000 
using the TruSeq SBS sequencing kit version 3 (Illumina, San Diego, CA). Reads 
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were analyzed using the CLC genomics platform (version 7.5); reads trimmed 
based on quality (quality: 0.001, ambiguous: 2, discard min:30, max: 100). To 
remove bias caused by remaining stable RNAs, the trimmed sequences were 
mapped to M. barkeri rRNA and tRNA sequences using the following parameters 
similarity: 0.9, length: 0.85, mismatch: 2, insertion: 3, deletion: 3.  The remaining 
reads were used for the RNAseq analysis (similarity: 0.9, length: 0.85, mis:2, 
ind:3, del:3, global alignment, maximum number or reads per read: 10).  
Expression values were calculated as RPKM (Reads Per Kilobase per Million 
reads). Reads were normalized and statistical analysis was performed using the 
empirical analysis of digital gene expression (Robinson and Smyth, 2008). To 
determine differential gene expression, reads from each mutant strain were 
compared against reads of the WT strain when grown in the same substrate. 
Genes showing fold expression changes greater than 2, or less than -2, with P-
values ≤ 0.05 were considered to be differentially expressed. The raw and 
processed RNA-seq data have been deposited in the GSE70370.  
2.3.5 Phenotypic characterization 
Growth rates were determined by monitoring optical density of three or more 
independent cultures at 600 nm using a Bausch and Lomb Spectronic 21. Gene 
essentiality tests were conducted using a modified procedure described 
previously (Buan et al., 2011). Briefly, 10 mL cultures were grown to saturation in 
HS-methanol broth with tetracycline (100 µg/ml), spun down and washed three 
times with plain HS medium, then resuspended in 5 mL HS medium. Aliquots of 
10 µl of a ten-fold dilution series was then spotted onto agar-solidified HS 
methanol media containing some, or all, of the following: tetracycline (100 µg/ml), 
pyruvate (100mM), acetate (100mM), 0.01% casamino acid, 0.01% yeast extract. 
2.3.6 Determination of enzymatic activities 
Pyruvate carboxylase was assayed from cell extracts by coupling the formation 
of oxaloacetate to malate dehydrogenase (Mukhopadhyay et al., 2001). NADH 
oxidation by malate dehydrogenase was measured spectrophotometrically (ε340 = 
6.22 mM-1cm-1) at 37°C. Crude cell extracts were prepared from mid exponential 
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phase cultures (OD600nm 0.5-0.6) by spinning down 10 mL cultures and 
resuspending in 500 µL of lysis buffer (3M KCl, 50mM Tris-HCl (pH8), 5% 
inositol, 5mM MgCl2, 2mM DTT, 0.5 mM phenylmethylsulfonyl fluoride). The 
reaction mixture consisted of 100 mM Tris-HCl (pH8), 4 mM MgCl2, 250mM KCl, 
20 mM KHCO3, 4 mM ATP, 0.2 mM NADH, 2 U malic dehydrogenase (Sigma 
Aldrich, St. Louis, MO) 20mM sodium pyruvate and 20 µL crude cell extract. 
Reactions were started by addition of 20 µL of sodium pyruvate into 1 mL of pre-
warmed assay mixture.  Preparation of cell extract and enzyme assays was 
performed under strictly anaerobic conditions. Phosphoenolpyruvate carboxylase 
activity was also measured by coupling its reaction to malate dehydrogenase. 
Crude cell extracts were prepared as described for pyruvate carboxylase activity. 
The reaction mixture contained 100 mM Tris-HCl (pH8), 4 mM MgCl2, 250 mM 
KCl, 20 mM KHCO3, 4 mM ATP, 0.2 mM NADH, 2 U malic dehydrogenase, 2mM 
phosphoenolpyruvic acid monosodium salt and 20 µL crude cell extracts. 
Reactions were started by addition of phosphoenolpyruvate to 1 mL of pre-
warmed assay mixture. Preparation of cell extracts and assays was performed 
under strictly anaerobic conditions.  
Pyruvate ferredoxin oxidoreductase was assayed by monitoring the CoA- and 
pyruvate-dependent reduction of benzyl viologen (ε578 = 8.65 mM-1cm-1) (Bock et 
al., 1996). Crude cell extracts were prepared as previously described using 50 
mM MOPS (2 mM DTT, pH 7) as lysis buffer.  The assay was performed under 
strictly anaerobic conditions.  The reaction mixture consisted of 2 mM benzyl 
viologen, 0.1 mM CoA, 10 mM sodium pyruvate, and 10 µL crude cell extract in a 
total volume of 1 mL. Reactions were started by addition of CoA to pre-warmed 
assay mixture. Protein concentration for all assays was determined by the 
Bradford method (Coomassie protein reagent, Sigma Aldrich, St. Louis, MO) 
using BSA as a standard. 
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2.4 Results 
2.4.1 Identification of mutations associated to the Pyr+ phenotype 
To identify the mutations responsible for the pyruvate–utilizing phenotype of the 
M. barkeri Fusaro mutant, the genome of two cell lines (Pyr-1 and Pyr-2) that had 
been independently maintained by periodic serial transfer over the course of a 
decade was sequenced. Additionally the genome of the parental strain (DSM804) 
from the DSMZ stock collection, which represents the closest available relative of 
the Pyr+ mutants, was sequenced as well.  
Eighteen differences, including sixteen single nucleotide polymorphisms (SNPs) 
and two relatively large deletions, were observed between the three newly 
sequenced strains and the published genome sequence (Table 2.4). It should be 
noted that the published M. barkeri genome sequence was obtained from a cell 
line that had also been independently maintained by serial passage in a high-salt 
medium to promote growth in the single-celled morphology (Sowers et al., 1993). 
Thus, numerous differences between the four strains were anticipated. 
Comparison of shared sequence differences allowed reconstruction of the most 
likely mutagenic history of the four strains (Fig. 2.1). Thirteen SNPs and both of 
the deletions are shared between Pyr-1, Pyr-2 and DSM804. These mutations 
clearly occurred after separation of the cell lines leading to the genome-
sequenced strain and the remaining three strains. Because the DSM804 is Pyr-, 
these mutations do not by themselves confer the ability to utilize pyruvate. A 
similar argument can be made for a mutation that is found only in Pyr-1, because 
Pyr-1 and Pyr-2 grow equally well on pyruvate. The two remaining mutations 
must have arisen in the ancestor of the Pyr+ lines, suggesting that one or both 
are responsible for the ability to use pyruvate. These putative Pyr+ mutations 
include a frameshift in the pycC gene (designated the pycC1 allele) and a glycine 
to arginine mutation (G59R) in the winged helix-turn-helix motif of a putative 
transcriptional regulator encoded by the Mbar_A2165 locus (Fig. 2.2).  
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Table 2.3 Primers used in this study.  
Primer  Sequence  Added sites 
Primers used for plasmid construction  
Mbar_A1588F AAAAAAAAAAAAAGCGGCCGCATACAGGTTACAC NotI 
Mbar_A1588R AAAAAAAAAAAAAACTAGTTGTCACCAGAAGCACGGC SpeI 
Mbar_A2165F GGCGCGCCGCGGCCGCGACTTTCCTACATTCGGATAG NotI 
Mbar_A2165R GGCGCGCCACTAGTCGCAGCCGAGCTCAGTGCCC SpeI 
por_up_F GGCGCGCCGGGCCCTCTTTTCCCTAATCTGC ApaI 
por_up_R GGCGCGCCCCATGGCAGGTATCCTGTTCTTT NcoI 
por_gene_F GGCGCGCCACTAGTGATTTCTCCGTCTGCCAT SpeI 
por_gene_R GGCGCGCCCATATGTGAAGGAAATCAGAATACACGG NdeI 
   
Primers used for resequencing of mutations  
Mbar_A0055F TTACTGCAAAGAATCTTCC none 
Mbar_A0055R TCCATCACATACAAAAATTTG none 
Mbar_A0540F TTGTGAAAGACTCGTTTATAGC none 
Mbar_A0540R TTTCCTGAAAGCTTATTCTG none 
Mbar_A1111F GCACTAGTTTATATTACAGACC none 
Mbar_A1111R GTTTCTCGCTAAAGATCG none 
Mbar_A1119F GAAGAGGGACTTGGAGAG none 
Mbar_A1119R AGCAAAGGATATTTTAGTTG none 
Mbar_A1236F TGAGTATAAAAACACCTGCCAG none 
Mbar_A1236R GAACTTCTAGAATATAGCTG none 
Mbar_A1407F CATAAAACATCTGGATGATG none 
Mbar_A1407R CACTCATTATTTTTATTCGTTC none 
Mbar_A1501F ATGGAAAAGGAAGTACTGG none 
Mbar_A1501R CTATAGAGACTTCTCTCCGG none 
Mbar_A1588F TGAAGTGCAGAAAGGAGG none 
Mbar_A1588R CTGGGGTTACTCCTACAG none 
Mbar_A1758F GCTGACAAACTCGCCAAG none 
Mbar_A1758R CAATTCTCTCGATGGCTG none 
Mbar_A2165F ATTAATTATGGTAAATATATGCG none 
Mbar_A2165R TATCAGGCGGTTTACAGG none 
Mbar_A3037F GGCAAAGTACCCTTTGCGCAATATCTC none 
Mbar_A3037R AGTCAGGAATTAATGCCAGCTCTGC none 
Mbar_A3249F CCAATGAGTCGTTATCAGG none 
Mbar_A3249R AAGAGCCAGAGAATTCGA none 
Mbar_A3466F TTACCTTCCTGTTGCCTC none 
Mbar_A3466R TCCGAGTCTGTAGCTATACT none 
Mbar_A3480F TTAAAGTGCTCACCGGGA none 
Mbar_A3480R ATAAATCGGATCCTTGAAAGCC none 
Mbar_A3644F GGTAGAGGAGAGATTTAGGA none 
Mbar_A3644R CTGTTATTCAAAGAATATCATG none 
Mbar_A3692F CCACAAGACCTTCCCTACC none 
Mbar_A3692R CATGCTTGCAGTTAGGGC none 
Mbar_A1226F ACTACGGGAGCGCAGAGG none 
Mbar_A1226R CGAACTTACTGCGATTCCTG none 
Mbar_A3656F CAAGAAATTCCTTAACCGATGACCAATG none 
Mbar_A3656R CTGGATCGTGTTTAATTTGATTTAGATGTA none 
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 Table 2.4 DNA sequence polymorphisms in M. barkeri Fusaro genome sequencesa. 
    Presence/absenceb 
Regionb/ 
Locus tag Annotation of altered gene Observed polymorphism
c AA changed Pyr-1 Pyr-2 DSM804 
Mbar_A0055 
(bp 67,649) 
CAAX protease self-immunity T=>C Leu => Ser + + + 
Mbar_A0540 
(bp 642,250) Oligosaccharide amylase A=>G Arg => Gly + + + 
Intergenic 
(bp 1,366,984) NA T=>C NA + + + 
Mbar_A1119 
(bp 1,377,047) UDP-glucose 6-dehydrogenase ΔT Ile => Phe + + + 
Mbar_A1236 
(bp 1,533,125) Hypothetical protein T=>C Thr => Ala + + + 
Mbar_A1407 
(bp 1,736,118) Transposase T=>C Val => Ala + + + 
Intergenic 
(bp 1,857,490) NA Ins:AT NA + + + 
Mbar_A1588 
(bp 1,958,354) 
Biotin-(acetyl-CoA carboxylase) 
ligase ΔA STOP codon + + - 
Mbar_A1758 
(bp 2,157,232) Predicted S-layer protein G=>A Arg => Gln + + + 
Mbar_A2165 
(bp 2,739,641) Predicted transcriptional regulator G=>A Gly => Arg + + - 
Intergenic 
(bp 3,911,323) NA ΔA A + - - 
Mbar_A3249 
(bp 4,169,592) Histidine kinase-like ATPases ΔA Frameshift + + + 
Intergenic 
(bp 4,445,293) NA A=>G NA + + + 
Intergenic 
(bp 4,462,290) NA C=>T NA + + + 
Mbar_A3644 
(bp 4,695,769) Flagellar assembly protein H G=>A Arg => Cys + + + 
Mbar_A3692 
(bp 4,753,372) 
DNA-directed RNA polymerase 
subunit A T=>C Ile => Met + + + 
Mbar_A1226 
(bp 1,514,571-1,514,834) 
Winged helix-turn-helix transcription 
repressor DNA-binding Δ264bp NA + + + 
Mbar_A3656 
(bp 4,713,304-4,715,008) Transposase Δ1705bp NA + + + 
aPutative Pyr+ mutations are shown in bold. 
bNumbering and sequence differences are relative to GenBank Accession number CP000099.1.  
cPresence (+) or absence (-) of the indicated polymorphism is shown. dNA, Not applicable, change is not within a coding sequence. 
	   40	  
2.4.2 Pyruvate carboxylase activity is abolished by the pycC1 mutation 
In M. barkeri, OAA is synthesized by pyruvate carboxylase (Pyc), a two-subunit, 
biotin-dependent enzyme encoded by the pycBAC-slp operon. The α and β 
subunits of Pyc are encoded by pycA and pycB, while pycC encodes a 
bifunctional protein that covalently attaches the essential biotin cofactor to PycB, 
while also serving as a transcriptional repressor for biotin biosynthetic genes 
(Mukhopadhyay et al., 2001). The frameshift mutation identified occurs early in 
the biotin protein-ligase domain (Fig. 2.2). Thus, it is likely that the mutation 
results in a non-functional Pyc. To validate this hypothesis, a pycC1 mutant in the 
strain background derived from the genome-sequenced strain (WWM85) was 
constructed and characterized. As expected, the resulting strain (WWM818) 
lacked Pyc activity; however, growth of the pycC1 mutant was similar to that of its 
isogenic parent (Fig. 2.3). 
The viability of the pycC1 mutant shows that M. barkeri has an alternate pathway 
for OAA biosynthesis. Many organisms, including some methanogenic archaea, 
use the enzyme phosphoenolpyruvate carboxylase (Ppc) for this purpose (Patel 
et al., 2004). Although previous efforts failed to detect Ppc activity in M. barkeri 
cell extracts (Weimer and Zeikus, 1979), a homolog of the archaeal ppc gene is 
found in the M. barkeri genome sequence (locus tag Mbar_A2632). Based on the 
Figure 2.1 Reconstruction of the most likely genetic history of the four sequenced 
Methanosarcina barkeri Fusaro genomes based on shared sequence differences. 
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Figure 2.2 Graphic depiction of the putative Pyr+ mutations. A frameshift mutation, designated 
pycC1, in the Mbar_A1588 locus introduces a STOP codon in the biotin protein ligase domain of 
the PycC protein. The mutated allele retains the potential to produce a truncated protein 
encompassing the DNA-binding domain of PycC. The second mutation results in a Gly to Arg 
change in the helix-turn-helix domain of the putative DNA-binding transcriptional regulator 
encoded by the Mbar_A2165 locus. The locus tags for each gene are shown above the arrows. 
Mbar_A2164 encodes a putative GTP binding protein, Mbar_A2166 encodes a putative 
phosphoribosyl-ATP-pyrophosphatase and Mbar_A2167 encodes a putative 3-isopropylmalate 
dehydratase. Mutations positions are shown by the yellow asterisk. 
idea that Ppc activity might be expressed in Pyr+ strains, I attempted, 
unsuccessfully, to assay this activity in crude extracts of the pycC1 mutant. Thus, 
the route of OAA synthesis in the mutant could not be biochemically established. 
2.4.3 Global transcriptomic profiling of Pyr+ mutants 
Because both of the putative Pyr+ mutations occur in genes encoding 
transcriptional regulators, it seems likely that altered gene expression plays a 
role in the ability of the mutants to use pyruvate as a growth substrate. To test 
this hypothesis, we performed global transcriptional profiling of the mutant and 
parental strains via RNA sequencing (RNA-Seq). Because the parental strain is 
incapable of growth on pyruvate, RNA was isolated after growth on methanol 
with and without added pyruvate and, because pyruvate is thought to be 
metabolized via acetate, after growth on methanol with pyruvate and acetate, 
methanol with acetate, and acetate alone. Pairwise comparisons of mRNA 
abundance were then made between each of the three strains for each of the 
growth conditions. The full dataset, including parsed tables showing only  
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Figure 2.3 Characterization of the pycC1 mutant. Panel A: Pyc activity was measured in a 
coupled reaction using malate dehydrogenase (Mdh) to reduce enzymatically-produced 
oxaloacetate to malate with concomitant oxidation of NADH. Activity for the complete reaction 
using extracts from the parental strain (WWM85) and the pycC1 mutant (WWM818) are shown, 
as are control reactions using pycC1 cell extract, but lacking the pyruvate substrate, (-) Pyr, and 
coupling enzyme, (-) Mdh. Error bars represent the standard deviation of three biological 
replicates. Panel B: Growth of the parental strain (WWM85) and the pycC1 mutant (WWM818) on 
HS-medium supplemented with methanol as substrate. Error bars represent the standard 
deviation of three biological replicates. 
significant differences and those shared in common between both mutant cell 
lines, has been submitted to NCBI Gene Expression Omnibus (GEO accession 
number GSE70370). 
Although numerous differences in mRNA abundance were observed, we 
reasoned that differential expression would need to be seen in both Pyr-1 and 
Pyr-2 in order to be relevant to the Pyr+ phenotype. Relatively few genes met this 
criterion, Table 3. Most notable among these are the genes of the por operon, 
which were expressed at significantly higher levels in the Pyr+ mutants. This 
phenotype was especially pronounced when the cells were grown in the 
presence of pyruvate or acetate. This substrate-specific phenotype can be 
explained by the observation that DSM804 down-regulates expression of por 
when pyruvate or acetate is present, whereas Pyr-1 and Pyr-2 do not (refer to 
RNAseq complete data set GSE70370). This regulatory phenotype exaggerates 
the differences seen between the mutants and their parent in media with 
pyruvate or acetate and minimizes the difference seen in media without these 
additions. Two other genes displayed a similar behavior: Mbar_A2632, which 
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encodes the putative Ppc enzyme mentioned above, and Mbar_A2011, which 
encodes an S-layer protein. 
Genes involved in nitrogen metabolism also showed substantially different 
expression in the Pyr+ mutants, although no clear pattern could be observed 
(Table 2.5). Thus, some nitrogen assimilation genes were up-regulated, with 
others down-regulated. Moreover, the expression pattern was reversed for many 
of these genes on methanol media containing either pyruvate or acetate to media 
with either methanol or acetate alone. Currently, there is no satisfactory 
explanation for this observation. Surprisingly, the expression of genes predicted 
to be regulated by PycC (Rodionov et al., 2002), including the pyc and bioY 
operons, is not significantly changed in the pycC1 mutants under most of the 
conditions examined.  
2.4.4 Mbar_A2165 is involved in regulation of Por 
To examine the role of the Mbar_A2165(G59R) allele in pyruvate metabolism, we 
attempted to recreate the mutation in the WWM85 strain background, yet despite 
numerous attempts, were unable to obtain this mutant. However, we were able to 
construct a double mutant (WWM940) containing both the pycC1 mutation and 
the G59R change in Mbar_A2165. Taken together, these data suggest that the 
Mbar_A2165(G59R) mutation is lethal in the presence of a wild-type pycC allele.  
To assess the regulatory phenotype of this mutation, a transcriptional profiling of 
the pycC1 single mutant, the pycC1/Mbar_A2165(G59R) double mutant and their 
isogenic parent, was conducted (refer to RNAseq complete data set, 
GSE70370). Comparison of the pycC1 mutant with the parent revealed only 
fourteen differentially expressed genes, none of which have obvious roles in 
pyruvate metabolism. In contrast, comparison of the double mutant to the parent 
revealed 34 differentially expressed genes, including porA (+2.3 fold), porB 
(+2.2-fold) and ppc (Mbar_A2632, +2.5-fold). Comparison of the single mutant to 
the double showed 78 regulated genes including the por operon (porA, +2.9 fold; 
porB, +3.1-fold, porC, +3.1-fold; porD, +2.75-fold), but not ppc. Consistent with 
the transcriptional data, Por activity was more than two-fold higher when the 
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Mbar_A2165 (G59R) mutation was present (specific activities: WWM85, 0.59 ± 
0.06; WWM940, 0.50 ± 0.04; WWM941, 1.28 ± 0.22). 
 
 2.4.5 Pyruvate ferredoxin oxidoreductase is an essential gene in M. barkeri 
Fusaro 
To probe the role of Por activity in pyruvate metabolism, we constructed a strain 
that expresses porCDAB from a tetracycline-regulated promoter (WWM941). 
Consistent with Por being required for pyruvate biosynthesis (Weimer and 
Zeikus, 1979), the strain grew well on methanol medium in the presence of the 
inducer tetracycline, but failed to grow in its absence, (Fig. 2.4, panels A & B). 
Similar results were obtained in liquid medium when the strain was grown on 
acetate, methanol with H2/CO2 and methanol/acetate mixture. 
 
However, unlike a previously characterized M. barkeri ech mutant, which is a 
pyruvate auxotroph (Meuer et al., 2002), this strain failed to grow in the absence 
of inducer in media supplemented with various combinations of pyruvate, 
acetate, casamino acids and yeast extract (Fig 2.4, panels C through H). The 
failure of supplementation to restore growth of the por-depleted strain indicates 
that Por, or one of its subunits, plays an additional essential role(s) beyond 
pyruvate biosynthesis.  
 
2.4.6 Suppressors of the Por phenotype  
To further asses pyruvate metabolism in M. barkeri, we constructed a strain that 
expresses porCDAB from a tetracycline controlled promoter in a background 
were the pyc operon has the pycC1 mutation (WWM945). Unlike strain WWM941 
this strain was able to grow in the absence of the inducer tetracycline (Fig. 2.5). 
Since no pyruvate or amino acids were supplemented in the medium these 
results suggests the presence of an alternative pathway to replenish these 
constituents in the cell. To identify genes that might be involved in these 
functions we isolated suppressors of the Por- phenotype by plating WWM941 in 
the absence of the inducer tetracycline.
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Table 2.5 Select mRNA abundance changes in Pyr-1 and Pyr-2 relative to DSM804a. 
  MeOH/Pyr MeOH/Pyr/Ac MeOH/Ac MeOH Acetate 
  Pyr-1 Pyr-2 Pyr-1 Pyr-2 Pyr-1 Pyr-2 Pyr-1 Pyr-2 Pyr-1 Pyr-2 
Locus Tag Annotation Fold Changeb 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Pyruvate induced genes  
Mbar_A0999 por operon 6.8 5.1 4.9 2.6 7.8 4.2 2.4 1.2 1.2 -1.3 
Mbar_A1000 por operon 7.7 4.3 4.3 2.5 5.8 3.0 4.2 1.2 1.1 -1.6 
Mbar_A1001 por operon 11.4 7.1 7.1 3.8 9.1 4.1 4.1 1.1 1.4 -1.4 
Mbar_A1002 por operon 15.3 7.9 8.1 4.5 9.0 3.9 3.6 1.1 1.2 -1.5 
Mbar_A2011 S-layer protein 34.2 19.7 8.6 4.8 82.7 39.5 -1.1 -3.5 2.0 1.3 
Mbar_A2632 pep carboxylase 4.4 3.7 2.9 1.6 4.37 2.9 4.0 1.9 -1.2 -1.4 
Putative PycC-regulated genes  
Mbar_A0583 bioY operon 1.1 1.1 -1.3 -1.3 -1.4 -1.1 1.5 1.8 1.2 1.2 
Mbar_A0584 bioY operon -1.0 -1.1 1.1 1.1 -1.2 -1.4 1.7 1.7 1.1 -1.1 
Mbar_A0585 bioY operon 1.6 1.3 1.2 1.1 1.5 1.3 1.8 1.5 -1.1 -1.1 
Mbar_A0586 bioY operon 2.3 1.9 1.7 1.1 2.5 1.8 3.6 1.6 1.8 1.4 
Mbar_A1586 pyc operon 1.5 1.2 1.0 1.1 1.5 1.0 2.8 1.3 1.7 1.2 
Mbar_A1587 pyc operon 3.8 1.9 1.8 1.7 3.3 2.0 2.0 -1.1 1.2 -1.1 
Mbar_A1588 pyc operon 1.6 1.3 1.2 1.2 2.4 1.7 1.2 -1.3 1.3 1.1 
Mbar_A1589 pyc operon 1.9 1.2 1.2 1.1 1.3 1.0 1.3 -1.5 1.2 -1.0 
Nitrogen fixation genes  
Mbar_A0165 Mo-Nitrogenase operon 2.4 1.2 2.3 1.7 2.8 2.0 -2.1 -1.8 -1.2 -1.2 
Mbar_A0166 Mo-Nitrogenase operon 3.9 1.7 4.1 2.8 3.5 2.4 -3.0 -2.4 -1.6 -1.6 
Mbar_A0167 Mo-Nitrogenase operon 3.5 1.4 5.4 3.6 5.8 3.9 -4.8 -3.6 -3.1 -3.4 
Mbar_A0168 Mo-Nitrogenase operon 4.2 1.7 6.0 3.9 6.2 4.2 -4.2 -3.3 -3.4 -3.2 
Mbar_A0169 Mo-Nitrogenase operon 5.3 1.9 6.4 4.1 5.3 3.5 -3.7 -2.9 -3.5 -2.9 
Mbar_A0170 Mo-Nitrogenase operon 4.1 1.8 5.9 3.9 8.8 6.0 -7.1 -5.7 -1.9 -1.6 
Mbar_A0171 Mo-Nitrogenase operon 6.7 2.7 8.9 5.6 -1.2 5.5 -4.9 -4.5 -4.3 -4.5 
aThe full datasets for each condition, including parsed tables showing only significant differences, are presented in GSE70370 . 
. 
bFold change of expression values of mutant strains compared to WT M. barkeri grown in the same substrate. Statistically significant values (P<0.05) are shown in bold.
	   46	  
 
Figure 2.4 The por operon is essential for viability in M. barkeri. The parental strain, which 
expresses por from its normal promoter (por+, WWM85) and a derivative that expresses por from 
a tetracycline-dependent promoter (portet, WWM941) were pre-grown in HS-methanol broth with 
tetracycline, then washed, serially diluted and plated on HS-methanol agar in the presence (A) or 
absence (B) of tetracycline. Cultures were also plated on HS-methanol agar, without tetracycline, 
supplemented with 100 mM pyruvate (C), 10 mM pyruvate and 100 mM acetate (D), 0.1% 
casamino acids (E), 0.1% yeast extract (F), 100mM pyruvate, 0.01% case amino acids, 0.01% 
yeast extract (G) or 100 mM pyruvate, 0.1% casamino acids, 0.1% yeast extract (H).  
 
After three weeks of incubation nine suppressors strains were obtained. Eight of 
the isolated strains (clones 2-9) showed a mutation in the promoter region of the 
tetracycline binding cite (Figure 2.6). The genome of the remaining strain was 
sequenced. A total of six mutations were identified including a mutation in a 
potential transcriptional regulator (Table 2.5).  Since most of he mutations are 
present in genes with unknown functions recreations of the mutations will be 
necessary to determine which role if any they play in the suppressor phenotype. 
 
2.4.7 Attempts to recreate the Pyr+ phenotype  
Based on the results presented above, it was expected that either the pycC1 or 
Mbar_A2165 (G59R) mutation, or both together, would be required for growth on 
pyruvate. Unfortunately, a direct test of this hypothesis is experimentally difficult 
due to the morphological properties of Methanosarcina cells and the unusual 
physiology of the Pyr-1 and Pyr-2 cell lines. Most Methanosarcina species grow 
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Figure 2.5 The por operon is essential for viability in M. barkeri. The parental strain, which 
expresses por from its normal promoter (pycC1-por+, WWM818) and a derivative that expresses 
por from a tetracycline-dependent promoter (pycC1-portet, WWM945) were pre-grown in HS-
methanol broth with tetracycline, then washed, serially diluted and plated on HS-methanol agar in 
the presence (A) or absence (B) of tetracycline.  
 
in large cellular aggregates that are encased in a thick polysaccharide cell wall. 
This cell wall presents a significant barrier to uptake of foreign DNA and despite 
numerous attempts, to our knowledge no one has yet succeeded in 
transformation of aggregated Methanosarcina cells. However, prolonged 
cultivation of aggregated cells in media of high osmotic strength with high 
concentrations of divalent cations results in conversion to a highly transformable, 
single celled morphology that lacks the polysaccharide cell wall (Sowers et al., 
1993, Metcalf et al., 1997). Thus, the WWM85 cell line used in this study grows 
as single cells and is genetically tractable, while the DSMZ804, Pyr-1 and Pyr-2 
strains grow as aggregates and are not transformable.  
As described in the preceding sections, we were able to recreate a pycC1 single 
mutant, and a pycC1, Mbar_A2165(G59R) double mutant in the WWM85 strain 
background. Because the single-celled strains lyse in the low-salt medium used 
for cultivation of DSM804, Pyr-1 and Pyr-2, we characterized the growth 
phenotype of these strains in high-salt (HS) pyruvate medium. Surprisingly, the 
aggregated Pyr-1 and Pyr-2 strains failed to grow on pyruvate in HS medium. 
Pyr-1 and Pyr-2 grow well in HS media with other substrates, suggesting that the 
10-1 10-2 10-3 10-4 10-5 10-6
pyc-por+
pyc-portet
pyc-por+
pyc-portet
A
B
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medium lacks some component of the low-salt medium that is required for growth 
on pyruvate, or that growth on pyruvate is blocked by some component of the 
high-salt medium. To examine this, numerous variants of HS medium that 
included the components of low salt medium at a range of concentrations were 
tested. We also tried variants with decreasing concentrations of the components 
of the high-salt medium; however, no change to the concentrations of NaCl (400 
mM) or MgCl2 (50 mM) was made, as these are required to prevent lysis. 
Although some of these media allowed limited pyruvate-dependent growth of 
Pyr-1 and Pyr-2, none would support growth upon serial transfer. We also 
attempted to develop a high osmotic strength, low salt medium using sucrose 
and MgCl2, but obtained similar results. Consequently, we were unable to assess 
whether the pycC1 and/or Mbar_A2165(G59R) alleles are necessary and 
sufficient for growth on pyruvate. 
Table 2.6 DNA sequence polymorphisms in M. barkeri Por- suppressor. 
Locus tag Annotation Protein prediction Polymorphism 
Amino acid 
change 
Mbar_A0824/Mbar_A0825 Hypothetical protein/ 
Universal stress protein 
Hypothetical protein / 
Universal stress protein 
T=>C Intergenic 
Mbar_A0824/Mbar_A0825 Bacterioferritin/5S 
ribosomal RNA 
Bacterioferritin/5S ribosomal 
RNA 
Δ1 bp Intergenic 
Mbar_A1672 Hypothetical protein Carbohydrate domain family G=>T Gly-Val 
Mbar_A3185 Hypothetical protein Archaeal ribulose 1,5-
bisphosphate synthetase, 
Rossmann like domain 
+G  
Mbar_A3314 Hypothetical protein Carboxypeptidase regulatory 
domain/HTH domain 
Δ2 bp Frame shift 
Mbar_A3681/Mbar_A3682 Hypothetical protein/ 
Hypothetical protein 
Hypothetical protein/ 
Hypothetical protein 
G=>A Intergenic 
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Figure 2.6 Suppressors of Por- phenotype. Promoter region of nine clones and parental strain 
were sequence. Annotated ATG site in orange, TetR binding region in red, mutated bases within 
TetR binding site in black.  
2.5 Discussion 
Previous studies showed that wild-type strains of M. barkeri Fusaro are incapable 
of growth on pyruvate, but that it is possible to select mutants with the ability to 
do so (Bock et al., 1994). Our analysis of these mutants suggests that the Pyr+ 
phenotype depends on the pycC1 and/or the Mbar_A2165(G59R) allele, because 
these mutations represent the only shared sequence differences between the 
Pyr+ strains and their isogenic Pyr- parent. Unfortunately, we were unable to 
rigorously establish whether one or both of the alleles are required due to the 
physiological and morphological constraints of our current experimental system. 
Thus, the possibility that additional polymorphisms between the DSM804 and 
WWM85 cell lines contribute to the Pyr+ phenotype can not be excluded. 
Nevertheless, the data presented in this chapter strongly suggest that both 
mutations are required for the phenotype because it appears that the 
Mbar_A2165(G59R) mutation is lethal in the absence of pycC1. 
The data show that the ability to grow on pyruvate requires two substantial 
changes in central metabolism (Fig. 2.5). First, instead of using the Pyc-
catalyzed carboxylation of pyruvate to form OAA, the strains use a two-step 
pathway involving conversion of pyruvate to PEP using the enzyme 
phosphoenolpyruvate synthase (Pps), followed by conversion of PEP to OAA via 
the enzyme Ppc. Although demonstration of Ppc activity in extracts of the 
mutants was not possible, it is known that the archaeal enzyme can be unstable 
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(Patel et al., 2004). Given that OAA biosynthesis is essential and that the ppc 
gene is upregulated in the mutants, it is highly likely that Ppc is functionally 
expressed in the Pyr-1 and Pyr-2 cell lines. The second key change found in the 
Pyr+ strains is a substantially higher level of Por activity. Transcriptomic analyses 
of recreated mutants show that the Mbar_A2165(G59R) mutation is responsible 
for increased expression of both Por and Ppc. Our data do not address whether 
this regulation is direct or indirect, but the phenotype is probably caused by the 
inability to repress expression of por and ppc in response to pyruvate and/or 
acetate, a regulatory phenotype seen in DSM804, but not in Pyr-1 and Pyr-2. The 
non-conservative, glycine to arginine change in winged, helix-turn-helix motif of 
the Mbar_A2165-encoded protein could easily prevent DNA-binding to cognate 
promoters, thereby abrogating repression.  
 
Figure 2.7 Proposed anabolic and catabolic metabolism of pyruvate in Methanosarcina barkeri 
Fusaro. The native aceticlastic pathway, which is used for catabolism of pyruvate, is shown in 
blue, the anabolic pathway for production of biomass is shown in red. The enzymes proposed to 
catalzye specific steps are shown in green: Mcr, methy-CoM reductase; Mtr, CoM:H4MPT 
methytransferase; Cdh, carbon monoxide dehydrogenase; Por, pyruvate:ferredoxin 
oxidoreductase; Pyc pyruvate carboxylase; Ppc, PEP carboxylase; and Pps, PEP synthase. 
Overexpression of Por and Ppc in the Pyr+ mutants, coupled with loss of Pyc, is sufficient to 
allow growth on pyruvate as the sole methanogenic substrate.  
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These physiological differences suggest a model for growth of the Pyr+ mutant. 
The key feature of this model is the inability of the mutant to down-regulate Por in 
response to pyruvate. High Por activity in the presence of exogenous pyruvate 
would thus allow the biosynthetic enzyme to take on a catabolic role, oxidizing 
pyruvate to acetyl-CoA and CO2. Subsequent conversion of acetyl-CoA to 
methane could then occur via the standard aceticlastic pathway as previously 
suggested. The requirement for the pycC1 mutation has two possible 
explanations in this model. In the first, pycC1 is required because the 
Mbar_A2165(G59R) mutation that allows Por overexpression is lethal in the 
presence of a functional Pyc. This mutation simultaneously increases expression 
of Ppc and speculate that the loss of Pyc is required to prevent futile cycling 
between OAA and pyruvate when both enzymes are present, as seen in other 
organisms (Flores and Gancedo, 1997). Alternatively, the loss of Pyc may direct 
pyruvate into the oxidative pathway by blocking its direct conversion to OAA. In 
this scenario, the kinetic parameters of the two-step pathway would favor 
channeling of pyruvate into the oxidative pathway, rather than the biosynthetic 
pathway.  
Perhaps the most surprising result was the observation that porCDAB expression 
is essential in M. barkeri, even when the media are supplemented with pyruvate. 
In many anaerobic microorganisms Por plays a catabolic role similar to that 
observed in the M. barkeri mutants. Por-deficient mutants have been made in 
several of these organisms and, although the mutants lose the ability to utilize 
specific substrates, they are viable and generally healthy (Kenta Nohara, 2014, 
McNeely et al., 2011). In contrast, autotrophic methanogens typically use Por as 
a biosynthetic enzyme to produce pyruvate by reductive carboxylation of acetyl-
CoA (Simpson and Whitman, 1993). Based on the fact that the mutants grow on 
pyruvate, and that pyruvate supplementation can rescue an M. barkeri ech 
mutant (Meuer et al., 2002), this phenotype is not caused by an inability to take 
up the substrate. Thus, Por clearly has an additional role beyond synthesis of 
pyruvate. Perhaps, this additional function is also biosynthetic, consistent with 
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the nature of the encoded gene, and because supplementation did allow slight 
growth of the Por-depleted cells (see Fig. 2.4, panel C through H). Biochemical 
characterization of M. barkeri Por showed that the enzyme has a rather narrow 
substrate range using only pyruvate and 2-oxo-butyrate (in the oxidative 
direction) (Bock et al., 1996). Thus, it is conceivable that the enzyme is required 
for production of either propionyl-CoA or 2-oxo-butryate, according to eq1. 
eq1 propionyl-CoA + CO2 + reduced-ferredoxin ó 2-oxo-butyrate + oxidized 
ferredoxin 
Por enzymes from other sources have additional activities, including 
hydrogenase and pyruvate decarboxylase (Eram et al., 2014, Ragsdale, 1996), 
so it is possible that one of these activities is required for viability.  It is also 
possible that one of the proteins in the porCDAB operon acts as a subunit for 
another required enzyme complex. Candidates include the small ferredoxin 
encoded by porD or one of the catalytic subunits, which have been shown to be 
interchangeable in other 2-oxo acid:ferrredoxin oxidoreductases (Kenta Nohara, 
2014, Arnulf Kletzin, 1996). If, as suspected, a biosynthetic block causes the 
lethal phenotype, then the required intermediate is either not present in yeast 
extract or casamino acids, or the cell does not take it up.  In cells were Pyc was 
no longer active Por was not essential even in the absence of pyruvate. The 
connection between Pyc and Por activities remain undetermined however we can 
speculate that it is possible that absence of both Por and Pyc induces the 
expression of an alternative biosynthesintetic pathway for the synthesis of 
pyruvate and other intermediates in the cell.  
Finally, our data shed some light on the role of pycC in biotin-dependent gene 
regulation. In E. coli, mutations in the biotin-protein ligase domain of the 
homologous protein affect regulation of biotin biosynthetic genes (Chakravartty 
and Cronan, 2012).  M. barkeri does not encode genes for biotin biosynthesis 
however, in silico analysis  has revealed the presence of two PycC binding sites 
in the genome, one presumably regulating the biotin transporter bioY and a 
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second one upstream the pyc operon (Rodionov et al., 2002). Our transcriptomic 
analysis did not reveal consistent and statistically significant changes in the 
expression of these genes across substrates. Thus, M. barkeri PycC does not 
regulate expression of genes related to biotin metabolism, at least to levels that 
can be detected by the RNA-seq methodology used here.  
Taken together, our results show that pyruvate-utilization in M. barkeri is an 
intricate process that balances the needs of anabolic and catabolic pathways. 
Moreover, the finding of novel anaplerotic reactions and the essentiality of Por 
suggest that further analyses of central metabolism in Methanosarcina are 
warranted. 
 
2.6 References 
 
1. ADAM M GUSS, M. R., JUN KAI ZHANG, GARGI KULKARNI AND WILLIAM 
METCALF 2008. new methods for tightly regulated gene expression and 
highly efficient chromosomal integration of cloned genes for 
Methanosarcina species Archaea, 2, 193-203. 
2. ARNULF KLETZIN, M. W. W. A. 1996. Molecular and phylogenetic 
characterization of pyruvate and 2-ketoisovalerate ferredoxin 
oxidoreductases from Pyrococcus furiosus and pyruvate ferredoxin 
oxidoreductase from Thermotoga maritima. J Bacteriol, 178, 248-257. 
3. AUSUBEL, F. M. 1992. Short protocols in molecular biology : a compendium 
of methods from Current protocols in molecular biology, New York, NY, 
Greene Pub. Associates ; Wiley. 
4. BOCK, A. K., KUNOW, J., GLASEMACHER, J. & SCHONHEIT, P. 1996. 
Catalytic properties, molecular composition and sequence alignments of 
pyruvate: ferredoxin oxidoreductase from the methanogenic archaeon 
Methanosarcina barkeri (strain Fusaro). Eur J Biochem, 237, 35-44. 
5. BOCK, A. K., PRIEGER-KRAFT, A. & SCHONHEIT, P. 1994. Pyruvate- a 
novel substrate for growth and methane formation in Methanosarcina 
barkeri Arch Microbiol 161, 33-46. 
6. BOCK, A. K. & SCHONHEIT, P. 1995. Growth of Methanosarcina barkeri 
(Fusaro) under nonmethanogenic conditions by fermentation of pyruvate 
to acetate - ATP synthesis via the mechanism of substrate level 
phosphorylation. J Bacteriol 177, 2002-2007. 
	   54	  
7.  BUAN, N., KULKARNI, G. & METCALF, W. 2011. Genetic methods for 
methanosarcina species. Methods Enzymol, 494, 23-42. 
8.  CHAKRAVARTTY, V. & CRONAN, J. E. 2012. Altered regulation of 
Escherichia coli biotin biosynthesis in BirA superrepressor mutant strains. 
J Bacteriol, 194, 1113-26. 
9.  ERAM, M. S., ODUARAN, E. & MA, K. 2014. The bifunctional pyruvate 
decarboxylase/pyruvate ferredoxin oxidoreductase from Thermococcus 
guaymasensis. Archaea, 2014, 349379. 
10. FLORES, C. L. & GANCEDO, C. 1997. Expression of PEP carboxylase from 
Escherichia coli complements the phenotypic effects of pyruvate 
carboxylase mutations in Saccharomyces cerevisiae. FEBS Lett, 412, 
531-4. 
11. FU, H. & METCALF, W. W. 2015. Genetic basis for metabolism of methylated 
sulfur compounds in Methanosarcina species. J Bacteriol, 197, 1515-24. 
12. FURDUI, C. & RAGSDALE, S. W. 2000. The role of pyruvate ferredoxin 
oxidoreductase in pyruvate synthesis during autotrophic growth by the 
Wood-Ljungdahl pathway. J Biol Chem, 275, 28494-9. 
13. GUSS, A. M., ROTHER, M., ZHANG, J. K., KULKARNI, G. & METCALF, W. 
W. 2008. New methods for tightly regulated gene expression and highly 
efficient chromosomal integration of cloned genes for Methanosarcina 
species. Archaea, 2, 193-203. 
14. KENTA NOHARA, I. O., SATOSHI NAKAMURA, TADAYUKI IMANAKA, 
TOSHIAKI FUKUI 2014. Genetic examination and mass balance analysis 
of pyruvate/amino acid oxidation pathways in the hyperthermophilic 
Archaeon Thermococcus kodakarensis. J Bacteriol, 196, 3831-3839. 
15. MCINERNEY, M. J., SIEBER, J. R. & GUNSALUS, R. P. 2009. Syntrophy in 
anaerobic global carbon cycles. Curr Opin Biotechnol, 20, 623-32. 
16. MCNEELY, K., XU, Y., ANANYEV, G., BENNETTE, N., BRYANT, D. A. & 
DISMUKES, G. C. 2011. Synechococcus sp. strain PCC 7002 nifJ mutant 
lacking pyruvate:ferredoxin oxidoreductase. Appl Environ Microbiol, 77, 
2435-44. 
17. METCALF, W. W., ZHANG, J. K., APOLINARIO, E., SOWERS, K. R. & 
WOLFE, R. S. 1997. A genetic system for Archaea of the genus 
Methanosarcina: liposome-mediated transformation and construction of 
shuttle vectors. Proc Natl Acad Sci U S A, 94, 2626-31. 
 
	   55	  
18. MEUER, J., KUETTNER, H. C., ZHANG, J. K., HEDDERICH, R. & 
METCALF, W. W. 2002. Genetic analysis of the archaeon Methanosarcina 
barkeri Fusaro reveals a central role for Ech hydrogenase and ferredoxin 
in methanogenesis and carbon fixation. Proc Natl Acad Sci U S A, 99, 
5632-7. 
19. MUKHOPADHYAY, B., PURWANTINI, E., KREDER, C. L. & WOLFE, R. S. 
2001. Oxaloacetate synthesis in the methanarchaeon Methanosarcina 
barkeri: pyruvate carboxylase genes and a putative Escherichia coli-type 
bifunctional biotin protein ligase gene (bpl/birA) exhibit a unique 
organization. J Bacteriol, 183, 3804-10. 
20. PAOLO BOCCAZZI, J. K. Z., WILLIAM METCALF 2000. Generation of 
dominant selectable markers for resistance to pseudomonic acid by 
cloning and mutagenesis of the ileS gene from teh archaeon 
Methanosarcina barkeri Fusaro Journal of Bacteriology, 182, 2611-2618. 
21. PATEL, H. M., KRASZEWSKI, J. L. & MUKHOPADHYAY, B. 2004. The 
phosphoenolpyruvate carboxylase from Methanothermobacter 
thermautotrophicus has a novel structure. J Bacteriol, 186, 5129-37. 
22. PRITCHETT, M. A., ZHANG, J. K. & METCALF, W. W. 2004a. Development 
of a Markerless Genetic Exchange Method for Methanosarcina 
acetivorans C2A and Its Use in Construction of New Genetic Tools for 
Methanogenic Archaea. Applied and Environmental Microbiology, 70, 
1425-1433. 
23. PRITCHETT, M. A., ZHANG, J. K. & METCALF, W. W. 2004b. Development 
of a markerless genetic exchange method for Methanosarcina acetivorans 
C2A and its use in construction of new genetic tools for methanogenic 
archaea. Appl Environ Microbiol, 70, 1425-33. 
24. RAGSDALE, S. M. A. S. W. 1996. Unleashing Hydrogenase Activity in 
Carbon Monoxide Dehydrogenase/Acetyl-CoA Synthase and 
Pyruvate:Ferredoxin Oxidoreductase Biochemistry, 35, 15814-15821. 
25. RAJAGOPAL, B. S. & LEGALL, J. 1994. Pyruvate as a substrate for growth 
and methanogenesis for Methanosarcina barkeri. Curr Microbiol, 28, 307-
311. 
26. ROBINSON, M. D. & SMYTH, G. K. 2008. Small-sample estimation of 
negative binomial dispersion, with applications to SAGE data. 
Biostatistics, 9, 321-32. 
27. RODIONOV, D. A., MIRONOV, A. A. & GELFAND, M. S. 2002. Conservation 
of the biotin regulon and the BirA regulatory signal in Eubacteria and 
Archaea. Genome Res, 12, 1507-16. 
	   56	  
28. SIMPSON, P. G. & WHITMAN, W. B. 1993. Anabolic pathways in 
methanogens. In: FERRY, J. G. (ed.) Methanogenesis. New York, NY: 
Chapman & Hall. 
29. SOWERS, K. R., BOONE, J. E. & GUNSALUS, R. P. 1993. Disaggregation 
of Methanosarcina spp. and growth as single cells at elevated osmolarity. 
Appl Environ Microbiol, 59, 3832-3839. 
30. THAUER, R. K., KASTER, A. K., SEEDORF, H., BUCKEL, W. & 
HEDDERICH, R. 2008. Methanogenic archaea: ecologically relevant 
differences in energy conservation. Nat Rev Microbiol, 6, 579-91. 
31. WEIMER, P. J. & ZEIKUS, J. G. 1979. Acetate assimilation pathway of 
Methanosarcina barkeri. J Bacteriol, 137, 332-9. 
32. WIDDEL, F. 1986. Growth of methanogenic bacteria in pure culture with 2-
propanol and other alcohols as hydrogen donors. Appl Environ Microbiol, 
51, 1056-62. 
33. WILLIAM METCALF, J. K. Z., XUN SHI, RAPLH S. WOLFE 1996. Molecular, 
Genetic, and Biochemical Characterization of the serC Gene of 
Methanosarcina barkeri Fusaro. J Bacteriol, 178, 5797-5802. 
34. WILLIAM METCALF, J. K. Z., XUN SHI, RAPLH S. WOLFE 1998. An 
Anaerobic, Intrachmber Incubator for Growth of Methanosarcina spp. on 
Methanol-Containing Solid Media. J Bacteriol, 64, 768-770. 
35. ZHANG, J. K., WHITE, A. K., KUETTNER, H. C., BOCCAZZI, P. & 
METCALF, W. W. 2002. Directed mutagenesis and plasmid-based 
complementation in the methanogenic archaeon Methanosarcina 
acetivorans C2A demonstrated by genetic analysis of proline biosynthesis. 
J Bacteriol, 184, 1449-54. 
 
 57	  
Chapter 3: An Archaeal-specific Family of DNA-binding Proteins Mediates 
Transcriptional Regulation of C-1 Metabolism in Methanosarcina 
acetivorans 1 
 
 
3.1 Abstract  
The mtaCB1 operon, which encodes one of three methanol methyltransferase 
isozymes in the methanogenic archaeon Methanosarcina acetivorans, is one of 
the most highly regulated transcriptional units known in Archaea. Previous 
studies showed that the homologous msrA and msrB genes are required for 
transcription of mtaCB1, suggesting that the products of these genes act as 
transcriptional activators; however, direct interaction of these proteins with the 
target promoter was not shown. To address this, we purified the MsrA and MsrB 
proteins after overexpression in Escherichia coli. The purified proteins from a 
heterodimer in solution and specifically bind to the mtaCB1 promoter, as shown 
by electrophoretic mobility shift assays. Global transcriptional profiling of msrA 
and msrB mutants via RNA-seq revealed mtaCB1 to be the sole positive target of 
the MsrA/B dimer. Mutants lacking MsrB, but not those lacking MsrA, showed 
constitutive expression of genes involved in methylamine catabolism during 
growth on methanol, a condition where these genes are normally repressed. 
Thus, MsrB is required for both positive and negative regulation of one carbon 
(C-1) metabolism, although the mechanism of the two processes is clearly 
distinct. Transcriptional and translational fusions, as well as RNAseq data, 
showed that the msr genes themselves are constitutively expressed and not 
subject to auto-regulation. Bioinformatics analyses show that MsrA and MsrB 
represent a novel, archaeal-specific family of DNA binding proteins that is 
particularly abundant in the Methanosarcinaceae family.  
 
                                                
1 This chapter presents work contributed by three authors: Arpita Bose (bioinformatics analysis of msr proteins, EMSA 
experiments to determine binding specificity), Petra Kohler (RNAseq experiments and size exclusion chromatography) 
and Madeline López Muñoz (RNAseq data analysis, qRT-PCR, determination of binding specificity by Footprint assay, 
EMSA experiment to confirm metal requirement and Western blot experiments)  
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3.2 Introduction 
Members of the Methanosarcinales, including Methanosarcina acetivorans, are 
the most metabolically diverse methanogens, being able to use H2/CO2, acetate 
and a variety of methylated compounds as substrates for methanogenesis 
(Zinder, 1993). In these organisms, reduction of C-1 compounds such as 
methanol, trimethylamine (TMA), dimethylamine (DMA) and monomethylamine 
(MMA) proceeds via the methylotrophic pathway of methanogenesis, in which 
substrates enter the methanogenenic pathway by transferring the methyl group 
to coenzyme M. Transfer of the methyl group occurs via two consecutive 
reactions catalyzed by heterodimeric substrate specific methyltransferase 1 
complexes (MT1) and non-specific methyltransferase 2 enzymes (MT2) (Keltjens 
and Vogels) (van der Meijden et al., 1983).  
 
The methanol-specific MT1 enzyme is composed of MtaC (corrinoid protein 
component) and MtaB (the methyltransferase component) (Sauer et al., 1997) 
encoded by the operon mtaCB (Sauer et al., 1997, Thauer, 1998). Interestingly, 
M. acetivorans C2A, M. barkeri Fusaro and M. mazei Gö1 each have three 
operons encoding methanol-specific MT1s, designated mtaCB1, mtaCB2, and 
mtaCB3. (Galagan et al., 2002, Maeder et al., 2006, Deppenmeier et al., 2002, 
Pritchett and Metcalf, 2005). Genetic analysis of these operons in M. acetivorans 
C2A showed that these genes have discrete roles during growth on methanol, 
with different expression patterns during exponential and stationary phases of the 
culture cycle (Pritchett and Metcalf, 2005). Moreover, methanol is the strongest 
inducer of the mtaCB1 and mtaCB2 operons causing 100 and 575-fold inductions 
respectively, one of the highest induction levels observed in Archaea to date 
(Bose et al., 2006).  
 
Previously, we showed that differential expression of the mtaCB1 operon is 
mediated by discrete promoter elements and by the trans acting methanol 
specific regulators MsrA and MsrB (Bose and Metcalf, 2008). The msrA and 
msrB genes are located directly upstream of the mtaCB1 operon and deletion of 
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either causes a decrease in the expression of mtaCB1, suggesting that they act 
as activators of mtaCB1 transcription (Bose and Metcalf, 2008). MsrA and MsrB 
form part of a larger family of transcriptional  regulators that have been shown to 
control expression of the methyltransferases needed for utilization of the C-1 
substrates methanol, methanethiol, dimethyl sulfide and 
methylmercaptopropionate (Bose et al., 2009, Fu and Metcalf, 2015). However, 
Msr family proteins are not known to be involved in the regulation of methylamine 
methyltransferases. Although MsrA and MsrB proteins are predicted to possess 
HTH DNA-binding domains, experimental demonstration of promoter binding has 
yet to be reported. Thus, the molecular mechanism by which the Msr proteins 
mediated regulation remains unproven. Moreover, the means by which C-1 
substrates are sensed to modulate regulation are also elusive.  
 
Here, we report a series of transcriptomic and biochemical experiments that 
address the function and mechanism of action of the Msr proteins. Our results 
show that MsrA and MsrB comprise an archaeal-specific family of regulators that 
bind in a sequence specific manner to the mtaCB1 promoter. In addition, our 
results show that msrB acts to repress several methylamine methyltransferases 
during growth on methanol and acetate, providing the first evidence for regulation 
of this group of C-1 substrates by an Msr family member. These results shed 
significant light into the complex regulatory network that controls methylotrophic 
metabolism in Methanosarcina spp. 
 
3.3 Materials and Methods 
3.3.1 Strains, media, and growth conditions 
Standard conditions were used for growth of E. coli strains (Wanner, 1986). 
DH5α/λ-pir (Miller and Mekalanos, 1988) was used as the host for all pir-
dependent replicons.  DH10B (Stratagene, La Jolla, CA) was used for all other 
plasmid replicons.  Methanosarcina acetivorans C2A (DSM 2834) (Sowers et al., 
1984) was from laboratory stocks. Methanosarcina were grown in single cell 
morphology (Sowers et al., 1993) at 37°C in high salt  medium containing either 
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125 mM methanol (HS-MeOH), 50 mM trimethylamine (HS-TMA) or 120 mM 
acetate (HS-Ac). Growth of M. acetivorans on media solidified with 1.5 % agar 
was as described previously (Boccazzi et al., 2000). All plating manipulations 
were carried out under strictly anaerobic conditions in an anaerobic glove box.  
Solid media plates were incubated in an intrachamber anaerobic incubator as 
described (Metcalf et al., 1998).  Puromycin (CalBiochem, San Diego, CA) was 
added from sterile, anaerobic stocks at a final concentration of 2 µg/ml for 
selection of Methanosarcina strains carrying the puromycin transacetylase gene 
cassette (pac) (Metcalf et al., 1997, Gernhardt et al., 1990). The purine analog 8-
aza-2,6-diaminopurine (8ADP) (Sigma-Aldrich, St. Louis, MO) was added from 
sterile, anaerobic stocks at a final concentration of 20 µg/ml for selection against 
strains expressing the hpt gene. 
 
3.3.2 DNA methods 
Standard methods were used throughout for isolation and manipulation of 
plasmid DNA from E. coli (Ausubel et al., 1992). DNA sequences were 
determined from double-stranded templates at the W. M. Keck Center for 
Comparative and Functional Genomics, University of Illinois.   
 
3.3.3 Construction of mutant strains 
Construction of ∆msrA and ∆msrB was previously described (Bose and Metcalf, 
2008). For construction of complementation strains or translational and 
transcriptional fusions all plasmids were integrated on the M. acetivorans C2A 
chromosome using site-specific recombination between the φC31 attB site on the 
plasmid with the φC31 attP using liposome mediated transformation as described 
previously (Guss et al., 2008).  Strains with a chromosomal tag of msrA or msrB 
were constructed using the CRISPR-Cas-9 system as described in (Nayak, 2017 
). Plasmids used for strain constructions are described in Table 3.1. Segments 
encoding the sgRNA and 1kb homology region were synthetized as double-
stranded DNA fragments (gBlocks) by Integrated DNA Technologies (Coralville, 
IA) and introduced into AscI-cut pDN201 using the NEBuilder HiFi DNA assembly 
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kit following the manufacturer’s instructions (New England Biolabs, Ipswich,MA). 
sgRNA sequences were designed  using the CRISPR site finding tool in 
Genieious version R9 (Kearse et al., 2012).  Standard methods were used for 
construction of plasmids. pJK41 and all derivatives do not replicate in 
Methanosarcina. The Gateway® BP Clonase® II enzyme mix (Invitrogen, 
Carlsbad, CA) was used to mediate site-specific recombination between 
pJK027A derivatives and pAH55 derivatives following manufacturer’s 
instructions. All plasmids and strains were verified by PCR, DNA sequencing 
and/or restriction digest. For primers, plasmids and strain genotypes refer to 
Tables 3.2, 3.3 and 3.4 respectively.  
 
3.3.4 Purification of His6-Msr proteins using Ni-NTA affinity 
chromatography 
 E. coli Rosetta™ (DE3) (Novagen, Gibbstown, NJ) cells carrying the appropriate 
overexpression plasmid were grown in LB broth with 25 µg/ml chloramphenicol 
and 50 µg/ml ampicillin to mid-exponential phase at 37°C. The cells were then 
incubated on ice for 15 minutes followed by induction with 1 mM IPTG and 
growth at 18oC for 24 hours. The cells were then pelleted at 4000 X g, the 
supernatant was discarded and cell pellets were frozen at -80 oC until use.  The 
cell pellets from 250 ml cultures carrying overexpressed His6-Msr proteins were 
resuspended in 5 ml ice-cold 50 mM NaH2PO4 (pH 8.0) buffer containing 0.5 M 
NaCl (1X Native binding buffer) with 1X Complete, EDTA-free, Protease Inhibitor 
Cocktail (Roche, Indianapolis, IN). Cells were broken by passage two times in a 
French pressure cell (20,000 psi) and cell debris was removed by centrifugation 
at 13,000 X g to pellet cell debris. The resultant supernatant was passed over a 
Ni-NTA agarose (2 ml bed volume) (Qiagen, Valencia, CA) gravity flow column 
pre-equilibrated with 10 bed volumes of 1X Native binding buffer. 
 
Contaminating E. coli proteins were washed off the column in a stepwise fashion 
with buffers identical to 1X Native binding buffer, but with varying concentrations 
of imidazole (20, 50, 100 and 200 mM; 10 bed volumes of each of the buffers 
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was used for washes). His6-Msr proteins were collected from the column after 
washing with 1 ml of buffers containing 250 or 500 mM imidazole. His6-Msr after 
affinity chromatography was purified to apparent homogeneity, as ascertained by 
SDS-PAGE followed by Coomassie Brilliant Blue staining. High-purity His6-Msr 
was desalted using Zeba™ Desalt spin columns (Pierce, Rockford, IL) as per the 
manufacturer’s guidelines, replacing the original buffer with 50 mM HEPES (pH 
7.2), 200 mM NaCl, containing 20% glycerol, 1 mM dithiothreitol (DTT) and 1 mM 
MgCl2. 
 
3.3.5 Analytical gel filtration chromatography 
The oligomerization state of the His6-tagged Msr proteins in solution was 
determined via size exclusion chromatography (SEC) using an Åkta fast protein 
liquid chromatography system (GE Healthcare Life Sciences) at 4°C with a 
constant flow-rate of 0.7 ml/min. Protein samples were prepared to a total of  
250 µg in Buffer C (50 mM NaH2PO4 pH 7.4, 120 mM NaCl, 5% glycerol, filtered 
and degassed). Freshly purifiedHis6-MsrA and His6-MsrB were combined in a 1 
to 1, a 2 to 1, and a 1 to 2 ratio. After 15 min of incubation at room temperature 
the samples were loaded onto a HiLoad 16/600 Superdex 75 prep grade Gel 
Filtration Column (GE Healthcare Life Sciences), equilibrated with Buffer C. 
Proteins were eluted with 120 ml Buffer C while monitoring the absorbance at 
280 nm. The molecular mass of monomeric and oligomerized Msr protein was 
estimated using a standard curve constructed from the respective logarithmic 
molecular weights of standard proteins: Vitamin B12 (1.3 kDa), Myoglobin (17 
kDa), Ovalbumin (44 kDa), γ−Globulin (158 kDa) and Thyroglobulin (670 kDa) 
(Biorad) plotted against their elution volume. The protein contents of the samples 
before SEC, and of the peak fractions were visualized via SDS-PAGE and 
Coomassie staining. 
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Table 3.1 gBlock sequences (underline homology regions for assembly; red: sgRNA 
sequence; blue: 3X-FLAG sequence; bold: ATG and mutations of gsRNA sequence).   
 
Name  Sequence 
msrA 
gsRNA 
AACAACATCAGTCACCTAAAAAGAGAAAACGAATTACACGATCACTAATTTTAA
ATTTTATATATGTTGACTGAGATTGCAAATTTGAACATTGAAATTTTTTACCCGC
TTGATCTGAATAATGACATTGTTCAAAAAAAGTACAAATGATAAAAAAGAAAGC
TTCTCAAAAAACAGTAAAGAAGTTCTCCCCAAAATCACCTCAAAAATTCAGAGC
TCTATTATCAGAAAAAGCGAGCTTAAAAAATTCAAAGGAAAGATACCCCTCTG
CACCCTCAAAATTTTAGACCCTGTGTTGACCTGTAAAAATCAGGAAAAAATTTC
CGTCGGTTATGGTATATGTGATGATTTCCCCTAATTATGCTGTAAGCACATGTA
GAGACCTCCTCTTACTGCTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGG
CTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTGCCCTCA
GTTCTCTTTTTCTTTTTCTTAAACTTCACGCACTGCACTTTTGTCCTCACTTTTT
TCATGCCGTCAGATTAACTACTTTTTCTATCCTTGAAATCAGCGGCTTTTCAGC
CCTCATGTAGGCGCGCCGGCGATCGCGGCCGCTTAATTAA 
 
msrA 
Homology 
TTTTTTCGAAGTTTAAACCTGCAGGCGCGCCAAAAATTTCAATGTTCAAAATCT
CAGTCAACATATATAAAATTTAAAATTAGTGATCGTGTAATTCGTTTTCTCTTTT
TAGGTGACTGATGTTGTTTTTCCTTCTATCTTGCAACTCTCTTCAACTGTTAAA
GTAAACTCAATTAGATTATCTCGCGTTTTAAATTATTCATCCAAATTCTTTTATA
TAAATCCATATAACGGTAATCTCTAATATATGGCGCAAACTCTTCCTCCTATTA
GGGTCGTATATGGCCCGAGTGTAACTCAAATCCTTATTCGCCCACATGTAAAC
ATTTTTTCCTTGCCGCATAATGCAGATTATCCTATATTTAAAGAAAAAAGAGAT
AGGAGTGGTTTGAATGCAAGACTACAAGGACCACGACGGTGACTACAAGGA
CCACGACATCGACTACAAAGACGATGACGACAAGTCTGAGTTAATAGATGTA
GTATTTCGTTCTCAGAAAAGAAGAGACCTCCTCTTACTCCTGGGAGAGGAAC
CCCGCACAATGGAAGATATTAAAGTCCTCCTTGATGTTTCTCCCACGGCTATC
TTGCCCCAGATCAAGAGGCTTACGGACAGTAACCTTGTTATTCAGAAAAATGG
CAGCTATGAATTGACAGATATGGGAGAGCAGGTCTTCAAAAAAGCCAGGGCC
CTTGTTGATGTCCTTACCCTGGTTGAAAAAGATAACTACTGGATCGAACACGA
CCTGGGGGGAATTCCCCAGTACCTACTTGATAAGATCGGGGAAATTAAGGAC
TGCAATCTGGTTAAAGCTGATCCCAGCCAGATTTTCGAGCCGAATACCGAGCT
TCTGGAATATTTCGCTTCTTCCCGCTACCTTATGGTATTTTCATCTTTCTACAG
GCCGGAGTTCCTGCCCCTCTATTCCAAGCTAGGAAGGCTTGAGTCAGAGGTC
TCCCTTATTTTCACGGAATCGGTACTCGAAAAGTTCCTGTATAACTATGAAAAG
AAAATCAGAAGGCTTCCAACAACATCAG 
 
 64 
Table 3.2 Primers used for cloning in this study. 
Primer Sequence (restriction sites underlined and mutated bases lower case) Added sites 
MA0459ndeIfor GGCGCGCCCATATGCAATCTGAGTTAATAGA AscI, NdeI 
MA0459bamHIrev GGCGCGCCGGATCCTCAGTGGAGGCTTAAGAGCAG AscI, BamHI 
MA0460ndeIfor GGCGCGCCCATATGAGTATGGAACTGCAG AscI, NdeI 
MA0460xhoIrev GGCGCGCCCTCGAGTCAGATTTCCTTTATCTCTTC AscI, XhoI 
MA0460pET-Duet1for GGCGCGCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATCATATGAGATGGAACTGCAGTT
AATAGATACT 
AscI, NdeI, 
XbaI 
MA0460pET-Duet1rev GGCGCGCCCTCGAGGCTAGCTCAGATTTCCTTTATCTCTTC AscI, XhoI 
MA0459NdeIfor GGCGCGCCCATATGCAATCTGAGTTAATAGATGTAG AscI, NdeI 
MA0459HindIIIrev GGCGCGCCAAGCTTTCAGTGGAGGCTTAAGAGCAGAGATTC AscI, HindIII 
MA0460NdeIfor GGCGCGCCCATATGAGTATGGAACTGCAGTTAATAG AscI, NdeI 
MA0460HindIIIrev GGCGCGCCAAGCTTTCAGATTTCCTTTATCTCTTC AscI, HindIII 
MA0459Ntermhisfor GGCGCGCCCATATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGC
AGCCACATGCAATCTGAGTTAATAG 
AscI, NdeI 
MA0460Ntermhisfor GGCGCGCCCATATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGC
AGCCACATGAGTATGGAACTGCAGT 
AscI, NdeI 
MA0459CtermHisrev GGCGCGCCAAGCTTTCAATGATGATGATGATGATGGTGGAGGCTTAAGAGCAGAGATTC AscI, HindIII 
MA0460CtermHisrev GGCGCGCCAAGCTTTCAATGATGATGATGATGATGGATTTCCTTTATCTCTTC AscI, HindIII 
MA0459uidArev GGCGCGCCCTGCGGCTTCTTCTGGCGTCATTGCCT AscI 
MA0459uidAfor AACCACTCCTATCTCTTTTTTCTTTAA none 
MA0460uidArev GGCGCGCCATATTAAAGTCCTCCTTGATGTTTC AscI 
MA0460uidAfor GTTCGGCCTCCTTCCGGTAGGAG none 
P0459pTC1for GGATCCGGCGCGCCTCTGCGGCTTCTTCTGGCGTCATTG AscI, BamHI 
P045930aarev GGCGCGCCGGATCCTTCCATTGTGCGGGGTTCCTCTCCCAGC AscI, BamHI 
P04601aarev GGCGCGCCGGATCCCATTCTGTTCGGCCTCCTTCC AscI, BamHI 
P0460pTC1for GGATCCGGCGCGCCATATTAAAGTCCTCCTTGATGTTTC AscI, BamHI 
CB1forSphI GGCGCGCCGCATGCGTCCGTAAGCCTCTTGATCTGG AscI, SphI 
uidArevEcoRI GGCGCGCCGAATTCTCATTGTTTGCCTCCCTGCTGCG AscI, EcoRI 
CB1rev(-SphI) CTCATGCCTGCATaCGGACATGTGCTTAC none 
CB2forPstI GGCGCGCCCTGCAGTGCAACTGGAAGACAGGAAGC AscI, PstI 
CB3forPstI GGCGCGCCCTGCAGTAGCAGTAACCTCTGGCAGGATCAACCAGAATTG AscI, PstI 
CB3rev(-PstI) GCAGAGACTCCTaCAGATGACGAGGG none 
uidArevPstI GGCGCGCCCTGCAGTCATTGTTTGCCTCCCTGCTGCG AscI, PstI 
CB1L GGCGCGCCACTAGTCCGTAAGCCTCTTGATCTGG AscI, SpeI 
uidArev GGCGCGCCGCATGCTCATTGTTTGCCTCCCTGC AscI, SphI 
msrAF GGCGCGCCAACATATGCAATCTGAGTTAATAGATGTAGT AscI, NdeI 
msrAR TTGGCGCGCCAAGCTTGGGGAAAAGCCTCAAAACTG AscI, HindIII 
msrBF GGCGCGCCAACATATGAGTATGGAACTGCAGTTAATAGATACTATTT AscI, NdeI 
msrBR TTGGCGCGCCAAGCTTAGAGCGGATCATTGAGGAGT AscI, HindIII 
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Table 3.3 Plasmids used in the study. 
Plasmid Description and/or construction Reference 
pET-15b Ampicillin resistant E. coli 6X histidine-tag fusion expression vector Novagen 
pET-11a Ampicillin resistant E. coli protein expression vector Novagen 
pET-Duet1 Ampicillin resistant E. coli protein expression vector Novagen 
pAH55 Kanamycin resistant CRIM plasmid with oriR and l attP site. (Haldimann and 
Wanner, 2001) 
pAMG82 Vector for construction of translational fusions to the uidA gene of E. coli (Guss et al., 
2008) 
pTC1 
Vector for construction of transcriptional fusions to the uidA gene of E. coli. AscI/BamHI cloning site, two stop 
codons, and the mcrB ribosome binding site (RBS) upstream of the uidA gene; contains pac gene (puromycin 
resistance), attP site, and fC31 integrase for insertion of fusions into M. acetivorans chromosome. 
This study 
pJK027A ΦC31-attB vector with PmcrB(tetO1) promoter fusion to the uidA gene of E. coli (Guss et al., 
2008) 
pJK026A ΦC31-attB vector with PmcrB promoter fusion to the uidA gene of E. coli (Guss et al., 
2008) 
pAMG40 Kanamycin resistant pC2A derivative, which serves as an E. coli-Methanosarcina shuttle vector for fosmid 
retrofitting using the attP site. 
(Guss et al., 
2008) 
pDN201 Plasmid used for expression of the CRISPR-Cas9 system in Methanosarcina acetivorans (Reference) 
pAB70 NdeI/BamHI-digested MA0459 PCR product (using primers MA0459ndeIfor and MA0459bamHIrev) was cloned into 
NdeI/BamHI-digested pET-15b. 
This study 
pAB71 AscI/HindIII-digested pAB98 subcloned into AscI/HindIII-digested pET-Duet1. This study 
pAB74 NdeI/BamHI-digested MA0459 PCR product (using primers MA0459ndeIfor and MA0459bamHIrev) was cloned into 
NdeI/BamHI-digested pET-11b. 
This study 
pAB75 NdeI/BamHI-digested MA0460 PCR product (using primers MA0460ndeIfor and MA0460xhoIrev) was cloned into 
NdeI/BamHI-digested pET-11b. 
This study 
pAB78 XbaI/XhoI-digested MA0460 PCR product (using primers MA0460pET-Duet1for and MA0460pET-Duet1rev) was 
cloned into XbaI/XhoI-digested pET-Duet1. 
This study 
pAB92 NdeI/HindIII-digested MA0459 PCR product (using primers MA0459NdeIfor and MA0459HindIIIrev) was cloned into 
NdeI/HindIII-digested pJK027A. 
This study 
pAB93 NdeI/HindIII-digested MA0460 PCR product (using primers MA0460NdeIfor and MA0460HindIIIrev) was cloned into 
NdeI/HindIII-digested pJK027A. 
This study 
pAB64 AscI-digested 1000 bp upstream region of MA0459 PCR product (using primers MA0459uidArev and 
MA0459uidAfor) was treated with T4 kinase and cloned into Ecl136II/AscI-digested pAMG82 
This study 
pAB65 AscI-digested 1000 bp upstream region of MA0460 PCR product (using primers MA0460uidArev and 
MA0460uidAfor) was treated with T4 kinase and cloned into Ecl136II/AscI-digested pAMG82 
This study 
pAB83 AscI/BamHI-digested 1000 bp upstream region including the 30 codons into the open reading frame of MA0459 
PCR product (using primers P045930aarev and P0459pTC1for) was cloned into AscI/BamHI-digested pTC1 
This study 
pAB84 AscI/BamHI-digested 1000 bp upstream region including the ATG start codon of MA0460 PCR product (using 
primers P04601aarev and P0460pTC1for) was cloned into AscI/BamHI-digested pTC1 
This study 
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Table 3.3 Continued  
pAB150 Gateway® BP Clonase™ was used as described in materials and methods to mediate site-specific recombination 
between the l attP site on pAMG40 with the l attB site on pAB92. 
This study 
pAB151 Gateway® BP Clonase™ was used as described in materials and methods to mediate site-specific recombination 
between the l attP site on pAMG40 with the l attB site on pAB93. 
This study 
pPK062 NdeI /HindIII digested msrB PCR product cloned into NdeI/HindIII digested pJK026A This study 
pML72 Gblocks for sgRNA and 1kb msrB homology region introduced into pDN201 linearized with AscI by NEBuilder HiFi 
DNA assembly kit 
This study 
pML79  Gblocks for sgRNA and 1kb msrA homology region introduced into pDN201 linearized with AscI by NEBuilder HiFi 
DNA assembly kit 
This study 
pML73 Gateway® BP Clonase™ was used as described in materials and methods to mediate site-specific recombination 
between the l attP site on pAMG40 with the l attB site on pML72. 
This study 
pML80 Gateway® BP Clonase™ was used as described in materials and methods to mediate site-specific recombination 
between the l attP site on pAMG40 with the l attB site on pML79. 
This study 
 
 
 
Table 3.4 Methanosarcina acetivorans strains used in this study. 
 
Strain Genotype or description Source or Reference 
C2A Wild type (DSM 2834) (Guss et al., 2008) 
WWM82 Δhpt:: ΦC31-int-attP (Bose and Metcalf, 2007) 
WWM60 Δhpt::PmcrB-tetR (Bose and Metcalf, 2007) 
WWM330 Δhpt::ΦC31-int-attP ΔmsrA (Bose and Metcalf, 2007) 
WWM331 Δhpt:: ΦC31-int-attP ΔmsrB (Guss et al., 2008) 
WWM401 Δhpt:: ΦC31-int-attR PmtaC1::uidA  PmcrB(tetO1)-msrA-attL ΔmsrA This study 
WWM404 Δhpt:: ΦC31-int-attR PmtaC1::uidA  PmcrB(tetO1)-msrB-attL ΔmsrB This study 
WWM416 Δhpt:: ΦC31-int-attR PmsrA::uidA -attL This study 
WWM417 Δhpt:: ΦC31-int-attR PmsrB::uidA -attL This study 
WWM422 Δhpt:: ΦC31-int-attR PmsrA(30aa)::uidA -attL This study 
WWM423 Δhpt:: ΦC31-int-attR PmsrB(1aa)::uidA -attL This study 
WMM934 Δhpt:: ΦC31-int-attR PmcrB::msrB-attL This study 
WWM1000 Δhpt::PmcrB-tetR::3xFLAGmsrB This study 
WWM1116 Δhpt::PmcrB-tetR::3xFLAGmsrA This study 
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3.3.6 Preparation of DNA substrates for gel-shift assays 
The DNA substrates for gel-shift assays were amplified by PCR with primers 
shown in Table 3.5 using M. acetivorans C2A chromosomal DNA as template. 
For some substrates ssDNA oligos were annealed as follows; oligos were 
dissolved in STE Buffer (10 mM Tris pH 8.0, 50 mM NaCl, 1 mM EDTA). Each 
oligo was dissolved at high concentration (1 - 10 OD 260nm units / 100 uL). The 
two strands were mixed together in equal molar amounts. The mixture was boiled 
and cooled gradually to room temperature. The PCR products or annealed oligos 
were 5ʹ′ radiolabeled with γ-[32P]-ATP and T4 polynucleotide kinase, and then 
separated by electrophoresis on a native 5 - 20% polyacrylamide-1X TBE gels. 
The gel was exposed to film for two minutes to determine the location of the 
labeled DNA fragment. The area of the gel containing the DNA fragment was cut 
out and the DNA was eluted in low salt buffer (10 mM Tris-HCl, pH 8, 100 mM 
NaCl, 1 mM EDTA) overnight at room temperature. The DNA was passed over 
DE-52 columns and eluted using high salt buffer (10 mM Tris-HCl pH 8, 1 M 
NaCl, 1 mM EDTA). Following ethanol precipitation, the DNA pellet was 
resuspended in Tris-EDTA buffer pH 8.0. The DNA concentration was 
determined by measuring absorbance at 260 nm.  
 
3.3.7 Electrophoretic mobility shift assays (EMSA)  
Two methods were used for EMSA experiments. EMSA reactions performed 
using radiolabeled substrates proceeded as follows. Binding reactions were 
prepared with the indicated concentrations of DNA in 50 mM HEPES (pH 7.2), 50 
mM NaCl, containing 20% glycerol, 1 mM dithiothreitol (DTT), 1 mM MgCl2, 1 mM 
EDTA, 0.25 mg/ml BSA and 0.075 mg/ml of herring sperm DNA. Appropriate 
amounts of the purified protein or crude extract to be tested were then added and 
the reactions were allowed to equilibrate at room temperature for 15-20 min. The 
equilibrated reactions were loaded on a 5% polyacrylamide 0.5X TBE gel that 
was pre-run at 200V for 30 - 60 min, and run at 200 V in 0.5X TBE, until the DNA 
had migrated through most of the gel. The gel was then transferred to Whatman 
filter paper and exposed to phosphorimager screens. The images were obtained 
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using a Fujifilm FLA-3000 phosphorimager. A non-radioactive EMSA assay was 
used for some experiments. Reactions were prepared with the following 
concentrations 50 mM HEPES (pH 7.2), 50 mM NaCl, 1 mM DTT, 10% glycerol, 
1 pmol 6FAM (Fluorescein)-labeled DNA and 100 µM MgCl2 or 100 µM MgCl2 
and 100 µM CaCl2.  Proteins used were incubated with 1 mM EDTA prior before 
concentrating and desalting as indicated in section 3.3.6. MsrAB was added to 
the reactions in the concentration indicated in Figure 3.2. Reactions were 
incubated at RT for 30 minutes and run in 7.5% Mini-PROTEAN® TGX Precast 
Protein Gels (Bio-Rad Laboratories, Hercules, CA). Gels were run at 150 V using 
1X TBE as running buffer. DNA bands were visualized by staining in 50 ml TBE 
with 1X SBR® Safe DNA Gel Stain for 30 min (ThermoFisher, Grand Island, NY).  
 
3.3.8 DNAse I footprinting  
Binding reactions were set up at room temperature with 50 mM HEPES (pH 7.2), 
50 mM NaCl, 1 mM DTT, 100 µM MgCl2, 100 µM CaCl2, 10% glycerol, 1 pmol  
fluorescein-labeled DNA, incorporated in the PCR primers used to prepare 
substrates, and 1000 pmol MsrA-MsrB. Reactions were incubated for 30 min.  
The complexes were digested with 50 mU DNAse I (New England Biolabs, 
Ipswich, MA) at 37°C for five minutes.  Reactions were stopped by addition of 
one volume of 0.5M EDTA and cleaned using the DNA Clean and Concentrator 
kit from Zymo Research following manufacturer’s instructions (Zymo Research 
Irvine, CA) eluting in 20 µl of water. Fragments were submitted for fragment 
analysis at the W. M. Keck Center for Comparative and Functional Genomics, 
University of Illinois. Genemapper Software version 3.7 (Applied Biosystems 
Foser City, CA) was used to analyze and map the fragment data.  
 
3.3.9 Transcriptomic analyses (RNA-seq) 
RNA was extracted from cultures grown to mid exponential phase using the 
Direct-zol RNA MiniPrep kit (Zymo Research Irvine, CA) following the 
manufacturer’s instructions. Ribosomal RNA was depleted using subtractive 
hybridization employing biotinylated rRNA probes as previously described (Fu 
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and Metcalf, 2015). The quality of the RNA was verified using a Agilent 
Bioanalizer. RNA sequencing was performed at the Keck Center for Comparative 
and Functional Genomics, University of Illinois using strand specific libraries 
prepared with the Illumina ScriptSeq kit version 2 (Epicentre Biotechnologies, 
Madison, WI). Bar-coded libraries were pooled, quantified by qPCR and 
sequenced for 101 cycles on a HiSeq2000 using the TruSeq SBS sequencing kit 
version 3 (Illumina, San Diego, CA). Reads were analyzed using the CLC 
genomics platform (version 7.5) and reads were trimmed based on quality 
(quality: 0.001, ambiguous: 2, discard min:30, max: 100). To remove bias caused 
by remaining stable RNAs, the trimmed sequences were mapped to M. barkeri 
rRNA and tRNA sequences using the following parameters similarity: 0.9, length: 
0.85, mismatch: 2, insertion: 3, deletion: 3.  The remaining reads were used for 
the RNAseq analysis (similarity: 0.9, length: 0.85, mis:2, ind:3, del:3, global 
alignment, maximum number or reads per read: 10).  Expression values were 
calculated as RPKM (Reads Per Kilobase per Million reads). Reads were 
normalized and statistical analysis was performed using the empirical analysis of 
digital gene expression (Robinson and Smyth, 2008). To determine differential 
gene expression, reads from each mutant strain were compared against reads of 
WT and each mutant strain. Genes showing fold expression changes greater 
than 4, or less than -4, with P-values ≤ 0.01 were considered to be differentially 
expressed. The raw and processed RNA-seq data have been deposited in the 
Gene Expression Omnibus (GEO) under the accession number (submission 
pending). 
 
3.3.10 qRT-PCR measurements 
RNA was extracted from biological cultures grown in triplicates to mid 
exponential phase using Direct-zol RNA MiniPrep kit (Zymo Research Irvine, CA) 
following manufacturer’s instructions. DNA was removed from RNA samples by 
digestion with DNaseI (New England Biolabs, Ipswich, MA).  The quality of the 
RNA was verified using Agilent Bioanalizer at the W. M. Keck Center for 
Comparative and Functional Genomics, University of Illinois. qRT-PCR reactions 
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Table 3.5 Primers used to generate substrates for gel-shift assays. 
 
Primer Sequence 
mtaCB1revmain TCTAAACCTCCATTTAGATCAAACAACAAAAAGGTC 
mtaCB1for100 GGCGCGCCACTTTACAAAGGCAAAACCGG 
mtaCB1for200 GGCGCGCCGTTTCGGTAACAGGAGAAAGAAATTCT 
mtaCB1for300  GGCGCGCCTAGACCCTGTGTTGACCTGTAAAAATC 
mtaCB1for400 GGCGCGCCCCTCAAAAATTCAGAGCTCTATTATC 
mtaCB1for500 GGCGCGCCTTTACCCGCTTGATCTGAATAATG 
mtaCB1for600 GGCGCGCCAACAACATCAGTCACCTAAAAAGAG 
mtaCB1rev300 GATTTTTACAGGTCAACACAGGGTCTA 
mtaCB1rev400 GATAATAGAGCTCTGAATTTTTGAGG 
mtaCB1for 700 GGCGCGCCCCGTTATATGGATTTATATAAAAGAAT 
mtaCB1for650 CTAATTGAGTTTACTTTAACAG 
mtaCB1for550 TTAAATTTTATATATGTTGACTG 
mtaCB1rev500 AAATTTCAATGTTCAAATTTGC 
mtaCB1rev450 TCATTTGTACTTTTTTTGAACAATGTC 
mtaCB1rev400 GATAATAGAGCTCTGAATTTTTGAGG 
mtaCB1rev350 ATCTTTCCTTTGAATTTTTTAAGC 
mtaCB1rev300 GATTTTTACAGGTCAACACAGGGTCTA 
cb1BS(3) topstrand TAAAGAAGTTCTCCCCAAAATCACCTCAAAAATTCAGAGCTCTATTATCAG
AAAAAGCGA 
cb1BS(3) botstrand TCGCTTTTTCTGATAATAGAGCTCTGAATTTTTGAGGTGATTTTGGGGAGA
ACTTCTTTA 
PmcrBfor TTCATTTATCGGAGAACACAAAAGATTTAAG 
PmcrBrev TTTGCTCCCTCCGATTATTCCCAATG 
mtaCB1_F300 TTGACTGAGATTGCAAATTTGAACA 
mtaCB1_R270 ATGTGCTTACAGCATAATTAGGGGA 
 
 
Table 3.6 qRT-PCR primers used in this study. 
 
Primer Sequence 
qRT_rpoA1F GGCAGAGACGAGACAGG 
qRT_rpoA1R GGTTCAGGATGGAACCTCT 
qRT_mtaBF CACGCAGTTCTCAGACCAGA 
qRT_mtaBR GATGAACATTGCGGTGTTTG 
qRT_mttBF GACTCCGTGGAACAGGACAT 
qRT_mttBR GTTAGTGCTTTGCGGTGTTT 
  
 
were performed with 200 ng of total RNA, using Mastercycler ep realplex 
(Eppendorf, Hamburg, Germany) and the SuperScript® III One-Step RT-PCR 
System with Platinum® Taq (Thermo Fisher Scientific, Waltham, MA) per 
manufacturer’s instructions. Changes in gene expression were calculated using 
the 2-ΔΔCt method (Livak and Schmittgen, 2001) using rpoA1 as the standard. For 
primers used refer to Table 3.6.   
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3.3.11 Western blots  
Cell lysates from mid exponential phase cultures grown on methanol or TMA 
were prepared as follows; 5 ml of cell cultures were centrifuged and resuspended 
in 500 µl of lysis buffer (50 mM Tris HCl, 3 M KCl and 5 mM MgCl2). Protein 
concentration was determined by the Bradford method (Coomassie protein 
reagent, Sigma Aldrich, St. Louis, MO) using BSA as a standard. Increasing 
amounts of protein from cell lysates were electrophoretically separated using 
SDS-PAGE  (4-20%), transferred onto PVDF membranes and blocked with 5% 
(w/v) milk in TBST buffer (150 mM NaCl, 5 mM Tris base and 0.05% Tween 20) 
for 30 min at room temperature. Membranes were incubated with 3 µl 
monoclonal anti-FLAG M2 murine antibody (Sigma-Aldrich, St. Louis, MO) and 
incubated over night at 4°C. Membranes were washed three times and incubated 
with 1 µl of Goat anti-Mouse IgG (H+L) Secondary Antibody, HRP conjugated 
(Thermo Scientific, Waltham, MA) for an hour. Reactions were detected by 
chemiluminescence using SuperSignal™ West Femto Maximum Sensitivity 
Substrate (Thermo Scientific, Waltham, MA).  
 
3.3.12 In silico methods 
Protein domain predictions were made using InterProScan (Mulder et al., 2007), 
HTH program (Dodd and Egan, 1990) and BLASTP (Altschul et al., 1990). 
Precise length of the domains were determined using CDD (Marchler-Bauer et 
al., 2007). Orthologs were identified using the Integrated Microbial Genomes 
System (Markowitz et al., 2006). CLUSTALW was used to determine sequence 
identity and to construct amino acid sequence alignments (Chenna et al., 2003). 
Start codon prediction for open reading frames was performed using GeneMark 
(Lukashin and Borodovsky, 1998). A rooted neighbor-joining tree was generated 
by the DRAWTREE program (http://workbench.sdsc.edu) (Thompson et al., 
1994, Higgins et al., 1992, Felsenstein, 1989). 
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3.4 Results 
3.4.1 Bioinformatics analyses suggest that MsrA and MsrB proteins are 
members of an archaeal specific family of DNA-binding proteins  
We previously reported that the MsrA and MsrB proteins from M. acetivorans 
C2A have orthologs in M. mazei Gö1 and M. barkeri Fusaro (Bose and Metcalf, 
2008). Careful pair-wise comparison of these proteins showed that the 
homologous proteins share 74-96% amino acid sequence identity between M. 
acetivorans, M. barkeri Fusaro and M. mazei Gö1, while paralogs share only 30-
50% identity (Table 3.7). Both MsrA and MsrB have a helix-turn-helix (HTH) 
DNA-binding motif that shares a weak similarity to the HTH motif of the ArsR 
family of regulators. However, in contrast to the ArsR proteins that only encode a 
HTH domain, the MsrA and MsrB proteins also have a C-terminal domain of 
unknown function (DUF1724) that is found solely in Archaea (Fig 3.1, panel A) 
(Busenlehner et al., 2003). Significantly, the Msr proteins lack the canonical ArsR 
family metal binding sites (data not shown), thus, they are unlikely to function as 
metal-repsonsive transcriptional regulators. Homology detection and structure 
prediction by Hidden Markov Model using HHpred  (Soding et al., 2005)predicted 
that both MsrA and MsrB are structural homologs of TrmBL2 and TrmB, an 
archaeal chromatin protein and a global transcriptional regulator from 
Pyrococcus furiosus respectively. Additional analysis using I-TASSER (Yang et 
al., 2015)  suggested the presence of a metal binding pocket in the C-terminus of 
the proteins, suggesting that although they lack ArsR-like conserved residues 
metals might still play a role  in MsrA/B function.  
 
Similarity searches against the non-redundant protein database reveal that MsrA 
and MsrB are members of a much larger protein family found solely in Archaea, 
which we have designated the Msr family (Fig 3.1). Msr proteins occur 
exclusively in the members of the domain Archaea including members of the 
Halobacteria, Methanobacteria, Archaeoglobi and Methanomicrobia. Although 
many archaeal species encode one or two Msr family members, there is a  
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Table 3.7 Percent amino acid identity of the Msr proteins in M. acetivorans C2A, M. barkeri Fusaro and M. mazei Gö1a. 
 Ma 
MsrA 
Mm 
MsrA 
Mb 
MsrA 
Ma 
MsrB 
Mm 
MsrB 
Mb 
MsrB 
Ma 
MsrC 
Mm 
MsrC 
Mb 
MsrC 
Ma 
MsrD 
Mm 
MsrD 
Mb 
MsrD 
Ma 
MsrE 
Mm 
MsrE 
Mb 
MsrE 
Ma MsrA - 83 77 31 34 33 31 36 29 41 40 42 35 34 32 
Mm MsrA  - 74 29 30 29 27 30 25 36 35 36 31 28 31 
Mb MsrA   - 34 34 35 31 34 28 39 38 40 35 33 35 
Ma MsrB    - 84 79 40 41 38 36 35 36 48 48 46 
Mm MsrB     - 82 39 42 37 40 38 39 50 50 48 
Mb MsrB      - 37 42 38 38 36 38 48 48 47 
a.CLUSTALW was used for calculations (Thompson et al., 1994). 
b. Ma: M. acetivorans C2A; Mb: M. barkeri Fusaro; Mm: M. mazei Gö1. 
 
  
 
 
Figure 3.1 Bioinformatic and phylogenetic analysis 
of MsrA and MsrB Panel A: Domain structure of the 
MsrA and MsrB proteins. Abbreviations: HTH, helix-
turn-helix domain; DUF1724, domain of unknown 
function present only in archaea. Panel B: 
Neighborhood-joining three of Methanosarcina Msr 
proteins. MM, M. mazei, MA, M. acetivorans and 
Mbar, M. barkeri. Red: MsrA and MsrB; Blue: MsrD 
and MsrE; Aqua MsrF, MsrG and MsrC .  
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substantial expansion in the Family Methanosarcinaceae, with at least 25 Msr-
like proteins in M. acetivorans, 16 in M. barkeri and 20 in M. mazei Gö1. To date 
8 members of this family in M. acetivorans. have been studied, all of which are 
involved in transcriptional regulation of C-1 metabolism (Bose and Metcalf, 2008, 
Bose et al., 2009, Fu and Metcalf, 2015). These include the methanol 
methyltransferase regulators, MsrA, MsrB, MsrD and MsrE, the dimethylsulfide 
methyltransferase regulators, MsrC, MsrF and MsrG (Bose et al., 2009, Bose 
and Metcalf, 2008) and the methylmercaptopropionate regulator MsrH (Fu and 
Metcalf, 2015). Several subgroups can be recognized within the family, with 
MsrA and MsrB falling into distinct clades (Fig 3.1, panel B). These subgroups 
are likely to reflect functional differences between the members. Although 
sequence analysis suggests that these proteins are DNA-binding proteins, the 
mechanism by which they regulate transcription has yet to be established. 
 
3.4.2 Promoter binding is sequence specific and requires both MsrA and 
MsrB 
To test the hypothesis that MrsA/B mediate transcriptional activation by direct 
binding to mtaCB1, we purified recombinant versions of the proteins after 
expression in E. coli and investigated their DNA binding activities by EMSA 
assays. When used alone, neither MsrA nor MsrB was able to bind the putative 
promoter region; however, when the two proteins were combined a pronounced 
gel-shift was observed, suggesting that an MsrA/MsrB complex is required for 
DNA binding  (Fig 3.2 A). Binding to the labeled fragment could be eliminated by 
addition of a large excess of unlabeled DNA containing the mtaCB1 promoter, 
whereas addition of a large excess of a non-target sequence did not (Fig 3.2 B). 
Thus, binding of the MsrA/B complex is sequence-specific. 
 
Subsequent EMSA experiments using truncated promoter fragments narrowed 
the MsrA/B binding region to a 134 bp fragment, beginning 81 bp upstream of 
mapped transcription start site (Bose and Metcalf, 2008). Thus, more distal, or 
more proximal, promoter fragments, were incapable of binding the recombinant 
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proteins. However, within this region, a series of non-overlapping fragments 
showed MsrA/B binding, suggesting that multiple binding sites are present in the 
mtaCB1 promoter (Fig 3.3 panel A). The observation of larger band-shifts due to 
increasing levels of recombinant protein is consistent with this interpretation (Fig 
3.2 B).   
 
Figure 3.2 Binding specificity of MsrA/B to the mtaCB1 promoter. Panel A: DNA substrate 
encompassing the mtaCB1 promoter was used to test the ability of MsrA and MsrB to bind to its 
promoter (360 bp to 544 bp upstream of the ATG start codon of the mtaC1 gene). 0.2 fmol of 
labeled substrate was reacted with 30 pmol of recombinant MsrA and MsrB and incubated in the 
presence (+) or absence (-) of the proteins. Panel B: Unless otherwise specified reactions 
included 0.2 fmol of DNA and 30 pmol of MsrA/B. Fragment K, 334-544 (Fig 3.3 panels A and B) 
was used as substrate. Lane 1: DNA only; Lanes 2-4: 30 pmol, 15 pmol and 7.5 pmol of MsrA/B 
respectively; Lanes 5-8 reactions have MsrA/B, DNA probe and unlabeled competitive substrate 
(UNC) in the following concentrations: 10 fmol, 5 fmol, 2.5 fmol and 1.25 fmol of DNA; Lane 9: 
MsrA and DNA probe; Lane 10: MsrB and DNA probe; Lane 11: MsrA/B, DNA probe and 1 pmol 
of unlabeled non-competitive substrate. 
 
3.4.3 MsrA/B footprint  
To determine the precise MsrA/B binding sequence, we performed a DNAseI 
footprint experiment using a probe that included the regions from 270 to 578 from 
the annotated ATG of mtaCB1. Protection in the presence of MsrA/B was 
detected over a region of 62 bp from positions 318 to 380  (Fig 3.3 and 3.4). An 
area of hypersensitivity was detected in position 314. 
 
3.4.4 The Msr proteins bind the mtaCB1 promoter as a heterodimer  
Because MsrA/B bind as a complex, we wanted to examine the oligomeric 
structure of the proteins in solution. To do this, we combined the two proteins in  
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Figure 3.3 Determination of the binding sites of the MsrA and MsrB to their target promoter mtaC. Panel A. 
Schematic depiction of promoter truncations used as probes for EMSA experiments. Green: fragments 
tested positive for binding, Red: fragments tested negative for binding, Blue: 38 bp fragment tested positive 
for binding, Black: footprint. Fragment position with respect to annotated ATG: A, 109; B, 230; C, 360; D, 
444; E, 544; F, 644; G, 545-751; H, 495-694; I, 418-594; J, 386-594; K, 334-544; L, 419-456; M, 457-494. 
Panel B: EMSA with truncated promoter regions. Reactions were performed in the presence (+) or absence 
(-) of MsrA/B. Panel C: EMSA with truncated promoter regions. Unless specified otherwise 0.1-0.3 fmol of 
DNA was incubated in the presence (+) or absence (-) of 30 pmol MsrA/B. Reactions on lanes 11 and 12 
had 21 fmol DNA probe and 100 pmol protein. Reactions on lanes 13 and 14 had 26 fmol of DNA and 100 
pmol of protein.  
 
various ratios and performed size exclusion chromatography (SEC). When 
combined in a 1:1 ratio the complex eluted as a single peak consistent with 
expected size for a heterodimeric complex (Fig 3.5). Two peaks were observed 
when mixtures containing an excess of either MsrA or MsrB were analyzed, one 
eluting in the same fraction as the heterodimer, the other eluting in fractions 
consistent with the expected size of the excess monomer (Fig 3.5). SDS/PAGE 
analysis of the various fractions is consistent with this interpretation. Thus, MsrA 
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Figure 3.4 DNAse I footprint of mtaCB1 promoter region. The x-axis represents length of the 
fragments. The y-axis represents fluorescence intensity. Panel A represents DNA only reaction, 
panel B represents BSA control and panel C represents a reaction containing 1000 pmol MsrAB. 
Protected region and its position regarding translation start site is presented on the figure.  
 
and MsrB form a heterodimer in solution, which most likely represents the 
minimal DNA-binding species; however, given the observation of multiple binding 
sites within the promoter, it is possible that higher order structures are required 
for transcriptional activation.  
 
3.4.5 Binding of MsrAB is enhanced by addition of metals 
Although MsrA and MsrB do not have the conserved metal binding residues 
conserved in the ArsR family of regulators, analysis of predicted protein structure 
and function suggests the presence of a metal binding pocket in the C-terminus 
of the proteins. To test if addition of metals improves MsrA/B binding we 
performed an EMSA experiment in the presence and absence of calcium. 
Addition of 100 µM of CaCl2 in the presence of equimolar amount of MgCl2 
caused a stronger shift in binding when compared to reactions performed in the 
presence of MgCl2 alone (Fig 3.6). These results suggest that MsrAB might 
require the presence of a metal to bind and regulate transcription of 
methyltransferases. Addition of Mn also improves binding of MsrA/B to mtaCB1 
promoter. More experiments are needed to determine which metal is bound to 
the proteins and the role they play in Msr function.  
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Figure 3.5 Oligomeric state of the MsrAB proteins. Analytical size exclusion chromatography 
(SEC) of MsrA and MsrB proteins. Red, 1:1 ratio of MsrA and MsrB; 1, dimer MsrAB (elution 58 
ml). Green, 2:1 ratio of MsrA and MsrB, 2, MsrAB dimer (elution 58 ml); 3, MsrA monomer 
(elution at 64 ml). Blue, 1:2 ratio of MsrA and MsrB. 4, MsrAB (elution 58 ml); 5, MsrB (elution 68 
ml). Inset shows an SDS/PAGE of MsrA and MsrB fractions collected during SEC run. M, marker; 
I, II, III MsrAB before SEC. 
 
3.4.6 Regulation of msrA and msrB genes 
The observation that recombinant MsrA/B proteins bind their target promoter 
suggests that substrate-specific gene expression is mediated at a different level, 
perhaps by regulating expression of the msrA and msrB genes. Therefore, we 
assessed the expression of these genes using RNAseq data. Wild-type M. 
acetivorans showed similar msrA or msrB mRNA levels when cells were grown 
on methanol or TMA (Table 3.9). Our data also showed that msrA expression 
was unaffected by deletion of msrB and that msrB transcripts are unaffected by 
deletion of msrA, suggesting that msr proteins do not regulate their own 
expression. Since no transcriptional level regulation was evident in our results, 
we decided to test if the MsrA and MsrB proteins were regulated post-
transcriptionally by protein degradation. To test this we constructed strains that 
0 
1 
2 
3 
4 
5 
6 
7 
8 
45 50 55 60 65 70 75 80 85 
A
bs
or
ba
nc
e 
(m
A
U
) 
Ve (ml) 
1 
2 
3 
4 
5 
M 1  I M 2  II 3 M 4  III 5
203
113
72
47
34
27
17
6
kDa
 79	  
expressed the chromosomal copy of either gene with a 3x-FLAG tag on the N-
terminus. qPCR  analysis of the strains showed the chromosomal tag did not 
affect the regulation of the mtaCB1 operon mediated by the Msr proteins (data 
not shown). Western blot analysis of the strains grown on methanol or TMA 
revealed that the proteins seem to be expressed at a similar level in cells grown 
on both substrates (Fig 3.7). 
       
                             
 
Figure 3.6 EMSA exeperiment in the abscence (panel A) or presence (panel B) of CaCl2  
Lane 1: no protein, lanes 2-8 had 8, 16, 32, 64, 128, 256 and 512 pmol of protein respectively.  
       
3.4.7 Global transcriptomic profiling of ΔmsrA and ΔmsrB strains 
To further investigate the regulatory functions of MsrA and MsrB we compared 
the transcriptional profile of wild-type M. acetivorans to that of msrA and msrB 
mutants after growth in a variety of media (Table 3.8). Deletion of msrA and msrB 
resulted in dramatically lower levels of the mtaCB1 transcript during growth on 
methanol, while no difference was observed in other media. This result is 
consistent with previously obtained reporter gene assays (Bose and Metcalf, 
2008). Interestingly, mtaCB1 was the sole transcript whose expression level was 
specifically affected by deletion of msrA. In contrast, deletion of msrB alone  
A
B
1 2 3 4 5 6 7 8
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Figure 3.7 Western blot analysis of 3X-FLAG tag MsrA and MsrB. Cell lysates of strains carrying 
a chromosomally tagged 3X-FLAG tag msrA and msrB were separated by SDS-PAGE, 
transferred onto nitrocellulose membrane and probe with anit-FLAG and anti-mouse antibodies. 
25 µg (lane 1), 12.5 µg (lane 2), 6.25 µg (lane 3), 3.12 µg (lane 4), 1.56 µg (lane 5) and 0.78 µg 
(lane 6) of total protein from cells lysates of methanol and TMA grown cells.  
 
had more widespread effects. Accordingly, msrB mutants showed significantly 
higher levels of transcripts of genes known to be involved in growth on 
monomethylamine (mttP, mtmB1, mtmC1, mtbA), dimethylamine (mtbC1, mttP, 
mtbB) or trimethylamine (mttb, mttC) when the cells were grown on methanol or 
acetate. The increase in abundance was still apparent when the mRNA levels 
between the two deletion strains was compared, suggesting that the role of MsrB 
in regulation of methylamine related genes is independent from MsrA and vice 
versa. To show that this affect was MsrB-specific, we complemented the deletion 
mutant with a copy of the gene expressed under the constitutive promoter pmcrB 
(WWM934). qPCR analysis of methanol-grown ΔmsrB  and WWM934 cells 
showed a decrease in mRNA abundance in the complemented strains when 
compared to WT (fold change regulation: ΔmsrB:mttB1, +750; WWM934:mttB1, 
+22; ΔmsrB:mtmB1, +32; WWM934:mtmB1, +1; ΔmsrB:mtaB1, -92; 
WWM934:mtaB1, +4).  
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3.5 Discussion 
The data presented in this Chapter are fully consistent with a model in which the 
positive transcriptional effects of MsrA and MsrB are mediated by binding to 
the mtaCB1promoter. Because transcript and protein levels for MsrA and MsrB 
do not change significantly in the presence of different substrates and addition of 
methanol to EMSA experiments did not enhanced binding, it is likely that in the 
presence of methanol MsrA/B might be subjected to conformational changes due 
to post-translational modifications that allow them to dimerize and bind the 
mtaCB1 promoter presumably to aid in the recruitment and stabilization of the 
RNA polymerase. 
 
This idea is supported by our EMSA experiments, which show that an MsrA/B 
complex binds the mtaCB1 promoter in a sequence specific manner. EMSA 
assays showed that a region between 419-456 from the ATG start codon of the 
mtaCB1 operon is sufficient for binding of MsrA/B. However, binding to this 
region was weak suggesting that surrounding regions might contribute to binding.  
In addition, it is important to mention that although we saw a strong footprint in 
the region of 318 to 380 the entire promoter fragment used as probe was 
protected in comparison to the no protein and BSA controls. This suggests that 
similar to TrmBL2 (Maruyama et al., 2011, Wierer et al., 2016), MsrAB might bind 
to multiple sites of its cognate promoter in vitro. Moreover, tools to predict and 
analyze protein structures (HHphred) have identified MsrA and MsrB as 
structural homologs to the TrmBL2 protein from P. furiosus thus supporting our 
hypothesis of TrmBL2-like behavior in Msr proteins. The location of the MsrAB 
binding site with reference to the TSS, TATA-box and BRE shows that there is a 
substantial distance between these two regions in comparison to that seen for 
other archaeal regulators like LysM, Ptr-2 and GvpE (Bauer et al., 2008, 
Brinkman et al., 2002, Ouhammouch et al., 2003, Ouhammouch and 
Geiduschek, 2005, Ouhammouch et al., 2005). This, in addition to the 
observation of multiple binding sites suggests that DNA looping might be a way 
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that MsrA/B contact the pre initiation complex and aids in the recruitment and 
stabilization of RNA polymerase.  
 
Contrary to the previously described methanogen regulators, MsvR and MreA, 
which bind their respective promoters as homodimers, the Msr proteins bind to 
their cognate promoter as heterodimers. Although common in eukaryotes, 
binding of target promoters by heterodimeric proteins is rarely seen in bacterial 
and archaeal regulators. Presumably, binding as heterodimers expands the 
regulatory properties of these proteins since it would allow them to pair up with 
multiple partners to regulate multiple genes. Only a few examples have been 
described in literature including the FlhDC complex, which activates expression 
of flagella synthesis in E. coli (Wang et al., 2006), the RcsB response regulator 
responsible for the activation of motility, biofilm and stress response genes in E. 
coli (Salscheider et al., 2014) and the CPE1446-CPE1447 complex in C. 
perfringens which activates the transcription of toxin synthesis genes in 
this organism (Obana and Nakamura, 2011). Some similarities exist between 
these systems and the MsrA/B complex including the expression of the genes in 
an operon and the proximity of the regulators to one of their target operons. 
However, the domain structure of the proteins is different since Msr proteins lack 
a canonical receiver domain (Fig 3.1) and as most of the archaeal transcription 
regulators it posses a sensing domain unique to the archaeal domain of life. This 
suggests a novel mechanism of regulation by the Msr proteins.  
 
Our experiments showed that expression of msrA and msrB is constitutive in all 
conditions tested (Table 3.9). Western blot analysis from N-terminus FLAG-
tagged cells grown on methanol or TMA revealed that not only is transcript made 
but also protein stability remains intact even in conditions were MsrA/B are not 
expected to regulate methyltransferase expression. Therefore it is probable that 
activity of these proteins is regulated by covalent modifications or by direct 
interactions with other members of the regulatory cascade. However, there is a 
caveat in our experiment design since it has been shown that some Archaea 
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proteins have degradation signals in the N-terminus domain. Hence, there is the 
possibility that proteins are stable in our experiment because the N-terminus 
FLAG-tag is preventing protein degradation. Bioinformatic analysis of the MsrA 
and MsrB amino acid sequence did not revealed any degradation signal in the N-
terminus of the proteins. However, we are constructing strains that have C-
terminus FLAG tag MsrA and MsrB to test for this possibility.  
 
Global transcriptional profiling of ΔmsrA and ΔmsrB strains revealed that in 
addition to activating the transcription of the mtaCB1 operon, MsrB represses the 
methylamine methyltransferase genes when the cells are grown on methanol or 
acetate (Table 3.8). Thus, MsrB has a dual function in transcription regulation. 
This dual regulatory function has also been proposed for the M. acetivorans 
regulator MreA (Reichlen et al., 2012). Since only ΔmsrB and not ΔmsrA strains 
showed an over-expression of methylamine related genes (Table 3.8) it is 
unlikely that MsrA and MsrB are forming a heterodimer to regulate these 
operons. Instead it is possible that MsrB is forming a homodimer like the M. 
acetivorans regulator MaMsvR (Isom et al., 2013). Another possibility is that 
similar to the E. coli RcsB response regulator, which has been shown to pair with 
different transcription regulators (Salscheider et al., 2014), MsrB might be pairing 
up with a different Msr protein to act as a repressor. However, further EMSA and 
pull down experiments discussed in Chapter 5 of this thesis would be necessary 
to asses binding of MsrB to the methylamines promoters and to identify other 
binding partners of MsrB. 
 
Although the DNA binding domain of the Msr family regulators shares a weak 
similarity to the bacterial ArsR family of regulators, numerous differences suggest 
that the Msr proteins are functionally and evolutionarily distinct. These 
differences include: i, the capacity of Msr proteins to act both as repressors and 
activators of transcription while ArsR regulators only act as repressors of 
transcription; ii, contrary to ArsR regulators MsrA/B function as heterodimers and 
iii, unlike ArsR regulators Msr do not regulate their own expression. Moreover, 
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Msr proteins do not contain the conserved metal binding residues found in other 
ArsR-family members (Busenlehner et al., 2003). Based on these observations 
we propose that the Msr proteins are not part of the ArsR family of regulators but 
rather form a novel family of DNA binding proteins exclusive to the domain 
Archaea.  
 
Despite our increased understanding of the mechanism of Msr action, numerous 
critical questions remain. In particular, our data shed no light on the mechanism 
of methanol sensing by M. acetivorans that ultimately leads to the expression of 
the methanol specific methyltransferases. Addition of methanol to gel-shift 
experiments did not affect the ability of these proteins to bind the mtaCB1 (data 
not shown), thus these proteins are not themselves the methanol sensors which 
strongly suggest that these proteins respond to the presence of methanol by an 
unknown mechanism. In addition, EMSA experiments showed that addition of 
metals improve binding of MsrAB to the mtaCB1 promoter. However, the role that 
metals have in DNA binding remains undetermined. Finally, to see binding our 
EMSA experiments required a large protein to DNA ratio but the binding to the 
promoter region was specific. These results suggest that there is a missing 
component to the system that we hypothesize could be in the form of a post-
translational modification or in a required third component of the system. In 
Chapter 5 of this thesis I propose experiments to identify the potential missing 
component. 
 
In conclusion, this study solidifies the basic scheme of the methanol regulatory 
network in M. acetivorans C2A. Although, the details of this network have not 
been worked out completely, a number of important clues were revealed from 
this study. We anticipate that information from future studies combined with 
present knowledge will shed light on the physiological significance of complex 
metabolic regulation in this environmentally significant group of organisms. 
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Table 3.8 Select mRNA abundance changes of ΔmsrA  and ΔmsrB strainsa (CLC genomics). 
 
  ΔmsrA ΔmsrB ΔmsrB vs ΔmsrA 
  MeOH TMA Ac MeOH TMA Ac MeOH TMA Ac 
Locus 
Tag Annotation 
Fold 
Changeb 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
Fold 
Change 
MA0143 mttP 1 2 -1 5 -1 3 5 -1 3 
MA0144 mtmB1 1 5 -1 44 1 5 42 -5 6 
MA0145 mtmC1 1 6 -1 52 1 6 41 -5 6 
MA0146 mtbA -1 4 -1 7 1 2 8 -4 2 
MA0455 mtaB1 -56 1 -1 -56 -2 -1 -1 -2 -1 
MA0456 mtaC1 -46 2 -1 -41 -1 -1 1 -2 -1 
MA0527 mtbC -1 3 -1 52 -2 25 60 -5 30 
MA0528 mttB -1 5 -1 76 -1 28 82 -6 32 
MA0529 mttC 1 7 -1 120 -1 28 108 -6 29 
MA0530 transmembrane protein MttP 1 3 
-1 
27 -2 10 26 -5 10 
MA0531 predicted protein 1 5 -1 39 -1 11 29 -5 12 
MA0532 mtbB 1 4 -1 44 -1 9 43 -5 10 
aThe full datasets for each condition, including parsed tables showing only significant differences, are deposited in (submission pending). 
bFold change of expression values of mutant strains compared to WT M. acetivorans grown in the same substrate. ΔmsrB vs ΔmsrA columns present fold change of expression values 
of ΔmsrB strains when compared to ΔmsrA grown in the same substrate. Statistically significant values (P<0.01) based on EDGE test are highlighted in bold.   
 
 
Table 3.9 Expression of msrA and mrsB.  
 
  Normalized expression values 
  WT ΔmsrA ΔmsrB 
Locus Tag Annotation MeOH TMA MeOH TMA MeOH TMA 
MA0459 msrA 403 331 1 17 479 584 
MA0460 msrB 166 215 229 130 1 2 
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Chapter 4: Characterization of Two-Component Regulatory Systems in 
Methanosarcina acetivorans C2A 
 
4.1 Abstract  
 
The Methanosarcinales are the most metabolically diverse methanogens using a 
variety of substrates, including the one-carbon (C-1) compounds methanol, 
methylamine and methyl sulfides. Use of these C-1 substrates requires the 
expression of highly specific methyltransferases, which are only expressed in the 
presence of their cognate substrates. The genes encoding these 
methyltransfereases are among the most regulated genes in archaea; however, 
the mechanism(s) by which Methanosarcina cells are able to sense and respond 
to the presence/absence of these substrates has yet to be established. Analysis 
of the genomic region surrounding the methyl sulfide methyltransferase genes 
mtsD, mtsF and mtsH allowed the identification of three histidine kinases 
(MA0863, MA4377, MA4561), one response regulator (MA4376) and an Msr-like 
protein (MA4375) in close proximity to the mts genes. In this chapter we examine 
the transcriptional regulation of mtsD and mtsF by the mentioned sensory 
transduction systems. To test this we performed global transcriptional profiling of 
strains that lacked the putative two-component systems in the presence of 
trimethylamine, methanol or a mixture of methanol and dimethylsulfide. 
Transcriptomic studies showed that three putative histidine kinases (MA0863, 
MA4377 and MA4561) act as negative regulators of mts genes in the presence of 
methanol. In addition, we have identified a putative response regulator (MA4376) 
that mediates the regulation of mts genes by interacting with two independent 
histidine kinases (MA0863 and MA4377). Finally, we show that an additional msr 
like protein is involved in the regulation of mts genes.  
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4.2 Introduction 
 
Two-component signal transduction systems are commonly used by bacteria to 
sense and respond to environmental changes including nutrients, pH, cellular 
redox changes and temperature (Ashby, 2006). Signal transduction is 
accomplished by the phosphorylation of an aspartate residue in a response 
regulator (RR) usually mediated by a membrane bound histidine kinase (HK). 
Typically, upon sensing environmental stimuli the histidine kinase is 
autophosphorylated at a histide residue. The phosphoryl group is then 
transferred to an aspartate residue in a response regulator; this triggers a 
conformational change in the RR that activates the output domain of the 
regulator allowing it to respond to the environmental stimuli. Histidine kinases 
can be membrane bound or cytoplasmic and consist of a conserved C terminus 
HATPase domain coupled with an array of sensory domains including PAS, 
CHASE4 and GAF. Response regulators can be coupled to an effector domain or 
can be found as stand alone receiver domains.  
 
Two-component systems are also found in many genomes within the 
Euryarchaeota (Salvado et al., 2015). However, they are poorly studied. Genome 
sequencing of M. acetivorans identified the presence of 50 histidine kinases (HK) 
(Galagan et al., 2002). In addition, 18 response regulator receiver domains were 
identified, seven present within histidine kinases and eleven single domain 
proteins of which only one is big enough to have both a receiver and an effector 
domain (Galagan et al., 2002). Thus far, only one system has been characterized 
in this strain, the methyl sulfide methyltransferase associated sensor MsmS 
(Molitor et al., 2013). MsmS has been described as a heme-based redox sensor 
that modulates its autophosphorylation activity through the redox state of its 
heme cofactor (Molitor et al., 2013). Deletion of MsmS resulted in strains that 
constitutively expresses the methyl sulfide methyltransferase MtsF, indicating 
that MsmS negatively regulates expression of the enzyme. The effect of MsmS 
on the expression of other methyl sulfide methyltransferases was not examined.  
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Based on their genomic localization two additional histidine kinases (MA0863 
and MA4377) and a response regulator (MA4376) might be involved in the 
regulation of the methyl sulfide methyltransferases mtsD and mstF. MA0863 was 
originally annotated as two genes MA0863 and MA0864; however, a previous 
work revealed that MA0863 encodes a pyrrolysine (Pyl) containing histidine 
kinase that might be involved in regulation of mts genes (O'Donoghue et al., 
2014).  Here we present an array transcriptomic experiments that show that the 
histidine kinases MA0863, MA4377 and MA4561 are involved in the regulation of 
all three methyl sulfide methyltransferases. Moreover, the response regulator 
MA4376 seems to be mediating the regulation of the mts gene by interacting with 
more than one histidine kinase. 
 
4.3 Materials and Methods  
 
4.3.1 Strains, media and growth conditions 
Methanosarcina strains used in the study are shown in Table 4.1. All 
Methanosarcina strains were grown under strictly anaerobic conditions. 
Derivatives of M. acetivorans WWM73 and WWM60 (Guss et al., 2008a) were 
grown at 37°C in high-salt (HS) medium (Metcalf et al., 1997). Growth substrates 
provided were 125 mM methanol, 120 mM acetate, 50 mM trimethylamine (TMA) 
and a mixture of 125 mM methanol with 5 mM dimethyl sulfate (DMS). 
Substrates were sterilized by filtration using a 0.2 µm filter. Growth on media 
solidified with 1.5% agar was as described previously (William Metcalf, 1996, 
Metcalf et al., 1997). All plating manipulations were carried out under strictly 
anaerobic conditions in an anaerobic incubator as described (William Metcalf, 
1998). Puromycin (CalBiochem, San Diego, CA) was added from sterile, 
anaerobic stocks at a final concentration of 2 mg/ml for selection of 
Methanosarcina strains carrying puromycin transacetylase gene (pac). The 
purine analog 8-aza-2,6-diaminopurine (Sigma, St. Louis, MO) was added from 
sterile, anaerobic stocks at a final concentration of 20 mg/ml for selection against 
the hpt gene. 
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4.3.2 Construction and verification of mutant strains 
 
M. acetivorans strains WWM586, WWM587, WWM926 and WWM975 were 
constructed by markerless genetic exchange via liposome-mediated 
transformation (Metcalf et al., 1997, Pritchett et al., 2004). Construction of the 
plasmid used for making WWM975 was made with a variation of the golden gate 
method (Liang et al., 2014). WWM977 was constructed using the CRISPR-Cas-9 
system as described in (Nayak, 2017 ). DNA fragments encoding the sgRNA 
were synthetized as double-stranded DNA fragments (gBlocks) from Integrated 
DNA Technologies (Coralville, IA) and introduced into pDN201 backbone 
linearized with AscI using the NEBuilder HiFi DNA assembly kit following 
manufacturer’s instructions (New England Biolabs, Ipswich,MA). The sgRNA 
sequence was designed using the CRISPR site finding tool in Genieious version 
R9 (Kearse et al., 2012). For construction of complementation strains, plasmids 
were integrated on the M. acetivorans C2A chromosome using site-specific 
recombination between the ϕC31 attB site on the plasmid and the ϕC31 attP site 
on the M. acetivorans chromosome using liposome mediated transformation as 
described previously (Guss et al., 2008b). All plasmids were confirmed via 
restriction endonuclease digestion and DNA sequencing. Sequencing was 
performed at the W. M. Keck Center for Comparative and Functional Genomics, 
University of Illinois. Chromosomal mutations were verified by PCR and DNA 
hybridization experiments (data not shown). DNA hybridizations were performed 
using the DIG System (Roche, Mannheim, Germany) as recommended using 
MagnaGraph Nylon transfer membranes (Micron Separations Inc, Westborough, 
MA). Standard methods were used to isolate and manipulate plasmid DNA from 
E. coli strains (Ausubel, 1992). For strain genotypes, plasmid descriptions, 
primers and gBlocks refer to Tables 4.1, 4.2, .4.3 and 4.4 respectively. 
 
4.3.3 Transcriptomic analysis (RNAseq) 
Strains were adapted to specific growth substrates for at least 30 generations 
prior to RNA isolation. RNA was extracted from triplicate cultures grown to  
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Table 4.1 Methanosarcina strains used in this study. 
Strain Genotype Source 
WWM60 Δhpt::PmcrB-tetR (Guss et al., 2008a) 
   
WWM82 Δhpt:: PmcrB-ϕC31int-attP (Guss et al., 2008a) 
   
WWM586 Δhpt:: PmcrB-ϕC31int-attP ΔMA4376 this study 
   
WWM587 Δhpt:: PmcrB-ϕC31int-attP ΔMA4377 this study 
   
WWM926 Δhpt:: PmcrB-ϕC31int-attP ΔMA4561 this study 
   
WWM975 Δhpt:: PmcrB-ϕC31int-attP ΔMA4375 this study 
   
WWM977 Δhpt::PmcrB-tetR ΔMA0863 this study 
   
WWM995 Δhpt::PmcrB-tetR PmcrB(tetO4)-MA0863-Pyl-Lys ΔMA0863  this study 
   
WWM1003 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4377-attL ΔMA4377 this study 
   
WWM1004 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4376-attL ΔMA4376 this study 
   
WWM1005 Δhpt::PmcrB-tetR PmcrB(tetO4)-MA0863 ΔMA0863 this study 
   
WWM1006 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4375-attL ΔMA4375 this study 
   
WWM1007 Δhpt::PmcrB-tetR PmcrB(tetO4)-MA4561 ΔMA4561 this study 
   
WWM1009 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4377-R2-Asp-Glu-attL ΔMA4377 this study 
   
WWM1010 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4377-His-Ala-attL ΔMA4377 this study 
   
WWM1011 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4377-R1-Asp-Ala-attL ΔMA4377 this study 
   
WWM1012 Δhpt:: ΦC31-int-attR PmcrB(tetO4)-MA4377-R2-Asp-Ala-attL ΔMA4377 this study 
 
mid-exponential phase using Direct-zol RNA MiniPrep kit (Zymo Research Irvine, 
CA) following manufacturer’s instructions. Ribosomal RNA was depleted using 
subtractive hybridization employing biotinylated rRNA probes as previously 
described (Fu and Metcalf, 2015). The quality of the RNA was verified using 
Agilent Bioanalyzer. RNA sequencing was performed at the W. M. Keck Center 
for Comparative and Functional Genomics, University of Illinois using strand 
specific libraries prepared with the Illumina TruSeq Stranded mRNAseq Sample 
Prep kit (Madison, WI). Bar-coded libraries were pooled, quantified by qPCR and 
sequenced for 101 cycles on a HiSeq4000 using the HiSeq 4000 sequencing kit 
version 1 (Illumina, San Diego, CA). Reads were trimmed using TrimmomaticSE 
(-threads 23, ILLUMINACLIP: 2:30:10, LEADING:28, TRAILING:28, MINLEN:30). 
Trimmed reads were mapped using the Rockhopper version 2.0.3 (Tjaden, 2015, 
McClure et al., 2013) mapping to a reference genome with the following 
parameters allowed mismatches: 0.15 and minimum seed length: 0.33. 
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Table 4.2 Plasmids used in this study. 
Plasmids Description Reference 
pJK026A ϕC31-attB vector with PmcrB promoter fusion to uidA (Guss et al., 2008a) 
   
pJK029A ϕC31-attB vector with PmcrB(tetO4) promoter fusion to uidA (Guss et al., 2008a) 
   
pMP44 Ampicillin resistant vector used to mutate cells using the markerless exchange method (Pritchett et al., 2004) 
   
pDN201 Plasmid used for expression of the CRISPR-Cas9 system in Methanosarcina acetivorans (reference) 
   
pJPK1 NotI/SpeI digested 2kb homology region surrounding MA4376 (using primers MA4376-del-up–R and MA4376-del-Dn-F) cloned into NotI/SpeI digested pMP44 This study 
   
pJPK2 NotI/SpeI digested 2kb homology region surrounding MA4377 (using primers MA4377-del-up–R and MA4376-del-Dn-F) cloned into NotI/SpeI digested pMP44 This study 
   
pML52 Plasmid for deletion of MA4375 assembled using golden gate assembly using primers MA4375_upF, MA4375_upR, MA4375_dF, MA4375_dR, pUC19_R2, pach-hpt_R3 This study 
   
pML55 NdeI/HindIII-digested MA4561 PCR product (using primers MA4376_start and MA4376_comp_R was cloned into NdeI/HindIII-digested pJK029A This study 
   
pML57 NdeI/HindIII-digested MA4561 PCR product (using primers MA4561_comp_F and MA4561_comp_R) was cloned into NdeI/HindIII-digested pJK029A This study 
   
pML58 NdeI/HindIII-digested MA0863 PCR product (using primers MA0863F and MA0863R) was cloned into NdeI/HindIII-digested pJK029A This study 
   
pML59 
NdeI/NsiI-digested MA4377 (receiver domain 1 Asp-Ala) PCR product (using primers 
MA4377_start_gib and MA4377_comp_R_gib) was cloned into NdeI/HindIII-digested 
pJK029A assembled using Gibson assembly 
This study 
   
pML60 
NdeI/NsiI-digested MA4377 (receiver domain 2 Asp-Glu) PCR product (using primers 
MA4377_start_gib and MA4377_comp_R_gib) was cloned into NdeI/HindIII-digested 
pJK029A assembled using Gibson assembly 
This study 
   
pML61 
NdeI/NsiI-digested MA4377 (receiver domain 1 Asp-Glu) PCR product (using primers 
MA4377_start_gib and MA4377_comp_R_gib) was cloned into NdeI/HindIII-digested 
pJK029A assembled using Gibson assembly 
This study 
   
pML62 
NdeI/NsiI-digested MA4377 (receiver domain 2 Asp-Ala) PCR product (using primers 
MA4377_start_gib and MA4377_comp_R_gib) was cloned into NdeI/HindIII-digested 
pJK029A assembled using Gibson assembly 
This study 
   
pML63 
2 kb PCR product of homology region of MA0863 (MA0864_CRISPR_PmeI and 
MA0863_CRISPR_AscI primers) amplified from pML53 was introduced into pDN201 
linearized with PmeI/AscI  
This study 
   
pML64 gBlocks for sgRNA was introduced into pML63 linearized with AscI by NEB Gibson Cloning Assembly Kit This study 
   
pML65 pML64 retrofitted into pAMG40 This study 
   
pML69 NdeI/HindIII-digested MA4375 PCR product (using primers MA4375_start and MA4375_comp_R) was cloned into NdeI/HindIII-digested pJK029A 
 
This study 
 
   
pML70 NdeI/HindIII-digested MA0863 PCR product (Pyl residue mutated to Lys) (using primers MA0863F and MA0863R) was cloned into NdeI/HindIII-digested pJK029A This study 
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Table 4.3 Primers used in the study. 
Primer Sequence (restriction sites underlined and mutated bases lower case) Added sites 
MA4376-del-up–F TTATTCTCCCAGATATTTATCGATCAGGGGTTCGACAATAAGAATTTCTTTCATCTTCAC  
MA4376-del-up–R GGCGCGCCACTAGTAAGAAAATTGTAAACTTACACA AscI,SpeI 
MA4376-del-Dn–F GGCGCGCCGCGGCCGCAGATGGAATGAAATGAAAATA AscI,NotI 
MA4376-del-Dn–R GTGAAGATGAAAGAAATTCTTATTGTCGAACCCCTGATCGATAAATATCTGGGAGAATAA  
MA4377-del-up–F TTATCTTCGACAATAAGAATTTCTTTCATCAATAACAAGAATTTTTCTACTCACATTCAT  
MA4377-del-up–R GGCGCGCCACTAGTTTTCTTCTGTTATTTTGCCGTA AscI,SpeI 
MA4377-del-Dn–F GGCGCGCCGCGGCCGCACGGTCAGGGTCTTTGAGGAAAACTACGATTACGTGATT AscI,NotI 
MA4377-del-Dn–R ATGAATGTGAGTAGAAAAATTCTTGTTATTGATGAAAGAAATTCTTATTGTCGAAGATAA  
MA4375_upF, GGCGCGCCCACCTGCAAAACGAGAGGCTCTGGGACCGGTTT  
MA4375_upR GGCGCGCCCACCTGCAAAATGGCATAGAAACGCCAGGTCAAT  
MA4375_dF GGCGCGCCCACCTGCAAAAGCCAGCTCTTTTTATATTATAAAGATATGTC  
MA4375_dR GGCGCGCCCACCTGCAAAAAGGGGCAACTTATTCCTTTACAAAACC  
pUC19_R2 GGCGCGCCCACCTGCAAAACCCTAGGTGGCACTTTTCGG  
pac-hpt_R3 GGCGCGCCCACCTGCAAAACTCGACAGGAACACTTAACGGC  
MA4561_comp_F ATGATTTTAATAAATTAAGGAGGAAATTCATATGATAGGTGTTGACATGAAACTGG  
MA4561_comp_R TATAGCATACATTATACGAAGTTATCAAGATTCCAGTTTCATTCCAGCTCACG  
MA0863F GTGGCCAGTGCCAAGCTTGCATGCCTGCATTCAACATTTACAGTAGTTCAAAATTGGTG  
MA0863R GAGTCGTCGCCACCAATCCCCATAGATTTTATCCAGGATATTATCGAGGTCAA  
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Table 4.3 Continued  
MA4377_start_gib ATGATTTTAATAAATTAAGGAGGAAATTCATATGAATGTGAGTAGAAAAATTCTTG  
MA4377_comp_R_gib TATAGATACATTATACGAAGTTATCAAGAAGCTTCAGAAGGTCCAGGATCAATTC  
MA4375_start GGCGCGCCCATATGAAAATATCACTTATTGACCTGGC AscI, NdeI 
MA4375_comp_R GGCGCGCCAAGCTTGCCGCCTCTGTCTTAAACATGT AscI, HindIII 
MA4377R1_D-A_F TGTTATCACTCTGgcaGTTTTACTTCCCGA  
MA4377R1_D-A_R TCGGGAAGTAAAACtgcCAGAGTGATAACA  
MA4377R1_D-E_F TGTTATCACTCTGgaaGTTTTACTTCCCGA  
MA4377R1_D-E_R TCGGGAAGTAAAACttcCAGAGTGATAACA  
MA4377R2_D-A_F GATATCCTCATCCTCgcaCTGCTGATGCCG  
MA4377R2_D-A_R CGGCATCAGCAGtgcGAGGATGAGGATATC  
MA4377R2_D-E_F GATATCCTCATCCTCgaaCTGCTGATGCCG  
MA4377R2_D-E_R CGGCATCAGCAGttcGAGGATGAGGATATC  
MA0863_PylF GGGTATGAAGAATGCACCaagGAGTACCGGGTCCTGACA  
MA0863_PylR TGTCAGGACCCGGTACTCcttGGTGCATTCTTCATACCC  
MA4377_H-A_F AATATGAGCGCAGAACTGCGG  
MA4377_H-A_R CCGCAGTTCTGCGCTCATATT  
MA4376_start GGCGCGCCCATATGAAGATGAAAGAAATTCTTATTGTCG AscI, NdeI 
MA4376_comp_R GGCGCGCCAAGCTTGAAAAATGTCTTTCCGACCGCA AscI, HindIII 
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Table 4.3 Continued 
MA0864_CRISPR_PmeI TATATATAGTTTAAACAAGCCCCCTGAAGATACTAATGAAT PmeI 
MA0863_CRISPR_AscI TATATATAGGCGCGCCGCTGCATCTACCGGGTCGTGTAGAGATT AscI 
 
 
 
Table 4.4 gBlocks used in this studya 
 
gBllock Sequence 
MA0863 
gRNA 1 
AATCTCTACACGACCCGGTAGATGCAGCGGCGCGCCAACAACATCAGTCACCTAAAAAGAGAAAACGAATTACACGATCACTAATTTTAAATTTTA
TATATGTTGACTGAGATTGCAAATTTGAACATTGAAATTTTTTACCCGCTTGATCTGAATAATGACATTGTTCAAAAAAAGTACAAATGATAAAAAAG
AAAGCTTCTCAAAAAACAGTAAAGAAGTTCTCCCCAAAATCACCTCAAAAATTCAGAGCTCTATTATCAGAAAAAGCGAGCTTAAAAAATTCAAAG
GAAAGATACCCCTCTGCACCCTCAAAATTTTAGACCCTGTGTTGACCTGTAAAAATCAGGAAAAAATTTCCGTCGGTTATGGTATATGTGATGATT
TCCCCTAATTATGCTGTAAGCACATGTGAAGTTGAATTCACATTGAGGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAA
CTTGAAAAAGTGGCACCGAGTCGGTGCTTTTGCCCTCAGTTCTCTTTTTCTTTTTCTTAAACTTCACGCACTGCACTTTTGTCCTCACTTTTTTCAT
GCCGTCAGATTAACTACTTTTTCTATCCTTGAAATCAGCGGCTTTTCAGCCCTCATGTAGGCGCGCCGGCGATCGCGGCCGCTTAATTAA 
 
MA0863 
gRNA 2 
TCAGCCCTCATGTAGTTTAAACCTGCAGGCGCGCCAACAACATCAGTCACCTAAAAAGAGAAAACGAATTACACGATCACTAATTTTAAATTTTAT
ATATGTTGACTGAGATTGCAAATTTGAACATTGAAATTTTTTACCCGCTTGATCTGAATAATGACATTGTTCAAAAAAAGTACAAATGATAAAAAAGA
AAGCTTCTCAAAAAACAGTAAAGAAGTTCTCCCCAAAATCACCTCAAAAATTCAGAGCTCTATTATCAGAAAAAGCGAGCTTAAAAAATTCAAAGG
AAAGATACCCCTCTGCACCCTCAAAATTTTAGACCCTGTGTTGACCTGTAAAAATCAGGAAAAAATTTCCGTCGGTTATGGTATATGTGATGATTT
CCCCTAATTATGCTGTAAGCACATGTCGGGCACAACCATGCATGTAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAA
CTTGAAAAAGTGGCACCGAGTCGGTGCTTTTGCCCTCAGTTCTCTTTTTCTTTTTCTTAAACTTCACGCACTGCACTTTTGTCCTCACTTTTTTCAT
GCCGTCAGATTAACTACTTTTTCTATCCTTGAAATCAGCGGCTTTTCAGCCCTCATGTAGGCGCGCCGGCGATCGCGGCCGCTTAATTAA 
a guide RNA sequences in bold  
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Expression values were calculated as RPKM (Reads Per Kilobase per Million 
reads) using the upper quartile of gene expression, differential expression was 
determined using Rockhopper (McClure et al., 2013) comparing the expression 
of mutant strains against WT. Genes showing fold expression changes greater 
than 4, or less than -4, with q-values ≤ 0.01 were considered to be differentially 
expressed.  
 
Figure 4.1 Schematic representation genomic region of the mtsD, mtsF and mtsH genes. 
Methyltransferase genes: red; Histidine kinase: green; Msr family genes: purple; Hsp60: light blue 
and hydantoinase: yellow.  
 
4.4 Results  
4.4.1 Bioinformatics analyses of putative histidine kinase and response 
regulators in M. acetivorans C2A  
A of total of three histidine kinases (MA4377, MA4561 and MA0863), one 
response regulator (MA4376) and an uncharacterized Msr-like family protein 
(MA4375) were identified in the vicinity of the methylsulfide methyltransferases 
mstD, mtsF and mtsH (Fig 4.1). Of the three HKs analyzed only one (MA4377) 
has the characteristic cytoplasmic HisKA and HATPase domains (Fig 4.2). 
MA4377 also has a predicted extracellular sensory domain CHASE4, a 
membrane spanning Hamp domain and two intracellular receiver domains (Fig 
4.2) all of which are common in prototypical membrane bound histidine kinases. 
Based on its domain composition, MA4377 is likely part of sensory transduction 
system that senses extracellular signals.  In addition, MA4377 seems to be 
forming a two-component system with the putative response regulator MA4376. 
MA4376 encodes the only stand-alone receiver domain containing-protein in the 
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analyzed region. MA4375 on the other hand has a domain distribution similar to 
the methanol specific regulators described in Chapter 3; it contains a helix-turn-
helix domain and the archaeal- exclusive DUF1724 domain.  
 
Six domains were identified in the previously described MsmS, including three 
PAS domains, two GAF sensory domains and a HATPase domain (Fig 4.2). 
Previous proteomic analysis of WT M. acetivorans and a strain in which the 
pyrrolysine tRNA was deleted showed that MA0863 and MA0864 are likely not 
individual proteins, but rather a single protein that has an in frame pyrrolysine 
residue (O'Donoghue et al., 2014). This conclusion was due to the fact that 
MS/MS analysis identified MA0863 peptides beyond the UAG codon, which 
indicated the presence of Pyl in the protein (O'Donoghue et al., 2014). Analysis 
of the full-length gene predicted MA0863 to have an identical domain 
composition to MsmS (Fig 4.2). The absence of extracellular and 
intramembranous domains suggests that these two regulators are likely to be 
sensing and responding to intracellular conditions, in fact it has been shown that 
MsmS serves as an intracellular redox sensor (Molitor et al., 2013).  
 
 
 
 
 
Figure 4.2 Schematic representation of the domain structures of HKs and RRs in this study. 
Abbreviations: CHASE4, sensory extracellular domain; Hamp, sensory domain, PAS, small 
molecule binding domain; HisKA,  phospho-acceptor domain, HATPase; Rec, receiver domain, 
GAF, sensory domain; HTH, helix-turn-helix domain; DUF1724, domain of unknown function 
present only in archaea.  
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4.4.2 Regulation of methyl sulfide methyltransferases by the putative two-
component system MA4376-MA4377 
Based on their proximity to previously characterized methanol and methylsulfide- 
specific methyltransferases, we hypothesized that the putative two-component 
system encoded by MA4376-MA4377 might be involved in C-1 substrate 
responsive gene regulation. To test this, strains that carried deletions of these 
genes were constructed and characterized by global transcriptional profiling 
using RNAseq. Strains carrying the deletion of the putative response regulator 
MA4376 did not show differential regulation of any methyltransferase gene when 
grown on methanol + DMS. However, when grown on methanol ΔMA4376 strains 
showed an increase of mRNA abundance of mstD and mtsF methyltransferase 
genes (Table 4.5). In addition, the ΔMA4376 mutant overexpressed the MA0857 
gene, which encodes a putative Hsp60 protein encoded in the vicinity of mtsD. 
Further, when grown on TMA, ΔMA4376 showed a decrease in mRNA 
abundance of mtsD. In contrast, the ΔMA4377 mutant showed an increase in 
mRNA abundance of mtsF when cells where grown on methanol or TMA. This 
mutation also caused a 23-fold increase in the expression of MA4386; another 
putative Hsp60 protein encoded in the vicinity of mtsF, and caused a decrease in 
the abundance of the MA4375 transcript, which encodes a putative Msr-family 
protein (Table 4.6). Taken together these results suggest that the putative two-
component system MA4376-MA4377 is involved in the regulation of expression 
of mtsF when cells are using methanol as substrate and in the regulation of mtsD 
expression when cells are grown on TMA. To our surprise, neither MA4376 nor 
MA4377 affected the expression of mtaCB2 or any other methanol specific 
methyltransferase, regardless of the growth substrate. Thus, MA4376-MA4377 
are not involved in the regulation of methanol specific methyltransferases.  
 
Because the Msr-family protein encoded by MA4375 is regulated by MA4376, we 
suspected that it might be a mediator in the signal transduction cascade. Thus 
we also constructed and characterized a strain with a deletion of this gene. 
Based on global transcriptional profiling, the ΔMA4375 mutation does not affect 
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any of the methyltransferase gene when the cells are grown on methanol + DMS. 
However, the mutant did exhibit an increase in mtsD mRNA when cells were 
grown on methanol and an increase of mtsF mRNA when cells were grown on 
TMA (Table 4.5).  
 
4.4.3 Global transcriptional profiling of mutants lacking histidine-kinases 
encoded by MA0863 and MA4561  
MA4561 was previously described as the methyl sulfide methyltransferase- 
associated sensor after deletion of MA4561 caused the constitutive synthesis of 
MtsF. However, the role of MA4561 in regulation of other genes was not 
assessed. To test this, we performed RNAseq experiments using an MA4561 
mutant grown on a variety of media. Deletion of MA4561 caused a decrease of 
mRNA abundance of mtsD when cells were grown on TMA. Meanwhile deletion 
of MA4561 resulted in an increase in expression of mtsF and the putative Hsp60-
encoded by MA4386. No significant regulation of methylotrophic methanogenesis 
genes was observed in ΔMA4561 strains grown on methanol or methanol+DMS.  
 
Similar, RNAseq experiments showed that deletion of MA0863 caused an 
increase of mRNA abundance of mtsD when cells were grown on methanol or a 
combination of methanol and DMS (Table 4.5). Deletion of MA0863 also affected 
the expression of other genes present in the vicinity of the predicted histidine 
kinase, including the up-regulation of a hydantoinase encoded by MA0858 in 
methanol+DMS grown cells and the increase in mRNA abundance of the Hsp60 
MA0857 when cells were grown on methanol (Table 4.6). Finally, during growth 
on TMA, ΔMA0863 strains showed an increase in expression of mtsF.  
 
4.4.4 Differentially regulated antisense RNA 
The Rockhopper software used to analyze our transcriptomic data also identified 
putative antisense RNAs whose expression is affected by the deletion of the HKs 
and RR in this study. Interestingly some of these differentially regulated predicted 
antisense RNAs are encoded within regions of the methyl sulfide 
methyltransferases or in genes that are in close proximity to them. For example, 
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deletion of the HK MA0863 resulted in a 53-fold increase in the abundance of an 
antisense RNA encoded within the msrD gene when cells were grown in a 
mixture of methanol and DMS. Another example is the over expression of several 
antisense RNAs within mtsH that are present when either MA4376 or MA4377 
are deleted in TMA grown cells. More experiments are needed to determine what 
role if any these putative regulatory RNA have on this signal transduction system. 
A list of predicted antisense RNA is presented in Table 4.7.  
 
4.5 Discussion  
 
Work presented in Chapter 3 characterized the regulation of methyltransferase 
gene expression mediated by members if the Msr family of proteins, revealing 
that Msr proteins mediate gene regulation by directly binding the promoter of 
their target genes. However the sensory transduction pathway that triggers the 
regulation of methylatransferase genes remains unidentified. In this chapter, I 
identified a predicted two-component system  (MA4376-MA4377) that we 
hypothesized would be involved in the regulation of the expression of the 
methyltransferases mtsD and mtsF. Our experiments support this model, but also 
showed that the regulatory network is more complex, including two additional 
HKs (MA0863 and MA4561) and a previously uncharacterized msr protein 
(MA4375). 
 
Previous work identified the multisensory domain histidine kinase MA4561 as a 
heme-based sensor that senses and responds in changes to the cellular redox 
state (Molitor et al., 2013). This study also showed that mutants lacking MA4561 
express MtsF constitutively during growth on methanol (Molitor et al., 2013). In 
contrast, our results showed that deletion of MA4561 did not affect the 
expression of mtsF in methanol grown cells. Similar differences in regulation of 
mtsF expression have been observed between mRNA levels and translational 
fusion data from methanol grown cells (Bose et al., 2009).Taken together these 
results suggest that members of the Mts system are regulated at both 
transcriptional and translational levels. One possibility is that MA4561 could 
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mediate mtsF regulation by affecting mRNA translation rather than expression, 
like the Pseudomona aeruginosa GacS/GacA system whose phosphorylation 
state affects the transcription of small RNAs that bind to specific mRNA targets 
inducing their degradation (Goodman et al., 2009). Although highly speculative, 
this scenario is consistent with our observation of antisense RNA encoded within 
mts genes. Further experiments are necessary to address this possibility.  
 
Our in silico analysis showed that the pyrrolysine-containing MA0863 protein, 
encodes a putative histidine kinase with a domain distribution similar to that of 
MA4561. Previous work showed that deletion of tRNAPyl caused cells to have a 
higher expression of MtsD, MtsF and MtsH (O'Donoghue et al., 2014). We 
suspect that the inability to translate the pyl codon in MA0863 is actually 
responsible for this phenotype. Consistent with this prediction, transcriptomic 
analysis of ΔMA0863 strains showed an increase in mRNA abundance of mtsD 
and mtsF. Experiments from our group have shown that the msr proteins MsrF 
 
Table 4.5 mRNA abundance changes of methyl sulfide methyltransferases. 
 
Fold change Methanola 
Gene ΔMA4375 ΔMA4376 ΔMA4377 ΔMA0863 ΔMA4561 
mtsD 10 14 1 13 1 
mtsF 3 14 12 4 1 
Fold change Methanol + DMSa 
Gene ΔMA4375 ΔMA4376 ΔMA4377 ΔMA0863 ΔMA4561 
mtsD 1 2 4 9 1 
mtsF 1 1 1 2 1 
Fold change TMAa 
Gene ΔMA4375 ΔMA4376 ΔMA4377 ΔMA0863 ΔMA4561 
mtsD 1 -8 -8 2 -5 
mtsF 12 2 6 11 8 
aFold change of expression values of mutant strains compared against WT M. acetivorans grown in the same substrate. 
Statistically significant values (q<0.01) are shown in shaded boxes.  
 
 
and MsrC are the direct transcriptional regulators of mtsD and mtsF respectively. 
MA0863 is localized directly upstream of msrF so it is possible that MA0863 and 
msrF act as a two component system to mediate regulation of mtsD (Fig 4.1). To 
control transcription of mtsF it is possible that MA0863 is mediating regulation 
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through msrC. Complementation experiments need to be performed to confirm 
the role of MA0863 in the regulation of Mts proteins and to determine what role if 
any the pyrrolysine residue plays in MA0863 function. 
 
Methanosarcina acetivorans encodes a total of 50 HKs and only 18 RRs. From 
the response regulators 11 form orphan proteins in the cell most of them without 
any DNA binding domain. Since there is not a 1:1 pairing of HKs and RRs, this 
suggests that each RR might be receiving signals from multiple histide kinases. 
Also, the lack of a DNA binding domain in these response regulators suggests 
that instead of directly binding to their target promoters they act by interacting 
with other DNA binding proteins possibly the previously characterized Msr 
proteins (Chapter 3). Our results are consistent with this model. For example, 
when cells are grown on methanol deletion of the RR MA4376 causes a 14-fold 
increase in mRNA abundance of mtsD. A similar increase is observed in 
ΔMA0863 (HK) and ΔMA4375 (msr) strains. Therefore it is possible that during 
growth on methanol MA0863 interacts with the RR MA4376 that in turn affects 
the function of the msr protein MA4375 to turn off the transcription of mtsD. 
Deletion of MA4376 also causes an increase in abundance of mstF in methanol. 
However, in this case a similar increase in mRNA abundance is present when 
MA4377 but not MA0863 is deleted in the strains (Table 4.5). These observations 
support the idea that in Methanosarcina a single RR can interact with multiple 
HKs. Once again these proposed pathways are highly speculative and further 
experiments are needed to confirm them.  
 
In the presence of methanol all the characterized systems are acting as negative 
regulators of mts expression, this could be the reason why we do not see any 
regulatory effect upon deletion of these genes when cells are grown in the 
presence of DMS. Since expression of mtsD, mtsF and mtsH is essential for 
growth in the presence of DMS, it is possible that during growth on this substrate 
the HK kinase and RR studied have a phosphorylation state that prevents them 
from repressing mts genes expression. Additional experiments using mutated 
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versions of MA4377 and MA0863 (Table 4.1) would allow us to identify the effect 
that the different phosphorylation states of the histidine kinase has on the 
expression of the mts genes. No regulation pattern can be established from the 
TMA transcriptomic data, since deletion of all five genes affected the expression 
of mstF (Table 4.5). More experiments are necessary to understand the 
regulation of mts genes in TMA-grown cells.  Other genes that have been shown 
to be regulated by four of the putative regulators in cells grown on TMA are the 
putative Hsp60 genes MA0857 and MA4377 (Table 4.6 and 4.7). MA0857 and 
MA4377 are homologs to the archaeal thermosome protein, a chaperonin that 
assists in the folding of nascent or denatured proteins (Klunker et al., 2003). Here 
we have proposed the Mts system is regulated at both transcriptional and 
translational levels. Hence, it is possible that these putative Hsp60 proteins are 
not responding to stress-induced situations in the cell but rather are necessary to 
aid in the regulation and folding of the Mts protein, explaining why they are 
regulated by the same system that controls mts gene expression. 
Taken together, our results show that a complex regulatory network that includes 
multiple histidine kinases, crosstalk with response regulators and msr DNA 
binding proteins mediates expression of mts genes in M. acetivorans. Further 
experiments are necessary to determine autophosphorylation capacity of the 
HKs, how their phosphorylation states affect regulation of the mts genes and to 
determine the role other proteins like Hsp60 play in this regulatory cascade.  
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Table 4.6 Select mRNA abundance changes in ΔMA4375, ΔMA4376 and ΔMA4377. 
  Fold change Methanola Fold change Methanol + DMSa Fold change TMAa 
Locus 
tag Gene ΔMA4375 ΔMA4376 ΔMA4377 ΔMA4375 ΔMA4376 ΔMA4377 ΔMA4375 ΔMA4376 ΔMA4377 
MA0857 Hsp60 2 4 1 2 1 1 92 -2 24 
MA0858 Hyd 2 2 1 2 1 2 1 -2 -2 
MA4375 Msr -3 1 -4 -4 1 -8 1 -10 -2 
MA4386 Hsp60 2 1 1 2 1 1 89 -3 23 
aFold change of expression values of mutant strains compared against WT M. acetivorans grown in the same substrate. Statistically significant values (q≤0.01) are shown in shaded 
boxes.  
 
 
 
Table 4.7 Select mRNA abundance changes in ΔMA0863 and ΔMA4561. 
  Fold change Methanola Fold change Methanol + DMSa Fold change TMAa 
Locus  
tag Gene ΔMA0863 ΔMA4561 ΔMA0863 ΔMA4561 ΔMA0863 ΔMA4561 
MA0857 Hsp60 5 1 2 1 83 66 
MA0858 Hyd 3 1 6 1 2 -2 
MA4386 Hsp60 4 1 2 1 81 72 
aFold change of expression values of mutant strains compared against WT M. acetivorans grown in the same substrate. Statistically significant values (q≤0.01) are shown in shaded 
boxes.  
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Table 4.8 Select mRNA abundance changes of selected predicted RNA. 
 
Fold change Methanol 
ΔMA4375 ΔMA4376 ΔMA4377 
Gene Fold change Gene Fold change Gene Fold change 
antisense: 
MA4384 76 
antisense: 
MA0858/ 
MA0859 
219 antisense: MA4558 13 
antisense: 
MA4558 
49 
 
antisense: 
MA4558 39   
      
Fold change Methanol + DMS 
ΔMA4375 ΔMA4377 ΔMA0863 
Gene Fold change Gene Fold change Gene Fold change 
antisense: 
MA4385 
MA4384 
-5 
antisense: 
MA0859 
 
14 
antisense: 
MA0859 
 
53 
      
Fold change TMA 
ΔMA4375 ΔMA4376 ΔMA4377 
Gene Fold change Gene Fold change Gene Fold change 
antisense: 
MA4558 17 
antisense: 
MA4558 -5 
antisense: 
MA4558 -4 
  antisense: MA0859 -160 
antisense: 
MA0859 -183 
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Chapter 5: Conclusions 
 
5.1 Summary 
 
5.1.1 PEP carboxylase is an alternative route of OAA biosynthesis in M. 
barkeri 
Methanosarcina barkeri genome encodes two oxaloacetate (OAA) generating 
enzymes: pyruvate (Pyc) and phosphoenolpyruvate (Ppc) carboxylase. Until this 
work it was believed that OAA synthesis in M. barkeri proceeded exclusively from 
Pyc. However, in Chapter 2 we demonstrated that introduction of a stop codon in 
the pyc operon resulted in cells that lacked Pyc activity, but showed no growth 
phenotype, suggesting an alternative route for synthetizing OAA in the cells. 
Previously reported in vitro biochemical data show that M. barkeri cells lacked 
Ppc activity even in the absence of Pyc (Mukhopadhyay et al., 2001), but 
RNAseq analysis showed an overexpression of the ppc operon in cells that 
lacked Pyc activity. Our results showed that M. barkeri is capable of expressing 
two independent enzymes to synthetize the essential physiological component 
OAA.  
 
5.1.2 Por is an essential gene in M. barkeri  
Pyruvate ferredoxin oxidoreductase (Por) catalyzes the reversible carboxylation 
of acetyl-CoA to pyruvate, a step that is crucial for carbon fixation in 
methanogens. Experiments using cells that expressed por under a tetracycline 
inducible promoter revealed that por is essential in M. barkeri. Moreover, cells 
could not be rescued by the addition of pyruvate, casamino acids, yeast extract 
or acetate. Taken together these results suggest that in Methanosarcina spp. Por 
has an additional role beyond synthesis of pyruvate. Some possibilities include 
the expression of additional activities like hydrogenase or pyruvate carboxylase 
both observed in other organisms (Eram et al., 2014, Ragsdale, 1996) and the 
utilization of one of the porCDAB subunits by another enzymatic complex.  
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5.1.3 A proposed pathway for pyruvate utilization in the M. barkeri Fusaro 
pyruvate-utilizing strain  
 
Experiments presented in Chapter 2 allowed the proposal of a model for pyruvate 
utilization in mutant M. barkeri strains. In this model pyruvate utilization requires 
the overexpression of pyruvate ferredoxin oxidoreductase and 
phosphoenolpyruvate carboxylase mediated by the potential regulator encoded 
in the Mbar_A2165 locus. The overexpression of ppc and por is coupled to the 
loss of activity of pyruvate carboxylase. These changes in central carbon 
metabolism allow the channeling of pyruvate into the oxidative pathway, which 
allows the growth of cells on pyruvate using enzymes involved in aceticlastic 
methanogenesis (Fig. 2.5).  
 
5.1.4 MsrAB bind to the mtaCB1 promoter as heterodimers  
Previous work had identified the methanol specific regulators MsrA and MsrB as 
the factors or proteins responsible for regulating the transcription of the methanol 
specific methyltransferase mtaCB1(Bose and Metcalf, 2008). Here, we describe 
a series of biochemical experiments that show that MsrAB regulates expression 
of mtaCB1 by directly binding to its promoter region. Moreover, we have shown 
that MsrA and MsrB form a heterodimeric complex in a 1:1 ratio and that 
formation of this complex is required for binding since neither protein can bind 
the promoter region by itself. Heterodimer formation potentially allows these 
proteins to expand their regulatory capacities by binding to multiple binding 
partners to regulate different genes. To the best of our knowledge, this is the first 
report of heterodimeric regulators in methanogenic archaea. 
 
5.1.5 MsrB acts as both activator and repressor of transcription  
 
Experiments in Chapter 3 showed that in addition to activating expression of 
methanol methyltransferases, MsrB seems to be mediating the repression of 
methylamine methyltransferase genes in the presence of methanol or acetate. A 
comparison of mRNA abundance in ΔmsrA and ΔmsrB strains revealed that the 
role of msrB in regulation of mtt, mtm and mtb genes is independent from msrA. 
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Finally, complementation experiments corroborated the role of msrB in the 
regulation of methylamine methyltransferases. These results suggest that similar 
to the previously described Methanosarcina regulator MreA (Reichlen et al., 
2012), MsrB acts as both co-activator and a repressor of transcription in the cells. 
The mechanisms by which this DNA binding protein is able to identify the 
presence or absence of a substrate to bind and regulate methyltransferase 
transcription remain undetermined.  
 
5.1.6 Regulation of methyl sulfide methyltransferases by putative signal 
transduction systems  
Methanosarcina acetivorans C2A has three methyl sulfide methyltransferases: 
mtsD, mtsF and mtsH. Previous experiments have shown that regulation of their 
transcription is mediated by the DNA binding proteins MsrF, MsrC and MsrG 
respectively (Bose et al., 2009). The Mts proteins have been shown to be 
undetectable in the presence of methanol (Bose et al., 2009, Oelgeschlager and 
Rother, 2009). Here, we have shown that regulation of the expression of mts 
genes in the presence of methanol involves the expression of at least two 
independent histidine kinases (MA0863 and MA4377), a response regulator 
(MA4376) and a fourth msr protein (MA4375). Each of these putative signal 
transduction systems seems to be acting as a negative regulators of mts genes, 
because deletion of any resulted in an increase in the levels of mRNA of either 
mtsD or mtsF (Table 4.5). The work presented in this dissertation provides 
insight into the complexity of regulatory network that controls expression of 
methyltransferases in M. acetivorans. Future experiments using complemented 
strains and phosphorylation assays will further characterize the signal 
transduction pathway that governs mts expression. 
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5.2 Future Directions 
 
5.2.1 Determination of the relationship between Pyc and Por in pyruvate 
metabolism 
Experiments presented in Chapter 2 showed that Por was no longer essential in 
strains that lacked Pyc activity. In addition, lack of Pyc activity seems to be 
related to por overexpression in Pyr+ strains. These results suggest that there is 
a different route to synthetize pyruvate and OAA that is induced in the absence of 
both Pyc and Por. To test for this possibility we could use transcriptomic 
experiments by RNAseq on strains that lack both activities. This would help 
identify the genes that are differentially regulated in these strains and determine 
what other genes might be involved in the synthesis of pyruvate in the absence 
of por and pyc. Since por is an essential gene in M. barkeri deletion of it was not 
possible. However, if lack of Pyc activity were indeed required to abolish por 
essentiality then construction of a double deletion mutant would be possible, thus 
confirming the relationship between por and pyc. In addition, there is the 
possibility that in the cells Pyc and Por are working in close proximity channeling 
substrates resulting in their rapid diffusion through the complexes.  To explore 
this possibility we could perform a pull down experiment using affinity tagged 
proteins to determine if there is complex formation.  
 
5.2.2 Determination of the role the identified mutations have on 
suppression of Por- essentiality 
Genome sequencing of a single Por- suppressor strain revealed six mutations 
that included point mutations, deletions and insertions both in genes and 
intergenic regions of the mutant genome (Table 2.6). All six mutations are 
present in regions of hypothetical proteins thus, to identify what role if any they 
play in pyruvate metabolism the mutations would need to be recreated in a WT 
background. Special interest relies on the mutation present in Mbar_A3314 
(deletion of 2 bp that causes a frame shift) since it is present in a gene that has a 
predicted helix-turn-helix domain.  
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5.2.3 Regulation of methylamine methyltransferases by MsrB  
In Chapter 3 we presented data that supports the idea that the methanol specific 
regulator MsrB is acting as both repressor and activator the methyltransferase 
genes. We have shown that in order to activate transcription of methanol 
methyltransferases genes MsrB must form a complex with MsrA. Repression of 
the expression of methylamine methyltransferases genes by MsrB remains 
understudied; MsrB could be regulating these genes by binding to the promoters 
by itself or by partnering with other Msr proteins. To test these ideas two 
experiments could be perform. The first would be to assess the binding of MsrB 
by itself to the promoter regions of the methylamine methyltransferases genes by 
EMSA experiments. This would allow us to identify if MsrB is binding alone to 
repress gene expression. If MsrB by itself is unable to bind the promoter region, 
a second experiment could be perform to identify potential binding partners of 
MsrB. In Chapter 3 we have used FLAG tag proteins to perform western blots. 
Since we know that this tag is not disrupting MsrB function, and that MsrB 
concentration in the cell is estimated to be low, we could make strains that have 
MsrB tagged with a FLAG/streptavidin tag to perform a tandem purification of the 
protein. Samples could then be sent for mass spectrometry analysis to identify 
which other proteins if any appear to be bound to MsrB.  
 
5.2.4 Identification of potential posttranslational modifications and metals 
bound to MsrA and MsrB 
 
The EMSA experiments shown in Chapter 3 demonstrated that addition of metals 
enhanced biding of MsrAB to its target promoter. Moreover, the three-
dimensional prediction of the protein structures identified a putative Zn binding 
site in both MsrA and MsrB. To identify which metal is bound to the proteins we 
could purify proteins from the native host (using the tandem approach suggested 
above) and submit them for Inductively coupled plasma mass spectrometry (ICP-
MS). Our experiments have shown that msrA and msrB are always transcribed 
and translated regardless of the substrate in which the strains are grown on, so 
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regulation of their activity must be mediated by another route. To test the 
possibility that post-translational modifications are mediating MsrA and MsrB 
regulation we could purify the proteins from the native host when cells are grown 
with methanol, TMA and acetate and perform mass spectrometry to identify and 
compare any covalent modification of the two proteins in different substrates. 
This would allow us to predict how Msr proteins sense and respond to substrate 
availability in the cells and might hint at a possible role for the domain of 
unidentified function DUF1724 at the C-terminal end of the proteins.  
 
5.2.5 Characterization of two component systems in M. acetivorans C2A 
In Chapter 4 we described the effect that multiple histidine kinases (HK) and 
response regulators (RR) have in the expression of methyl sulfide 
methyltransferase genes (mts). To confirm the effect that deletions of the putative 
HKs and RR have in the expression of the Mts system we have complemented 
the deletion strains with WT copies of the HKs and RR genes (Table 4.1). qPCR 
analysis of mts gene expression in the complemented strains will allow us to 
confirm if in fact their transcription is controlled by these putative two-component 
systems. In addition, we have complemented ΔMA4377 with copies of the gene 
with key histidine and aspartate residues mutated to either glutamate or alanine 
to mimic phosphorylation states of the histidine kinase (Table 4.1). We expect 
that the His-Ala change would mimic a histidine kinase that is always de-
phosphorylated or whose function is always off. Changing Asp residues to Glu in 
the other hand would mimic a system in which the receiver domain of the HK is 
always phosphorylated and potentially could result in the constitutive expression 
of the genes regulated by the system. Epistasis analysis using strains containing 
mutated His and Asp residues would allow the characterization of the signal 
transduction pathway that MA4377 regulates. We have also identified a 
pyrrolysine containing HK (MA0863), to investigate the role of the Pyl residue in 
MA0863 function; we mutated the residue to lysine (Table 4.1). To test the effect 
this mutation has on the cells we could preform a qPCR probing for the 
expression of the mts genes. Finally we would like to assay the kinase and 
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phosphatase activities of the putative HKs and their ability to transfer phosphate 
groups to the proposed response regulator MA4376.  
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